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Chromatin Biology
Nearly every cell that constitutes a metazoan organism shares a copy of its genetic 
information. However, every cell type expresses a unique set of genes, also referred to as the 
transcriptional program of the specific cell type. Cell type-specific transcriptional programs 
lead to diverse phenotypes observed for different cell types. As the genetic information is 
similar in all these cell types, transcriptional diversity has to be regulated on a different level. 
It is now appreciated that transcription is regulated by the interplay of transcription factors 
and the compaction of DNA (Margueron et al., 2005). DNA is compacted together with histone 
proteins to form chromatin and this is stored within the nucleus of a cell. The compaction of 
chromatin and post-translational modifications (PTMs) on histones influence accessibility of 
underlying genes and thereby regulate transcription of these genes (Campos and Reinberg, 2009). 
Additionally, proteins interact with the histone PTMs and these proteins can both activate 
or repress transcription (Musselman et al., 2012). Chromatin compaction, histone PTMs and the 
interacting proteins are important for transcriptional regulation and therefore they are also 
thought to be important in the specification of cell type specific transcriptional programs. 
However, the molecular mechanisms of transcriptional regulation by histone PTMs and their 
interacting proteins are not fully understood. 
DNA and Chromatin
The dogma linking deoxyribonucleic acid (DNA) to genetic information only became 
apparent in the forties and fifties of the last century (Avery et al., 1944; Hershey and Chase, 1952). 
This observation was strengthened by the work of Watson and Crick as well as of Franklin 
and Gosling that DNA is build out of two strands which are structured as a double helix 
(Franklin and Gosling, 1953; Watson and Crick, 1953a) (Fig. 1). As the two strands are complementary, 
DNA is the perfect media for safe storage of genetic information (Watson and Crick, 1953b). 
DNA is not found in isolation inside cells, but it instead interacts with many proteins. 
Both DNA and histone proteins were isolated from the cell nucleus by the 19th century 
(Miescher, 1871; Kossel, 1884). These findings, as well as the characteristic staining of the nuclear 
interior, led Flemming to term this nuclear substance ‘chromatin’ (Flemming, 1882), a term 
still commonly employed nowadays to refer to the DNA-histone complex. Histone proteins 
were initially thought to act in a purely structural manner to compact DNA. However by 
the 1950s, histones were suspected to have a negative regulatory function on transcription 
(Stedman, 1950; Huang and Bonner, 1962). Two decades later it was shown that chromatin could 
be transcribed and histones could not be solely considered as repressors (Cedar and Felsenfeld, 
1973). Further studies by Kornberg and coworkers later demonstrated that DNA associates 
with histone multimers to form the nucleosome (Kornberg and Thomas, 1974). The model was 
later refined to the currently accepted configuration, being an octamer of histone proteins 
wrapped in 147 base pairs of DNA as identified by x-ray structures of the nucleosome 
(Richmond et al., 1984; Luger et al., 1997). Nucleosomes are now appreciated to be the fundamental 
repeating units of chromatin, whose primary structure is described as ‘beads on a string’ 
(Olins and Olins, 1974). The latter further compacts into the 30 nm fiber and more complex 
higher-order structures (Gall, 1966) (Fig. 1). 
Histone Modifications
Histones not only function as DNA packaging scaffolds, but also possess regulatory functions 
that modulate a number of processes involving DNA. The first line of evidence to this effect 
came from the apparent correlation between histone acetylation and transcription (Allfrey 
et al., 1964). Further research showed that it was specifically the N-terminal histone tails 
protruding from the nucleosome that are needed for gene expression activation (Durrin et 
al., 1991). Eventually, this led to the seminal work of Allis and coworkers, which showed that 
the conserved transcriptional regulator protein Gcn5 acetylates specific lysine residues on 
histones. The observation directly connected for the first time histone acetylation with 
transcriptional activation (Brownell et al., 1996; Kuo et al., 1996). This notion was further supported 
by the fact that perturbation of histone deacetylates deregulated gene silencing and 
expression (Rundlett et al., 1996).
This revolutionary work inspired others to study a wide array of histone post-translational 
modifications (PTMs) and their putative biological functions (Table I). The current repertoire 
of histone marks entails at least 130 PTMs (Tan et al., 2011). The best studied modifications are 
methylation, acetylation and ubiquitylation of lysines, as well as phosphorylation of serines, 
threonines and tyrosines (Kouzarides, 2007). The correlation between histone acetylation and 
transcriptional activation, described above, has been observed for acetylation on multiple 
DNA
Nucleosome
beads-on-a-string
30 nm fiber
Figure 1. Schematic representation of chromatin compaction. DNA is wrapped around histones to form 
nucleosomes that assemble in nucleosomal strings which compact in the 30 nm fiber and more complex higher-
order structures.
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histone tail residues (Spencer et al., 1997; Grant et al., 1999; Suka et al., 2001). This also paved the way 
for additional studies examining the effect of other modifications on transcription regulation. 
Interestingly, histone lysine methylation is implicated in both transcription activation and 
repression. H3K4me3 typically marks active promoters (Bernstein et al., 2002; Santos-Rosa et al., 
2002; Ng et al., 2003), whereas H3K36me3 (Xiao et al., 2003; Carrozza et al., 2005; Keogh et al., 2005) and 
H3K79me2 (van Leeuwen et al., 2002) can be found on gene bodies of active genes. On the other 
hand, H3K9 methylation (Aagaard et al., 1999; Nakayama et al., 2001), H3K27 methylation (Cao et al., 
2002; Czermin et al., 2002; Kuzmichev et al., 2002; Muller et al., 2002) and H4K20 methylation (Schotta 
et al., 2004) are all correlated with repressive chromatin. Ubiquitination is mostly studied in 
the context of H2AK119 and H2BK120 (H2BK123 in yeast), which show opposite regulation 
of transcription. H2AK119ub is clearly associated with transcription repression (Wang et al., 
2004; Cao et al., 2005), whereas H2B ubiquitination is linked with active gene expression and 
is even required for the deposition of other active methylation marks (H3K4 and H3K79 
methylation) (Briggs et al., 2002; Sun and Allis, 2002; Pavri et al., 2006). Phosphorylation is mainly 
implicated in DNA repair and mitosis. Among others, H3S10 (Fischle et al., 2005) and H3T3 (Dai 
et al., 2005) phosphorylation occur during condensation of chromosomes. In DNA repair, the 
best studied phosphorylation events are that of H2A.X (van Attikum et al., 2004) and H2AS129 
(Downs et al., 2000), which are important for the recruitment of DNA repair factors, and H4S1 
which stabilizes the nucleosomes at the DNA break (Cheung et al., 2005). 
The modifications occur on many different residues and are therefore not intrinsically 
mutually exclusive. This notion inspired Allis and coworker to develop the so-called ‘histone 
code hypothesis’ in which the combination of histone modifications specify a functional 
outcome (Strahl and Allis, 2000).
DNA Methylation
In parallel to the discovery of the regulatory function of histone modifications, it was 
discovered that DNA itself can also be modified. Methylation of DNA was first described on 
cytosine bases from calf thymus DNA (Hotchkiss, 1948). In mammals, DNA methylation mainly 
occurs on cytosine-bases. Pioneering work from Bird and co-workers identified cytosine-
guanine rich islands (CpG islands) that were either fully methylated or unmethylated 
(Bird, 1978; Bird and Southern, 1978). Due to the symmetrical methylation of the palindromic 
CG dinucleotides, the methylation mark is transmitted via a single parental strand to the 
daughter strands during replication (Bird, 1978). Importantly, DNA methylation was shown 
to inhibit transcription in vitro (Keshet et al., 1985). Interestingly, imprinted genes, i.e. genes 
that show preferentially maternal or paternal expression, are methylated on the inactivated 
allele (Cattanach and Kirk, 1985). This raised the hypothesis that DNA methylation inactivated one 
of the parental genes, causing allele specific expression. Eventually, Jaenisch and co-workers 
showed that DNA methyltransferase deficient mice expressed the normally parentally 
methylated and inactive H19 allele, proving the transcriptionally repressive function of DNA 
methylation in vivo (Li et al., 1993). 
After these groundbreaking observations, it became apparent in the last decade that the 
definition of DNA methylation as a repressive mark was too general (Jones, 1999, 2012; Spruijt 
and Vermeulen, 2014). The first refinement to make is the localization of the methylation mark. 
Promoter methylation is mainly associated with transcriptional repression, whereas gene 
body methylation correlates with active gene expression (Hellman and Chess, 2007; Lister et 
al., 2009). Enhancer methylation seems to be more promiscuous and cell-type dependent 
(Schmidl et al., 2009; Stadler et al., 2011).  Initial reports showed loss of binding of DNA sequence-
specific TFs upon DNA methylation, but recent proteomics studies identified additional DNA 
methylation specific interactors (Hu et al., 2013; Spruijt et al., 2013). The second refinement came 
from studies identifying specific developmental time points at which promoter methylation 
is uncoupled from repression (Bogdanovic et al., 2011; Hammoud et al., 2014). Therefore, the 
repressive potential of DNA methylation is also restricted in time.
Modiﬁcation Modiﬁed residue Implication in Reference 
Acetylation H3K9 Transcriptional activation  (Spencer et al., 1997) 
H3K14 Transcriptional activation (Spencer et al., 1997) 
H3K18 Transcriptional activation (Grant et al., 1999) 
H3K27 Transcriptional activation (Suka et al., 2001) 
H4K16 Transcriptional activation (Kuo et al., 1996) 
Methylation H3K4 Transcriptional activation (Bernstein et al., 2002; Santos-Rosa et al., 2002; Ng et 
al., 2003) 
H3K9 Transcriptional silencing (Aagaard et al., 1999; Nakayama et al., 2001) 
H3K27 Transcriptional silencing (Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 
2002; Muller et al., 2002) 
H3K36 Transcriptional activation (Xiao et al., 2003; Carrozza et al., 2005; Keogh et al., 
2005) 
H3K79 Transcriptional activation (van Leeuwen et al., 2002) 
H4K20 Transcriptional silencing (Schotta et al., 2004) 
Ubiquitination H2AK119 Transcriptional silencing (Wang et al., 2004; Cao et al., 2005) 
H2BK120 Transcriptional activation (Briggs et al., 2002; Sun and Allis, 2002; Pavri et al., 
2006) 
Phosphorylation H2AS129 DNA repair (Downs et al., 2000) 
H2A.XS139 DNA repair (van Attikum et al., 2004) 
H3T3 DNA condensation (Dai et al., 2005) 
H3S10 DNA condensation (Fischle et al., 2005) 
H4S1 DNA repair (Cheung et al., 2005) 
Table I. Histone modiﬁcations and their implications in processes involving DNA
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Histone Variants
In addition to modifications of DNA and histone tails, there are also multiple different 
histone variants that differ in their amino acid sequence from canonical histones and can 
also be incorporated in nucleosomes. The first variant that was discovered was the H2A 
variant macroH2A, which is specifically incorporated in the nucleosomes of the inactivated 
X-chromosome (Costanzi and Pehrson, 1998). macroH2A is linked to transcriptional repression and 
is localized on the inactivated X-chromosome and a subset of inactive genes on autosomes. 
Another H2A variant, H2A.Z, was found to be important and critical in mammalian 
development (Faast et al., 2001). It is primarily localized on promoters of genes independent 
of their transcriptional activity (Raisner et al., 2005) and seems to mark lineage-specific genes 
in development (Creyghton et al., 2008). H3.3, a variant of histone H3, was discovered to mark 
active chromatin (Ahmad and Henikoff, 2002). In subsequent experiments, the activity of H3.3 
marked genes was even shown to be inherited after nuclear transfer in an H3.3-dependent 
manner (Ng and Gurdon, 2005, 2008). Besides these transcriptional regulatory functions, histone 
variants are also reported to function in DNA repair and centromere formation, namely 
H2A.X (Fernandez-Capetillo et al., 2003) and CENP-A (Howman et al., 2000), respectively. 
Modern Epigenetics 
The regulatory function of histones and DNA methylation in gene expression led to a 
revolution in the field of epigenetics. The term ‘epigenetics’ was introduced by Waddington 
in 1942 to explain different phenotypic outcomes arising from the same genotype: “between 
genotype and phenotype, and connecting them to each other, there lies a whole complex 
of developmental processes” (Waddington, 2012). Since DNA was identified as the carrier of the 
genotype, epigenetics could be described in molecular detail as “the study of mitotically 
and/or meiotically heritable changes in gene function that cannot be explained by changes 
in the DNA sequence” (Russo et al., 1996).
Histone variants, histone PTMs and DNA methylation shape the transcriptional landscape 
and can be heritably transmitted through mitosis and/or meiosis (Bird, 1978; Ng and Gurdon, 2008; 
Hathaway et al., 2012). They can therefore be seen as carriers of epigenetic information. It should, 
however, be noted that there is no evidence for a heritable role in transcriptional regulation 
for every single histone variant and PTM. Therefore, chromatin marks cannot be defined 
as epigenetic marks in general, but a subset of marks are epigenetic as described above 
(Hathaway et al., 2012; Audergon et al., 2015; Ragunathan et al., 2015). The most recent amendment to 
the term ‘epigenetics’ includes a separation of the epigenetic maintenance system from the 
initiator cue, meaning that the epigenetic state is maintained in the absence of the initial 
stimulus (Berger et al., 2009) (Fig. 2).
Epigenetic Initiation and Maintenance
The epigenetic model emphasizes the important role of DNA sequence-specific transcription 
factors (TFs) that are able to activate or repress transcription (Fig. 2 – step 1). Transcriptional 
activation is dependent on the recruitment of general transcription factors, whereas 
repression requires the recruitment of (co-)repressor complexes (Fig. 2 – step 2). One of 
the first TFs that was reported to mediate gene expression was MyoD. In a series of papers, 
MyoD was shown to force conversion of fibroblasts to myoblasts by binding specific targets 
in the genome (Davis et al., 1987; Tapscott et al., 1988; Lassar et al., 1989; Weintraub et al., 1989). Ever since 
these observations, TFs are a prime research area. The discovery of Takahashi and Yamanaka 
that a set of only four TFs can reset the epigenome to a pluripotent state, represents one of 
the most fascinating examples of the importance of TFs, as their work showed that (Takahashi 
and Yamanaka, 2006).
Once the epigenetic state is initiated, the state is maintained and faithfully replicated 
by self-propagating systems (Fig. 2 – step 3). The maintenance of DNA methylation is 
TF binding
Chromatin modifier recruitment and deposition of marks
Maintanance of the epigenetic state
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Figure 2. The modern model for epigenetics. The epigenetic state is initiated by a DNA sequence-specific 
transcription factors that recruits co-factors to change the epigenetic marks. Once the initial stimulus is gone, the 
epigenetic state is maintained.
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better understood compared to other epigenetic factors. The DNMT1 protein is mainly 
responsive for the maintenance and replication of the mark. DNMT1 shows preference 
for hemimethylated DNA (Hermann et al., 2004), a product found at newly replicated DNA. Its 
expression peaks during S-phase (Robertson et al., 2000) and it can associate with the replication 
fork via interactions with PCNA (Chuang et al., 1997). Thereby, it is found at the right spot at the 
right moment to copy the hemimethylated pattern to a full, symmetrical mark. 
The transmission of histone variants and histone PTMs through replication is far less 
understood. The mechanism cannot be as straightforward as for DNA methylation, because 
existing ‘parental’ histones have to be evicted in front of the replication fork and distributed 
over the two daughter strands. New histones lacking most PTMs are interspersed between 
parental histones. There is however evidence for self-propagation of PTMs on chromatin 
from parental to newly synthesized histones. The first chromatin mark reported to be self-
propagating is histone 3 lysine 9 (H3K9) methylation that recruits the protein HP1, which in 
turn recruits the enzyme Suv39H1 (Bannister et al., 2001; Lachner et al., 2001; Nakayama et al., 2001). 
Suv39H1 has catalytic activity for H3K9 methylation and can spread this mark to neighboring 
nucleosomes. In line with these findings, another heterochromatin mark was shown to have 
a similar maintenance system. Histone 3 lysine 27 trimethylation (H3K27me3) is catalyzed 
by the polycomb repressive complex 2 (PRC2),  which consists of both a subunit (EED) with 
affinity for this mark and the enzyme (EZH1/2) catalyzing the mark  (Hansen et al., 2008; Margueron 
et al., 2008; Margueron et al., 2009). By reading and catalyzing the same histone PTM, this feed-
forward loop can spread and maintain the associated epigenetic state. Interestingly, H3K9 
methylation was recently reported to be inherited through mitosis and meiosis (Hathaway 
et al., 2012; Audergon et al., 2015; Ragunathan et al., 2015), supporting the epigenetic character of 
histones and their PTMs.
Chromatin Interactors
Chromatin interactors are important to accurately preserve and read an epigenetic state. 
These chromatin-binding proteins can be divided in three different groups: The chromatin 
interactors with enzymatic activity to introduce chromatin marks can also be referred to 
as ‘writers’, whereas chromatin-binding enzymes that remove these marks can be called 
‘erasers’. The final category of chromatin interactors do not catalyze the modification of 
chromatin and can be classified as ‘readers’. It should be noted that numerous proteins 
function in protein complexes and these complexes can combine reading, writing and/or 
erasing capabilities.
Important writers include histone acetyltransferases (HATs) and methyltransferase (HMTs). 
Interestingly, HATs tend to be less residue specific than HMTs (Kouzarides, 2007). For example, 
the MLL and SET1  proteins only methylate H3K4 (Briggs et al., 2001; Milne et al., 2002) and G9A 
only catalyzes H3K9 methylation (Tachibana et al., 2001), whereas GCN5 mainly acetylates 
multiple lysines on H3 (Kuo et al., 1996; Sterner and Berger, 2000). This specificity is also in line 
with the differential biological functions of different methylation marks, as described above. 
Erasers of histone methylation are the so called histone demethylases (HDMs), which also 
tend to be residue specific in contrast to the erasers of histone acetylation, called histone 
deacetylases (HDACs) (Kouzarides, 2007).
DNA methylation can be catalyzed by DNMT1, DNMT3A and DNMT3B, of which DNMT3A 
and DNMT3B are thought to be de novo methylases whereas DNMT1 is considered to 
be the maintenance methylase as described above (Bestor et al., 1988; Okano et al., 1998). The 
DNA demethylation pathways are less well understood. DNA demethylation can occur 
passively by constraining methylation of hemimethylated DNA which is the product of DNA 
replication. However, recently active demethylase activity has been reported. The first clue 
came from the discovery of the oxidation of methylcytosine (mC) to hydroxymethylcytosine 
(hmC), which is catalyzed by the ten-eleven-translocation (TET) proteins (Tahiliani et al., 2009; 
Ito et al., 2010). Subsequently, it was reported that TET proteins can further oxidized hmC to 
formyl- and carboxycytosine (fC and caC, respectively) (He et al., 2011; Ito et al., 2011). These 
oxidized products are recognized by TDG, a DNA glycosylase, which is responsible for base 
excision (Cortazar et al., 2011; Cortellino et al., 2011). The resulting abasic site is identified by the 
DNA repair machinery and is repaired via base excision repair to an unmethylated residue.
Bridging the Epigenome and Phenotype: Chromatin Readers
A subset of chromatin marks can directly stabilize or weaken histone-DNA contacts and 
thereby alter the structure of chromatin. An example of such a mark is H4K16 acetylation, 
for which it was shown to inhibit the formation of higher-order structures such as the 30 
nm fiber (Shogren-Knaak et al., 2006) (Fig. 1). Other marks, such as DNA methylation or lysine 
methylation, do not weaken histone-DNA contacts. This category of marks is dependent on 
appropriate proteins that ‘read’ the marks to orchestrate a biological response. 
Chromatin marks serve as docking sites for readers that harbor specific protein domains. The 
first discovered histone PTM-interacting domain was the bromodomain, which has a strong 
affinity for acetylated lysines (Dhalluin et al., 1999). Quickly after this initial study, many other 
readers-domains have been characterized (Musselman et al., 2012). Noteworthy is the so-called 
royal family that utilizes aromatic cages to capture methylated residues. This family includes 
the PHD domain with affinity for methylated H3K4 (Li et al., 2006; Pena et al., 2006; Shi et al., 2006; 
Wysocka et al., 2006) and H3K9 (Lan et al., 2007; Ooi et al., 2007) or unmodified H3K4 (Iwase et al., 2007; Li 
et al., 2008), the chromodomain which recognizes H3K9 and H3K27 methylation states (Bannister 
et al., 2001; Fischle et al., 2003b; Min et al., 2003), the WD40 domain which has affinity for H3K9 
and H3K27 methylation (Margueron et al., 2009; Xu et al., 2010a) but also for methylated arginines 
(Migliori et al., 2012), and finally the PWWP domain which can bind to methylated H3K36, 
H3K79 and H4K20 (Wang et al., 2009b; Vezzoli et al., 2010). DNA methylation binding proteins used 
to be restricted to the family of proteins containing the methyl-binding domain (MBD), of 
which methyl-CpG binding protein (MeCP-1) was the founding member (Boyes and Bird, 1991). 
However, a decade later, zinc-finger domains in Kaiso-like proteins (Prokhortchouk et al., 2001) 
and SRA domains in UHRF proteins (Unoki et al., 2004) were also reported to preferentially bind 
to methylated DNA. More recently, the number of mC interactors has increased drastically 
(Hu et al., 2013; Spruijt et al., 2013; Spruijt and Vermeulen, 2014).
While the ‘reader’ domains of a protein define the chromatin-protein interaction, additional 
domains and protein-protein interactions will help dictate the functional outcome of this 
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binding. From a transcriptional perspective, readers have been identified that function as 
basal transcription factors, co-activators and co-repressors. As previously mentioned, H3K9 
methylation (Bannister et al., 2001; Lachner et al., 2001; Nakayama et al., 2001) and K27 methylation 
(Hansen et al., 2008; Margueron et al., 2008; Margueron et al., 2009) recruit repressive complexes that 
contain methylase activity for the exact same mark. H3K4me3 recruits TAF3 a subunit of 
the basal transcription factor complex TFIID, which initiates transcription (Vermeulen et al., 
2007) and this is clearly in line with the occurrence of H3K4me3 on active promoters. The 
repressive, deacetylase Rpd3 complex has affinity for H3K36me3 and is thought to repress 
intragenic transcription (Carrozza et al., 2005; Keogh et al., 2005). Interestingly, the Tip60 acetylase 
complex was recently reported to bind the enhancer mark H3K4me1 and at these enhancer 
elements the complex could enhance transcription (Jeong et al., 2011).
It is however important to stress that such general correlations are context specific. 
Modifications can also recruit readers with opposite output, H3K4me3 for example can also 
be bound by ING2 of the Sin3 complex, which is transcriptional repressive (Shi et al., 2006). 
Acetylated histones are mainly bound by bromodomain containing proteins, the so-called 
BRD family. This family comprises 46 members which all act as transcriptional regulators. 
Although they all bind acetyl groups, a mark generally associated with transcriptional activity, 
these proteins are not exclusively associated with active gene expression (Filippakopoulos et al., 
2012).
Among the BRD family are the BET proteins, BRD2, BRD3, BRD4 and Brdt, which are 
implicated in transcriptional activation. Interestingly, small molecules have been generated 
that block the interaction between acetylated histone tails and the BET proteins, representing 
the first chromatin reader drugs (Filippakopoulos et al., 2010; Dawson et al., 2011). Besides small 
molecules targeting reader domains, multiple drugs are in development or even already 
FDA approved targeting chromatin writers and erasers (Dawson and Kouzarides, 2012). These 
recent developments highlight the huge potential of drugs targeting chromatin factors, the 
so called epidrugs.
Outline of the thesis
In this thesis, we aim to better characterize chromatin and its interactors in order to get 
a better understanding of the molecular mechanisms of their function in transcriptional 
regulation. We use quantitative mass spectrometry-based proteomics for the comprehensive 
study of proteins, their modifications and their interactions. To set the stage for the mass 
spectrometry-based studies on chromatin, an introduction is given in the biology of 
chromatin and epigenetics (Chapter 1). Subsequently, mass spectrometry and the workflows 
used to study proteins involved in chromatin biology are introduced (Chapter 2).
Mass spectrometry-based proteomics can be used to identify protein-protein interactions 
(PPIs). State-of-the-art proteomics workflows detect high-confidence PPIs, however 
they lack information on the abundance of these interactions. To add this quantitative 
dimension, we incorporated the intensity-based absolute quantification (iBAQ) algorithm 
in our PPI screens (Chapter 3). This allowed us to distinguish core from substoichiometric 
protein complex subunits for the NuRD and PRC2 complexes. The relative abundance of 
proteins within one complex also gives a measure of the protein stoichiometry, which is 
highly valuable for structural biologists.
Once this methodology was established, we used it to study a set of SET1/MLL complexes, 
which catalyze methylation of histone H3 lysine 4 (Chapter 4). These complexes have a 
shared core of four subunits, but they differ in their additional, peripheral subunits. With 
our workflows, we were able to dissect the exact complex compositions and could pinpoint 
preferential interactors for some of the peripheral subunits.
Many affinity purification workflows, such as the GFP-fusion system we use, are based 
on epitope tagging. However, these protein or peptide tags can weaken or even abolish 
interactions between the tagged protein and its protein interactors or DNA target. To 
circumvent this problem, we set up a novel protein-enrichment workflow based on genetic 
incorporation of unnatural amino acids (UAA) and bioorthogonal chemistry  (Chapter 5). 
The feasibility of this workflow was shown by the enrichment of MBD3, a NuRD complex 
subunit. Using the current reaction conditions and incorporation site of the unnatural amino 
acid, we could identify two MBD3 interactors.
The eviction of histones from chromatin and deposition of histones onto chromatin is 
dependent on histone chaperones. In Chapter 6, we used interaction proteomics to obtain 
a comprehensive interactome of H3.1, the replication-coupled histone H3 variant. The 
interactions are distinct for different cellular compartments and could be dissected into 
twenty separate complexes. The complexes contain eleven different histone chaperones 
that have distinct functions through the course of DNA replication in histone processing, 
deposition, eviction and repair.
Finally, the work described in this thesis is discussed and a perspective is given on the 
future directions of proteomics to study chromatin biology (Chapter 7). As this thesis covers 
methodological advancements in interaction proteomics that provide novel perspectives on 
biology, this chapter will mainly focus on, what I envision as, the next steps in quantitative 
interaction proteomics.
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Abstract
In recent years, quantitative mass spectrometry-based proteomics has proven itself as a 
powerful technology to study chromatin structure and function in eukaryotic cells. Multiple 
methodologies have been developed which enable a comprehensive identification of 
chromatin readers and the characterization of the dynamic protein complexes these readers 
assemble in. These advancements in technology have made a big impact in the field of 
chromatin biology and have led to new fundamental insights. In this chapter, we will discuss 
the quantitative mass spectrometry-based methodologies used for identification and 
characterization of chromatin readers and the new biological insights that these approaches 
have generated.
Introduction
During the last two decades, our molecular understanding of chromatin structure and 
function has increased tremendously. Nucleosomes, which form the basic repeating unit 
of chromatin, were previously thought to merely serve for compaction and storage of 
DNA inside eukaryotic cells. This view has radically changed and nucleosomes are now 
appreciated to actively regulate nuclear processes such as replication, transcription and 
DNA repair. Chromatin-associated proteins, which interact with nucleosomes and some of 
which can modify them, form a major downstream target in signal transduction pathways 
and chromatin therefore plays a central role in cell cycle control and mitosis, growth 
factor signaling and in stress response pathways. Fundamental in these processes are the 
nucleosomes and the post-translational modifications (PTMs) on the N-terminal histone tails 
that protrude from the nucleosome. These tails are subjected to a large number of PTMs, 
such as acetylation, phosphorylation, methylation and ubiquitination (Kouzarides, 2007) (Fig. 
1). In addition, the DNA itself can be modified through (hydroxy)methylation of cytosine 
residues (Fig. 1). These modifications can affect gene expression and cellular phenotype, 
and modification patterns can be inherited from mother to daughter cells. Histone PTMs 
and DNA (hydroxy)methylation therefore provide epigenetic information which, together 
with genetic information embedded in DNA, determines the phenotype of a eukaryotic cell 
or organism. 
One of the major downstream functions of histone PTMs is the recruitment or stabilization 
of effector proteins which are also called ‘readers’ (Campos and Reinberg, 2009) (Fig. 1). The 
biological function of these readers often correlates to the biology of the epigenetic mark 
they bind to; indicating that the ‘reading’ function of epigenetic modifications is rather 
important (Taverna et al., 2007). Identifying and characterizing chromatin readers and the 
(dynamic) protein complexes that these readers assemble in is therefore crucial to further 
our understanding of epigenetic modifications and their role in determining gene expression 
and cell fate. We have recently developed and applied a number of methods based on 
quantitative mass spectrometry-based proteomics technology that can be used to identify 
and characterize chromatin readers. In this chapter the workflow and methodology behind 
these methods as well as the biological insights that these approaches have generated will 
be discussed in detail. 
Quantitative mass spectrometry-based proteomics to decipher the chromatin interactome 
As mentioned above, core histones are subjected to a large number of PTMs, such as lysine 
acetylation and lysine and arginine methylation (Kouzarides, 2007). Most of these site-specific 
modifications are associated with particular functional chromatin states. For example, 
trimethylation of histone H3 on lysine four (H3K4me3) is associated with promoters 
of genes that are being actively transcribed. In contrast, H3K27me3 is associated with 
transcriptional repression. Similarly, ubiquitination of H2B at lysine 120 is linked to activation 
of transcription, whereas H2A ubiquitination at lysine 119 is linked to gene repression (Weake 
and Workman, 2008). Other modifications, such as phosphorylation of H3S10 and H3S28 are 
important for mitosis, whereas tyrosine phosphorylation of the histone variant H2A.X plays 
an important role in the DNA damage response (Xiao et al., 2009). In order to understand the 
molecular mechanisms underlying these associations, it is essential to characterize the 
proteins and protein complexes that specifically interact with the epigenetic modifications. 
Several domains capable of binding selectively to a particular histone modification have 
recently been described. Examples include the chromodomain of heterochromatin protein 
1 (HP1) which binds to H3K9me3 (Bannister et al., 2001; Lachner et al., 2001) and the PHD finger of 
the chromatin remodeling factor BPTF, which recognizes H3K4me3 (Li et al., 2006). 
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Figure 1. Graphical representation of chromatin structure and chromatin-associated complexes. Nucleosomes 
form the basic repeating unit of chromatin and both the histone tails and the DNA can be modified. The chromatin 
can be specifically bound by ‘readers’ that have a strong affinity for either the modified or the non-modified 
molecule. These readers assemble in protein complexes.
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Current state-of-the-art in quantitative MS-based interactomics
To identify interactions between proteins and histone PTMs, several approaches have been 
developed during the last couple of years. For example, candidate chromatin ‘reading’ 
domains can be expressed recombinantly and immobilized on arrays which are subsequently 
incubated with modified histone peptides, a method that was pioneered by the Bedford 
lab (Kim et al., 2006). The disadvantage of this approach is that it is not unbiased but based 
on a selection of candidate domains that are then screened for putative interactions 
with modified histone peptides. To identify interactions with histone modifications in an 
unbiased manner, researchers typically make use of in vitro synthesized modified and 
non-modified histone peptides in pull-down experiments from crude nuclear or whole 
cell lysates. Following incubation and washes, proteins bound to the modified and non-
modified immobilized histone peptide are then resolved using a SDS-PAGE gel and mass 
spectrometry is applied to identify the proteins in both samples (Wysocka, 2006). However, 
identifying specific interactors in pull-downs from crude lysates is far from trivial since these 
interactions are usually masked by a large amount of high-abundant background proteins. 
In particular when making use of modern mass spectrometers, which are very sensitive 
and capable of sequencing thousands of peptides in complex samples in a matter of hours, 
researchers end up with a long list of identified proteins in the control and specific pull-down 
and it is often not immediately evident which are the PTM specific binders. This approach 
therefore demands a quantitative filter that can be used to discriminate high abundant 
background proteins from specific interactors. In recent years, several methodologies have 
been developed that add a quantitative dimension to mass spectrometry measurements. 
Most of these methods rely on the introduction of stable isotopes in the proteins or peptides 
that are analyzed. This can be achieved through metabolic labeling during cell culture, the 
most popular method of which is called SILAC (stable isotope labeling by amino acids in 
cell culture) (Ong et al., 2002) or by chemical labeling at the protein or peptide level (Eberl et al., 
2011). Differential labeling of proteins or peptides with ‘light’ and ‘heavy’ isotopes allows for 
a quantitative comparison of peptide and protein abundance between two experimental 
conditions. Prior to mass spec analysis, the light and heavy samples are combined. As a 
result, every peptide that is identified in the mass spectrometer has a light and a heavy 
peak and the ratio between these two peaks, which can be quantified using automated data 
analysis software, reveals the relative abundance of that peptide and the corresponding 
protein in the two different samples. 
Identification of Histone PTM Readers
In the context of PTM-dependent interactions, this quantitative filtering principle can also be 
applied. In this approach, in vitro synthesized peptides that are either unmodified or carry 
the PTM of interest are immobilized on a solid resin (Fig. 2). These peptides are separately 
incubated with light or heavy labeled extracts. Following washes, beads from both pull-
downs are combined and bound proteins are analyzed by LC-MS/MS. The quantitative 
abundance ratio of every peptide and corresponding protein in the mass spectrometer 
indicates whether this protein is a background protein (H/L ratio close to 1) or a specific 
reader of the PTM (H/L ratio significantly deviating from 1). This method was first applied to 
identify phospho-tyrosine dependent interactions in signal transduction pathways (Schulze and 
Mann, 2004). We adapted this approach to identify specific interactions with H3K4me3 using a 
SILAC-based histone peptide pull-down approach and discovered that the basal transcription 
factor TFIID binds to this mark with a high affinity (Vermeulen et al., 2007). This discovery is highly 
relevant given the genome-wide correlation between H3K4me3 and active promoters. The 
interaction is mediated via a PHD finger in the C-terminus of the TAF3 protein and the Kd 
is ~0.16 micromolar, stronger than any of the other reported interactions with H3K4me3 
(Vermeulen et al., 2007). Interestingly, the TFIID complex also contains a subunit (TAF1) that 
harbors a double bromodomain. Bromodomains specifically interact with acetylated lysines 
(Dhalluin et al., 1999). Given the general co-occurrence of H3K4me3 and acetylation of certain 
lysine residues such as lysine 9 and 14 of histone H3 on active promoters, this implies a 
combinatorial agonistic recognition of these histone modifications by TFIID.
To investigate such potential cross-talk between modifications occurring in close proximity 
on histone tails, we made use of a so-called triple pull-down approach. Cells can be SILAC 
labeled with two different stable isotope-containing versions of heavy lysine and arginine 
(lysine 4 and 8; arginine 6 and 10). Together with a third culture labeled with light amino acids, 
this allows incubating three different immobilized histone peptides with three differentially 
SILAC labeled nuclear extracts. Every SILAC-labeled peptide in the mass spectrometer now 
appears as a triplet and the abundance of each of these three peaks indicates the relative 
affinity of that peptide and corresponding protein for each of the three baits. Using this 
approach, we were indeed able to show that H3K4me3 acts agonistically with H3K9 and 
H3K14 acetylation to anchor the TFIID complex on active promoters, which generally carry 
these modifications. Conversely, the triple pull-down approach was also used to show 
that another modification on the histone H3 tail, the asymmetric dimethylation of H3R2 
(H3R2me2a), acts to prevent TFIID from binding to H3K4me3. 
These initial encouraging observations led us to screen five major lysine trimethylation 
sites on histone H3 (H3K4me3, H3K9me3, H3K27me3 and H3K36me3) and H4 (H4K20me3) 
for novel readers (Vermeulen et al., 2010). In this study, in addition to performing the SILAC-
based histone peptide pull-down as described above (called a ‘forward’ pull-down), we 
also performed pull-downs using a SILAC label swap experiment in which the unmodified 
immobilized histone peptide is incubated with heavy SILAC labeled extract whereas the 
modified histone peptide is incubated with the light extract. This is called a ‘reverse’ pull-
down. In this setup, PTM specific readers that have a high ratio in the forward pull-down, for 
example a ratio of 10, will have a low ratio in the reverse experiment (0.1 ideally). Eventually 
all the identified and quantified proteins in the forward and reverse pull-downs are plotted 
against each other in a 2-dimensional plot. Background proteins cluster around the origin 
of the figure, whereas the PTM-dependent interactors group together in one quadrant. 
Similarly, non-SILAC labeled contaminants appear together in a single quadrant (low forward 
and low reverse ratio) and proteins for which binding to the peptide is abolished by the PTM 
also cluster (low forward ratio, high reverse ratio). Using this approach, we identified a large 
number of novel readers for each of the epigenetic trimethyl lysines on histone H3 and H4. 
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For example, we discovered that the human SAGA complex, which is a major transcripti onal 
co-acti vator complex, binds to H3K4me3 via a tudor domain in its subunit Sgf29. H3K9me3 
is mainly read by HP1 isoforms, Polycomb proteins and CDYL and CDYL2. Polycomb proteins 
also interact with H3K27me3, whereas proteins carrying a PWWP domain mainly recognize 
H3K36me3. Finally, the origin recogniti on complex interacts with H4K20me3. In fact, this 
protein complex reads all three repressive epigeneti c modifi cati ons (H3K9me3, H3K27me3 
and H4K20me3). In this study we further made use of the triple pull-down approach to 
show that the binding of TFIID, SAGA, PHF8 and BPTF to H3K4me3 is sti mulated by H3K9 
and H3K14 acetylati on. Apparently, multi ple proteins and multi -protein complexes have 
evolved to harbor a combinati on of domains that can specifi cally recognize these diff erent 
epigeneti c modifi cati ons that are commonly present on promoters of genes that are acti vely 
transcribed. The triple pull-down approach was also used to show that phosphorylati on of 
H3S10 and H3S28 selecti vely inhibits the binding of proteins to H3K9me3 and H3K27me3, 
respecti vely. Thus, multi ple micromolar affi  nity histone PTM interacti ons together with 
specifi c DNA interacti ons eventually result in a very high affi  nity interacti on of chromati n 
readers to their target genes. Furthermore, these interacti ons can be ‘tweaked’ by adding 
or removing a certain reader within the complex or by adding an inhibitory modifi cati on in 
close proximity to the trimethylated lysine residue. 
Identi fi cati on of DNA and Nucleosome Readers
The approach described above is not restricted to modifi ed pepti des but can also be used 
to identi fy specifi c DNA interacti ons (Mitt ler et al., 2009). In this case syntheti c bioti nylated and 
immobilized oligonucleoti des are used as baits in affi  nity pull-downs from nuclear extracts 
(Fig. 2). This method can be used to identi fy proteins binding to a parti cular transcripti on 
factor binding site or a single nucleoti de polymorphism that may be linked to a certain 
disease or phenotype (Butt er et al., 2010; Butt er et al., 2012). In the context of epigeneti cs, this 
method can also be used to identi fy proteins that specifi cally recognize methylated or 
hydroxymethylated DNA (Mitt ler et al., 2009; Spruijt et al., 2010; Bartels et al., 2011). 
Finally, complete in vitro reconsti tuted modifi ed nucleosomes can be used as affi  nity 
baits (Fig. 2). Using this approach one can investi gate histone PTM cross-talk between 
modifi cati ons occurring on diff erent core histones as well as studying the interplay between 
DNA and histone modifi cati ons (Bartke et al., 2010; Nikolov et al., 2011). In the future this approach 
can also be used to investi gate the combinatorial eff ects of transcripti on factor binding sites 
on DNA and PTMs on core histones. 
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Figure 2. Integrati on of the multi ple qMS-based interacti on screens. Specifi c ‘readers’ of (modifi ed) histone tails, 
DNA strands or nucleosomes can be identi fi ed using qMS, as described in the text. For further characterizati on, these 
readers are tagged with GFP using BAC TransgeneOmics. The interactors of GFP fusion proteins can be identi fi ed 
using two diff erent workfl ows; a SILAC-based AP-qMS can be used, in which GFP and WT cells are diff erenti ally 
isotopically labeled and nuclear extracts obtained from these cells are applied to GFP-AP, mixed aft erwards and 
analyzed by LC-MS/MS. Alternati vely, a label-free AP-qMS workfl ow can be applied, in which GFP and WT cells are 
both cultured in normal medium. Nuclear extracts from these cells are subjected to GFP-AP followed by LC-MS/
MS. Furthermore, the stoichiometry of the ‘reader’ complex can be determined using iBAQ-based calculati ons 
on label-free AP-qMS data. In additi on to its use in mass spectrometry-based workfl ows, the GFP tag can also 
be used for cellular localizati on studies using microscopy and genome-wide localizati on studies using chromati n-
immunoprecipitati on followed by deep sequencing (ChIP-Seq).
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Identification of protein-protein interactions
The approaches described in the previous section can be used to identify readers of 
epigenetic histone and DNA modifications. However, these experiments do not reveal any 
information about the protein complexes that these readers assemble in. Most cellular 
proteins perform their function in protein complexes, consisting of multiple stable core 
subunits and transient, substoichiometric interactors. Chromatin-associated proteins are no 
exception to this rule. Well studied chromatin-associated complexes, such as the Polycomb 
repressive complexes (PRC1 and PRC2) (Margueron and Reinberg, 2011), the nucleosome 
remodeling and deacetylase (NuRD) complex (Lai and Wade, 2011) and mixed lineage leukemia 
(MLL) complexes (Schuettengruber et al., 2011; Shilatifard, 2012), harbor multiple (dynamic) subunits 
with different chromatin binding domains and/or enzymatic activities towards histones and 
DNA. To understand the biological function of identified chromatin ‘readers’, it is therefore 
crucial to identify their protein-protein interactions (PPIs). These experiments also help to 
discriminate direct PTM-mediated interactions from indirect, PPI-mediated binding to an 
epigenetic modification. 
Current State-Of-The-Art
Mass spectrometry has recently become an important platform to comprehensively identify 
PPIs of proteins of interest. The earliest approaches relied on tandem affinity purification 
(TAP) of the bait protein and its interactors. Two introduced affinity tags were sequentially 
used for affinity purification under stringent washing conditions, leading to relatively 
pure protein complexes. These complexes were separated by SDS-PAGE gel and individual 
gel bands were cut out and identified by mass spectrometry (Gavin et al., 2006; Krogan et al., 
2006). However, mass spectrometers became extremely sensitive in recent years, and TAP 
tag purifications typically result in the identification of hundreds of proteins using the 
current state-of-the-art instrumentation and data analysis software, even if the complexes 
appear relatively pure on gel. To overcome this problem, novel quantitative approaches 
that have been introduced in the previous section were developed. In these approaches, 
affinity purified samples are compared to control samples in a quantitative manner and this 
enables separating background binders from specific interactors (Vermeulen et al., 2008). As a 
consequence, there is no need for extensive purification of protein complexes, allowing for 
single-step affinity purifications and less stringent washes. This facilitates the identification 
of transient, substoichiometric but potentially important interactors in addition to core 
complex subunits (Vermeulen et al., 2008).
To obtain a quantitative dimension in the mass spectrometric analyses, the earliest studies 
introduced stable isotope labels. As described above, this can be done in a chemical manner, 
in which peptides or proteins are chemically labeled, or in a metabolic manner, in which 
cells are grown in the presence of stable isotope labeled amino acids (Ong and Mann, 2005). 
Both chemical and metabolic labeling strategies allow the mixing of samples prior to mass 
spec analysis, thereby enabling direct comparison of peptide abundance. The disadvantage 
of peptide labeling approaches is that this mixing occurs later in the workflow, which may 
induce more handling errors (Ong and Mann, 2005). Recently, label-free quantification methods 
were developed in PPI screenings (Rinner et al., 2007; Sardiu et al., 2008; Sowa et al., 2009; Hubner et 
al., 2010; Choi et al., 2011). In these approaches, the obtained mass spectrometry intensities 
are used to compare protein levels in different mass spectrometry runs. However, label-
free quantification relies on more complex computational analyses compared to isotopic 
labeling, in which ratios can be directly derived from the light and heavy peptide pair. 
Therefore, label-free approaches are often slightly less accurate compared to stable isotope 
labeling approaches, although in large high-throughput datasets this lack of accuracy is 
compensated for by more robust statistics as a result of the large amount of samples. 
During the last couple of years, multiple affinity purification methods combined with 
quantitative mass spectrometry (AP-qMS) have been developed. Several of these 
approaches make use of endogenous antibodies against proteins of interest. In QUantitative 
Immunoprecipitation Combined with Knockdown (QUICK), a control immunoprecipitation 
experiment is performed in a lysate in which the protein of interest is knocked down using 
RNA interference (Selbach and Mann, 2006). The protein that is knocked down and its interaction 
partners have a quantitative abundance ratio deviating from the background population. 
Malovannaya and colleagues adopted endogenous AP-qMS using a large number of 
antibodies (>3000 IPs) against nuclear proteins, thereby identifying over ten thousand 
proteins and even more PPIs to define the nuclear ‘complexome’ (Malovannaya et al., 2011). 
In this approach, rather than using a control pull-down for each immunoprecipitation, the 
complete dataset serves as a control for each individual immunoprecipitation. Other AP-
qMS methods rely on the introduction of tags into proteins, such as FLAG (Sowa et al., 2009; Mak 
et al., 2010) and GFP (Poser et al., 2008). Importantly, workflows have been adapted such that PPIs 
can be detected in a gel-free manner and using a single LC-MS/MS run, thereby significantly 
increasing the throughput. A potential problem of tagging approaches is that these methods 
tend to result in an over-expression of the bait relative to the endogenous protein. This issue 
can be addressed by inducible expression systems that allow for a sophisticated fine tuning 
of expression levels (Glatter et al., 2009). An alternative is using BAC TransgeneOmics, in which 
GFP tagging of proteins in mammalian cells is accomplished at near endogenous level by 
bacterial artificial chromosomes (Poser et al., 2008). We used this approach to identify PPIs for 
chromatin readers of interest, as will be discussed in detail next. 
Assigning Chromatin Readers into Complexes
The SILAC-based workflow of AP-qMS using GFP-tagged nuclear proteins is optimized and 
thoroughly explained in recent methodology chapters (Smits et al., 2013; van Nuland et al., 2013). 
Briefly, cells expressing the fusion protein (GFP cells) and control cells (WT cells) without 
the fusion protein are differentially SILAC labeled (Fig. 2, Interactor identification – SILAC). 
Nuclear extracts obtained from these cells are applied to GFP-AP using GFP-nanotrap beads 
(Rothbauer et al., 2008) and mixed afterwards followed by on-bead trypsin digestion and LC-
MS/MS (forward experiment). A second experiment is performed in which the SILAC labels 
of the GFP and WT cells are swapped (reverse experiment). In both experiments, proteins 
that bind nonspecifically to the AP beads are found in similar levels in the WT and GFP 
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cells. Peptides derived from these proteins will show a one to one (1:1) ratio in the mass 
spectrometer. In contrast, the GFP tagged protein and its interactors will be more abundant 
in the GFP-AP compared to the WT pull-down and will have a ratio that is significantly 
deviating from the background population. 
This approach was extensively used to characterize the protein complexes harboring 
chromatin readers. In our comprehensive analyses of readers for trimethylated lysines on 
histone H3 and H4, many new interactors were discovered. Quite a few of these readers were 
previously uncharacterized proteins, which were not known to be involved in chromatin 
structure and function. One of these proteins, LRWD1, was found to have affinity for three 
transcriptionally repressive histone trimethyl lysine marks (H3K9me3, H3K27me3 and 
H4K20me3). Interestingly, these marks are also bound by the origin recognition complex 
(ORC), suggesting that LRWD1 may be a novel interactor of the ORC complex. Indeed, GFP 
tagging and purification of ORC2 revealed that LRWD1 is a direct interactor of this complex 
(Bartke et al., 2010; Vermeulen et al., 2010). Independently LRWD1 was also identified by others as 
a novel ORC complex subunit called ORCA (Shen et al., 2010). The same approach was used to 
identify two novel subunits of the human BPTF/NuRF complex. We also identified a large 
number of novel HP1 interactors, many of which carry zinc fingers such as POGZ and Znf828. 
These proteins may serve to recruit HP1 isoforms to target sites in the genome. 
The GFP-tag based purification can also be applied in a label-free approach (Hubner and 
Mann, 2011). In this method, GFP and WT cells are both cultured in normal medium after 
which nuclear extract preparation and GFP-AP MS are done separately (Fig. 2, Interactor 
identification – label-free). After raw data analysis, the normalized intensity of a protein 
is compared between the GFP-AP and the control. To quantitatively distinguish PPIs from 
background proteins an adapted t-test with a permutation-based false discovery rate (FDR) 
is performed using Perseus (MaxQuant software package (Cox and Mann, 2008)). A prerequisite 
of this t-test is that the specific and control pull-downs have to be performed at least in 
triplicate. We used this workflow to study PPIs of important chromatin-associated complexes. 
Purification of the PRC2 and MBD3/NuRD complex resulted in the identification of multiple 
novel interactors. For PRC2, these included two uncharacterized proteins, C17orf96 and 
C10orf12, which we hypothesize to affect PRC2 activity or play a role in recruiting PRC2 to 
target sites in the genome (Smits et al., 2013) . The NuRD complex interacts with multiple zinc 
finger proteins including ZMYND8 and Znf592 (Eberl et al., 2012; Smits et al., 2013). The function 
of these proteins is not well understood, but they were recently identified as a major 
transcriptional coregulator complex (Malovannaya et al., 2011). These results therefore establish 
a new link between the NuRD complex and regulation of transcription.
Label-free stoichiometry determination of PPIs
All of the above mentioned stable isotope labeling and label-free approaches provide high-
confidence PPI data. These experiments however, do not reveal any information about the 
stoichiometry of the detected interactions. The identification of core subunits is, of course, 
of major importance in order to determine the key affinities and enzymatic activities of the 
complex of interest. In order to obtain stoichiometry information, the relative abundance of 
interactors needs to be determined. In recent years, different strategies have been deployed 
to obtain (relative) quantification of the abundance of proteins in a particular sample (Wepf 
et al., 2009; Bennett et al., 2010; Schmidt et al., 2010). Many of these strategies rely on a spike-in of 
isotope labeled reference peptides of which the exact concentration is known. The use of 
these peptides is, however, expensive, not straightforward and it is not suitable for high 
throughput screening. In a recent study, the abundance of proteins was estimated using 
an algorithm that normalizes the sum of peptide intensities of a protein for the theoretical 
number of its tryptic peptides, so called intensity based absolute quantification (iBAQ) 
(Schwanhausser et al., 2011). Using this algorithm, it is now possible to combine label-free PPI 
identification with an estimation of the relative abundance of the protein of interest and 
its interactors (Smits et al., 2013). This facilitates the stoichiometry determination of protein 
complex subunits, by scaling one of the interactors, for example the GFP tagged protein, to 
1 (Fig. 2 – Stoichiometry determination). In a recent study, we applied this stoichiometry 
determination methodology to the PRC2 and NuRD complexes (Smits et al., 2013). To determine 
the MBD3/NuRD complex stoichiometry, we tagged MBD3 in HeLa cells and applied AP-qMS 
on nuclear extracts. The stoichiometry determination exposed a core complex of 1x CHD3/4, 
HDAC1/2 and MBD3, 2x GATAD2A/B and DOC1, 3x MTA1/2/3 and 6x Rbbp4/7. The newly 
identified zinc finger proteins Zmynd8 and Znf592 were found to be substoichiometric, 
which can be expected of interactors that serve to recruit the core complex to specific target 
genes. Since the structure of the NuRD complex is still unknown, this information is of high 
value and it might pave the path to recombinantly reconstitute and model this complex. For 
PRC2, we tagged EED with GFP in HeLa cells and performed AP-qMS. This revealed a core 
PRC2 complex, consisting of one molecule of EED, Suz12 and Ezh1/2. Recently published 
cryo electron microscopy data for PRC2 confirms these observations (Ciferri et al., 2012). Other 
known interactors such as Rbbp4/7, PCL1/2/3, AEBP2 and Jarid2 bind substoichiometrically. 
The same holds true for the novel PRC2 interactors C17orf96 and C10orf12. This result 
implies a functional diversification of distinct PRC2 subcomplexes each containing different 
interactors as a stoichiometric component, which may serve to affect PRC2 complex activity 
or recruitment to target loci in a highly regulated spatio-temporal manner.
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Integrating MS-based interactomics technology to study chromatin structure and 
epigenetics
To exemplify the different workflows described in this chapter and to emphasize the 
complementary nature of these experiments, we present an example in Figure 3. In this case, 
interactors of methylated DNA were explored using immobilized DNA strands with or without 
CpG methylation. Nuclear extracts from light and heavy labeled HeLa cells were separately 
incubated with the unmodified and CpG methylated DNA, respectively. Additionally, a 
reverse experiment was performed using a label-swap. Plotting the SILAC ratios of both 
experiments in a scatterplot revealed that the NuRD complex specifically binds to the 
methylated DNA, whereas CXXC-domain containing proteins and zinc finger proteins show a 
higher affinity for the non-methylated DNA (Fig. 3A). CXXC domain containing proteins are 
known to have a preference for non-methylated CpGs (Thomson et al., 2010). To characterize the 
subunit composition of the NuRD complex, its core subunit DOC1, which was identified as a 
specific interactor in the methylated DNA pull-down, was tagged with GFP and its interactors 
were identified using label-free AP-qMS. Using the described permutation-based FDR t-test 
(FDR=0.001 and s0=1), all known NuRD subunits are identified as interactors together with 
a zinc finger protein and CSB, which was recently discovered as a NuRD associated factor 
at rRNA genes (Xie et al., 2012) (Fig. 3B). To distinguish core subunits from substoichiometric 
interactors and to characterize the stoichiometry of the complex, we performed the iBAQ 
based calculations. After scaling the relative abundance data to RBAP46/48, we obtain 
stoichiometries for the core subunits highly similar to previously published data (Smits et al., 
2013) (Fig 3C). Strikingly, both CSB and the zinc finger protein are highly substoichiometric, 
as one might expect from the fact that CSB, and probably the finger finger protein as well, 
target the NuRD complex to only a subset of target genes (Xie et al., 2012).
Summary and outlook
In this chapter we have outlined recent developments in the field of quantitative mass 
spectrometry-based interactomics and we have illustrated how this technology can be 
used to answer important questions in the field of epigenetics, in particular to identify and 
characterize chromatin readers. In the future such studies can be extended to virtually all 
organisms and cell types including embryonic stem cells or to cells arrested in a particular stage 
of the cell cycle to identify mitosis or S-phase specific readers for epigenetic modifications 
of interest, for example. These quantitative approaches can be further developed to deduce 
the dissociation constants of detected chromatin reader-PTM interactions (Sharma et al., 2009). 
Furthermore, to complement these global interaction profiling experiments, techniques 
need to be developed that can be used to characterize the proteome and epigenetic 
modification profile of particular genomic loci in a spatio-temporal and quantitative manner. 
Several technologies that can be used for this have recently been developed (Dejardin and 
Kingston, 2009; Lambert et al., 2009; Fujita and Fujii, 2011; Byrum et al., 2012).
Due to the fact that epigenetic modifications are all reversible, the writers, readers and 
erasers of these marks are attractive as potential drug targets. Therefore, identification and 
characterization of chromatin readers is not only important from a basic scientific interest, 
but also from a clinical perspective. For example, bromodomain containing chromatin readers 
such as Brd2, Brd3 and Brd4 recently received a lot of attention, since small molecules that 
inhibit binding of these proteins to acetylated histones have been developed (JQ1 and I-BET) 
(Filippakopoulos et al., 2010; Nicodeme et al., 2010). These compounds have therapeutic potential 
and can be used for the treatment of MLL translocation induced leukemia to inhibit aberrant 
expressed of proteins such as Myc in the tumor cells (Dawson and Kouzarides, 2012). Such 
‘epidrugs’ may also be developed for other chromatin readers, including those interacting 
with trimethylated lysines on histone H3 and H4, to treat cancers that are characterized by 
aberrant lysine methylation patterns.
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Abstract 
Many cellular proteins assemble into macromolecular protein complexes. The identification 
of protein-protein interactions and quantification of their stoichiometry is therefore crucial 
to understand the molecular function of protein complexes. Determining the stoichiometry 
of protein complexes is usually achieved by mass spectrometry-based methods that rely on 
introducing stable isotope labeled reference peptides into the sample of interest. However, 
these approaches are laborious and not suitable for high-throughput screenings. Here, we 
describe a robust and easy to implement label-free relative quantification approach that 
combines the detection of high-confidence protein-protein interactions with an accurate 
determination of the stoichiometry of the identified protein-protein interactions in a single 
experiment. We applied this method to two chromatin-associated protein complexes for 
which the stoichiometry thus far remained elusive: the MBD3/NuRD and PRC2 complex. For 
each of these complexes we accurately determined the stoichiometry of the core subunits 
while at the same time identifying novel interactors and their stoichiometry.
Introduction
Many cellular proteins assemble into protein complexes consisting of stable core subunits 
as well as dynamic and substoichiometric but functionally relevant secondary interactors. 
During the last decade, mass-spectrometry has proven itself as a powerful tool to identify 
protein-protein interactions. The first qualitative, systems-wide protein-protein interaction 
landscapes were generated in yeast using TAP-tagging approaches (Gavin et al., 2006; Krogan et al., 
2006). In recent years, quantitative mass spectrometry-based proteomics approaches have 
been developed and these can be used to determine cellular protein-protein interactions 
with high confidence when performing single affinity purifications from crude lysates. Since 
mass spectrometry is not inherently quantitative, most methods rely on the introduction of 
stable isotopes in the specific pull-down and the control. This allows a pair wise, quantitative 
comparison of peptides between the two samples and enables discrimination of highly 
abundant background proteins from specific interactors (Vermeulen et al., 2008). Recently, novel 
label-free quantification algorithms leading to comparable although slightly less accurate 
results have been implemented (Rinner et al., 2007; Sowa et al., 2009; Hubner et al., 2010). 
Each of the abovementioned methods can be used to identify specific protein-protein 
interactions, but they do not reveal any information about the stoichiometry of the 
interactions. This would require an estimation of the relative abundance of all the proteins 
co-purified specifically during affinity enrichment. In recent years, several groups have 
developed absolute quantification strategies that mostly rely on introducing isotope labeled 
reference peptides after affinity purification (Wepf et al., 2009; Bennett et al., 2010; Schmidt et 
al., 2010). These labeled reference peptides have to be synthesized and this can be quite 
costly. Furthermore, designing the appropriate reference peptides is in many cases not 
trivial. Therefore, these methods have not yet been applied in a high-throughput and 
comprehensive manner. As an alternative to isotope labeled reference peptides, label-free 
absolute quantification methods have been developed, such as emPAI, APEX and iBAQ 
(Ishihama et al., 2005; Lu et al., 2007; Schwanhausser et al., 2011). In iBAQ or intensity-Based Absolute 
Quantification, the sum of intensities of all tryptic peptides for each protein is divided by 
the number of theoretically observable peptides. The resulting iBAQ intensities provide an 
accurate determination of the relative abundance of all proteins identified in a sample.
Here, we show that iBAQ, in combination with label-free quantification of single affinity 
enrichments, enables accurate determination of the stoichiometry of detected statistically 
significant interactions. We benchmarked the method using a complex for which the 
stoichiometry was determined previously using labeled reference peptides. The approach 
was then used to determine the stoichiometry of two chromatin associated protein 
complexes: MBD3/NuRD and PRC2. We show that the MBD3/NuRD complex contains 6 
molecules of RbAp48/46 per complex, a trimer of MTA1/2/3, a GATA2a/2b dimer, a DOC-1 
dimer and only one HDAC1/2 and CHD3/4 molecule per complex. The PRC2 complex contains 
a monomer of each of its three core subunits Ezh2, EED and Suz12 and we identify C17orf96 
and C10orf12 as two novel substoichiometric PRC2 interactors. The method described in 
this study is simple, robust and generic and can be applied to determine the stoichiometry 
of all cellular protein-protein interactions.
Results
Recently, iBAQ has been described, which, in combination with a spike-in of a protein 
standard mixture with known molar concentration, converts peptide intensities measured 
by mass spectrometry into absolute protein amounts (Schwanhausser et al., 2011). In a recently 
published comparison of different absolute quantification methods, iBAQ was shown to be 
most accurate (Arike et al., 2012). We reasoned that iBAQ, when applied to label free single-
step affinity enrichment experiments without a protein standard spike-in, could be used 
to determine the stoichiometry of detected protein-protein interactions. To this end, we 
devised an experimental setup based on a recently published label-free single GFP-affinity 
enrichment method called QUBIC (Hubner et al., 2010). In this method, genes of interest are 
tagged with GFP at near endogenous levels using BAC-transgenomics (Poser et al., 2008). 
Nuclear extracts are generated from these cells, as well as from wild type HeLa cells. These 
lysates are then subjected to single step GFP-affinity enrichment (ipGFP) in triplicate. In 
addition to making use of nuclear extracts from wild-type HeLa cells as a control (cWT), 
nuclear extracts from the GFP-tagged cell line are incubated with beads that do not contain 
GFP binder (cBEAD). Thus, nine pull-downs are performed in total, three specific pull-downs 
targeting the GFP tagged protein and six control pull-downs (Fig. 1A). The precipitated 
proteins are then subjected to on-bead trypsin digestion after which peptide mixtures 
are analyzed by nanoLC-MS/MS on an Orbitrap-Velos mass spectrometer. After raw data 
processing using MaxQuant, the obtained label-free (LFQ) intensities are used to determine 
statistically enriched proteins in the GFP-BAC IP as described previously (Hubner et al., 2010) 
(Fig. 1B). Next, iBAQ intensities for statistically enriched proteins are calculated in each of 
the nine pull-downs. The iBAQ values obtained in the six control samples (cBEAD and cWT) 
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indicate background binding. These iBAQ intensities are therefore subtracted from the iBAQ 
intensity in the GFP pull-downs (triplicate iBAQ (ipGFP-cBEAD); x axis and triplicate iBAQ 
(ipGFP-cWT); y axis) (Fig. 1C). The resulting corrected iBAQ intensity for the GFP-tagged 
protein is set to 1 and the iBAQ values of the interacting proteins with their standard 
deviation are scaled accordingly. This finally results in a stoichiometry determination of all 
the interactors relative to the bait protein. 
Benchmarking the method: the spliceosomal PRP19/CDC5L complex
The spliceosomal PRP19/CDC5L complex was chosen to benchmark our method since 
the stoichiometry of this complex has been determined previously using isotope labeled 
reference peptides (Schmidt et al., 2010). This protein complex is known to harbor four salt-
stable core subunits: PRP19, CDC5L, Spf27 and PLRG1 in an apparent stoichiometry of ~ 
4:2:1:1, respectively. In addition, the complex contains three additional interactors, namely 
AD-002, CTNNBL1 and HSP70 (Grote et al., 2010; Schmidt et al., 2010). We generated a BAC-GFP 
transgenic cell line that expresses full-length CDC5L with a C-terminal GFP tag at near 
endogenous levels. Affinity purifications of CDC5L-GFP resulted in the identification of 
~50 interacting proteins, including all previously described PRP19/CDC5L protein complex 
subunits (permutation-based FDR t-test; p=0.0001 and S0=0.4) (Fig. 2A). These 50 proteins 
were subsequently analyzed to determine their stoichiometry relative to CDC5L as described 
above. We obtained 10 interactors showing a stoichiometry relative to CDC5L of > 0.05 (Fig. 
2B,C). Consistent with previous data, the known four core subunits of the complex show 
BAC-GFP WT
+nonGFP
beads
+GFP
beads
cBEAD (3x) ipGFP(3x) cWT(3x)
Mass Spectrometry
9 samples x 2.5 hours
Data analysis
MaxQuant and Perseus
m/z
In
te
ns
ity
GFP NE GFP NE WT NE
Interactors
Background
T test - BAC-GFP vs control
Relative abundance of interactors
1:1 to bait
Sub stoichiometric
Dimers
C
BA
-L
og
10
 (P
-v
al
ue
 (T
 te
st
))
log2 (LFQ (bait / control))
Stoichiometry (iBAQ(ipGFP-cBEAD))
S
to
ic
hi
om
et
ry
 (i
BA
Q
(ip
G
FP
-c
W
T)
)
Figure 1. Stoichiometry of protein complexes revealed by label-free quantitative proteomics. (A) Nuclear extracts 
from BAC-GFP transgenic cell lines and HeLa WT cells are subjected to single-step GFP-affinity enrichment using 
GFP trap beads in triplicate (ipGFP and cWT, respectively). As an additional control, BAC-GFP cell line nuclear extract 
is incubated with beads lacking GFP binder in triplicate (cBEAD). Thus, nine separate pull-downs are performed 
and each of these is separately analyzed by LC-MS/MS. (B) Statistically enriched proteins in the GFP-BAC IP are 
identified by permutation-based FDR corrected T-test. The LFQ intensity of the GFP pull-down over the control is 
plotted against the –Log10 (p-value) and the red line indicates the permutation-based FDR threshold. The proteins 
in the upper right corner represent the bait and its interactors. (C) Stoichiometry of the interactors is determined 
by calculating the iBAQ intensities. Since the iBAQ values obtained in the control samples (cBEAD and cWT) indicate 
background binding, these iBAQ intensities are subtracted from the iBAQ intensity in the GFP pull-down (iBAQ 
(ipGFP-cBEAD); x axis and iBAQ (ipGFP-cWT); y axis). The remaining values were scaled according to the abundance 
of the bait protein, resulting in the stoichiometry of the interactors relative to the bait.
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Figure 2. Benchmarking the method using the PRP19/
CDC5L spliceosomal complex. (A) Significant interactors 
of CDC5L-GFP are identified by permutation-based FDR 
corrected T-test (threshold: FDR=0.0001 & s0=0.4). The 
LFQ intensity of the GFP pull-down over the control 
is plotted against the –Log10 (p-value). The red line 
indicates the permutation-based FDR threshold. (B,C) 
Stoichiometry determination for the 11 most abundant 
and statistically significant CDC5L-GFP interactors. The 
abundance of the interactors in the specific pull-down 
(iBAQ value) was corrected for the obtained abundance 
in the control pull-downs: iBAQ (ipGFP-cBEAD) (x-axis (b) 
or grey bar(c)) and iBAQ (ipGFP-cWT) (y-axis (b) or black 
bar (c)) pull-down. The remaining values were scaled 
according to the abundance of the bait protein (CDC5L-
GFP, green), which was set to 1. Error bars indicate the 
standard deviation in the triplicate pull-downs.
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the highest stoichiometry: PRP19 2.08, Spf27 0.62 and PLRG1 0.37. Given the fact that 
CDC5L forms a dimer, this results in a stoichiometry of: PRP19 4.16, CDC5L 2, Spf27 1.24 
and PLRG1 0.72. This data is in very good agreement with the previously published data 
from Schmidt et al. (Schmidt et al., 2010). Besides these core complex subunits, we determined 
the stoichiometry of two PRP19/CDC5L interactors (AD-002 and HSP70) to be 0.37 (=0.74) 
and 0.20 (=0.40), respectively. Schmidt and co-workers did not determine the stoichiometry 
of AD-002 in their complex purifications since they were not able to synthesize suitable 
reference peptides for this protein. Finally, the CDC5L interacting protein CTNNBL1 showed 
a stoichiometry of 0.06 (=0.12) in our pull-down, whereas Schmidt et al. determined this 
protein to have a stoichiometry of 0.5 relative to CDC5L. Since CTNNBL1 is not part of the 
salt stable core PRP19/CDC5L complex, this protein-protein interaction most likely did not 
remain stable in our GFP-pull-down (pull-down and washes in the presence of 300 mM 
NaCl). In summary, these results show that our label-free quantification approach is yielding 
data of similar quality compared to reference peptide based methods but at a fraction of the 
time and effort and in a comprehensive and unbiased manner. 
Stoichiometry determination of chromatin-associated protein complexes 
MBD3/NuRD: Next, we applied our method to chromatin-associated protein complexes 
for which the stoichiometry thus-far remained elusive. The first complex we studied is the 
MBD3/NuRD protein complex, which contains ATP-dependent chromatin remodeling and 
histone deacetylase activity (Le Guezennec et al., 2006; Lai and Wade, 2011). Purification of MBD3-
GFP and label-free quantification resulted in the identification of 14 significant interactors, 
many of which are known MBD3/NuRD core subunits (Fig. 3A) (Le Guezennec et al., 2006; Spruijt et 
al., 2010). iBAQ-based stoichiometry determination revealed a stable core complex with the 
following stoichiometry: 6x RbAp48/46, 3X MTA1/2/3, 2x DOC-1, 2x GATAD2a/b, 1x MBD3, 
1x CHD3/4 and 1x HDAC1/2 (Figure 3B and C). RbAp48 and RbAp46 are highly similar in their 
amino acid sequence and therefore share a large number of tryptic peptides. It is therefore 
not possible to specify the individual iBAQ intensity for each of these proteins. To overcome 
this problem, the iBAQ intensities for RbAp48 and RbAp46 are collapsed into a single 
value which accurately reflects their combined stoichiometry. In a similar logic, the iBAQ 
intensities for MTA1/2/3, GATAD2a/b, CHD3/4 and HDAC1/2 are also collapsed into four 
stoichiometry values (Fig. 3B,C). We used western blotting to show that the MBD3 protein is 
monomeric (Figure 3D) and DOC-1 was recently shown to form dimers (Ertekin et al., 2012), thus 
revealing that the observed stoichiometry is indicative of the amount of subunit molecules 
per MBD3/NuRD complex. Finally, we identified two novel zinc finger proteins (ZMYND8 
and ZNF592) as potential substoichiometric interactors of the MBD3-NuRD complex. Each 
of these proteins has a stoichiometry of ~0.01. These substoichiometric NuRD interacting 
proteins may serve to recruit the NuRD complex to a specific subset of target genes in the 
genome and are therefore expected to be of lower stoichiometry compared to the core 
subunits. 
PRC2: The second protein complex we focused on is PRC2, a well-studied and important 
Polycomb complex that methylates histone H3 on lysine 27 and represses transcription 
(Margueron and Reinberg, 2011). PRC2 consists of three core subunits: EED, Ezh2 and Suz12, 
which were, among other proteins, identified in our EED-GFP purification (Fig. 4A). 
Quantification of EED-GFP interactors revealed that the PRC2 core complex assembles in 
a 1:1:1 stoichiometry (Fig. 4B,C). Co-immunoprecipitation experiments revealed that EED 
does not form multimers (Fig. 4D). Thus, we conclude that the core PRC2 complex contains 
one molecule of EED, Ezh1/2 and Suz12. Besides known substoichiometric interactors of 
PRC2, such as RbAp48/46 (0.6), PCL3 (0.35), AEBP2 (0.2) and Jarid2 (0.12), we also identified 
a novel substoichiometric interactor called c17orf96 (0.47). The stoichiometry of this protein 
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Figure 3. Stoichiometry of NuRD revealed by label-free quantitative proteomics. (A) Identification of specific 
interactors of MBD3-GFP by a permutation-based FDR corrected T-test (threshold: FDR=0.01 & s0=0.5). Layout as in 
Fig. 2A. (B,C) Stoichiometry determination of the statistically significant interactors of MBD3-GFP. Layout as in (Fig. 
2B,C). (D) Western blot analysis of MBD3-GFP affinity purification reveals that MBD3-GFP does not form multimers, 
as no endogenous MBD3 was detected in the GFP affinity purification. Nuclear extracts from MBD3-GFP and WT 
HeLa cells were subjected to GFP-affinity enrichment and probed with an antibody against GFP (upper panel) as 
well as an endogenous antibody to MBD3 (lower panel).
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relative to the core complex is higher than most other known PRC2 interactors, indicating 
that this may be an interaction of substantial importance. A second previously unknown 
substoichiometric PRC2 interactor is C10orf12. This protein has a stoichiometry of ~0.1 
relative to the core subunits. 
Discussion
In this study we have described a novel method that can be used to determine the 
stoichiometry of protein-protein interactions using label-free quantitative mass-
spectrometry-based proteomics. Since this method does not rely on labeled reference 
peptides, a priori knowledge of interaction partners is not required. Thus, in a single 
experiment, known and novel protein-protein interactions are detected and for these 
interactions the stoichiometry is immediately determined. We first benchmarked our 
method using a protein complex for which the stoichiometry was determined previously 
using labeled reference peptides (PRP19/CDC5l) and we show that our method is equally 
accurate. We then went on to determine the stoichiometry of two important and well-
studied chromatin associated proteins complexes: MBD3/NuRD and PRC2. Strikingly, 
despite being studied for over a decade, the stoichiometry of these two complexes thus far 
remained elusive. 
The stoichiometry analysis of the MBD3/NuRD complex revealed that the DOC-1 protein 
is present within the complex as a stoichiometric dimer. Given its small size of 12 kDa, 
DOC-1 has most likely been overseen in many previous gel-based characterizations of the 
NuRD complex. Our results now unambiguously reveal that DOC-1 indeed is a core NuRD 
complex subunit, as we have suggested previously (Le Guezennec et al., 2006; Spruijt et al., 2010). 
One surprising observation is the fact that there is only one HDAC1/2 molecule per MBD3/
NuRD complex. Previously it was always assumed that there is one HDAC1 and one HDAC2 
molecule present in each NuRD complex. We cannot exclude the possibility that a fraction 
of HDAC1 and/or HDAC2 get removed from the complex during affinity purification but 
in this case it would be unlikely to yield a stoichiometry of exactly 1 relative to MBD3. 
Furthermore, affinity purification of DOC-1-GFP from HeLa cells revealed a stoichiometry 
between RbAp48/46, MTA1/2/3 and HDAC1/2 of 6:3:1 (data not shown), which is in perfect 
agreement with the stoichiometry of these proteins in the MBD3-GFP pull-down (Figure 
3). Nevertheless, cross-linking approaches to ‘freeze’ cellular protein-protein interactions 
could be applied to further investigate whether HDAC1 and HDAC2 molecules are partially 
displaced from the core NuRD complex during the affinity purification. The same holds true 
for the substoichiometric interactions that we observe in our experiments. Our method 
does not reveal whether these interactions are indeed substoichiometric or whether 
they get partially washed away during affinity purification. The dynamic nature of certain 
interactions could also be further investigated using stable isotope labeling and mixing of 
light and heavy lysates prior to the pull-down (Mousson et al., 2008). 
Purification of GFP-EED from HeLa cells followed by quantitative mass spectrometry 
revealed that the core PRC2 complex consisting of EED, Suz12 and Ezh1/2 assembles in 
a 1:1:1 stoichiometry with each subunit being present as a monomer. Consistent with 
previous observations, a number of proteins interact with PRC2 in a substoichiometric 
manner, such as AEBP2, Jarid2, RbAp48/46 and PCL3. In addition, we identified two novel 
uncharacterized proteins as substoichiometric EED interactors: C17orf96 and C10orf12. 
Based on our results it is impossible to distinguish whether these observed interactions 
all occur simultaneously, or whether there are PRC2 subcomplexes each containing one 
or more of the substoichiometric interactors as a stoichiometric component. Reciprocal 
tagging and purification of PRC2 interactors can be performed to address this question. 
Given the extremely high sensitivity and sequencing speed of modern mass spectrometers, 
gel-free single step affinity purifications will yield both core protein complex subunits as well 
as transient, substoichiometric protein-protein interactions. Our method is a powerful tool 
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2B,C. (D) Western blot analysis of EED-GFP affinity purification reveals that EED-GFP does not form multimers, since 
no endogenous EED is detected in the GFP-EED affinity purification. Nuclear extracts from EED-GFP and WT HeLa 
cells were subjected to GFP-affinity enrichment and probed with an antibody against GFP (upper panel) as well as 
an endogenous antibody to EED (lower panel).
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to efficiently discriminate these different interactions, which is crucial to understand the 
biology of the complexes. Furthermore, our affinity enrichments yielded high peptide counts 
for the bait and its interactors (37 measured peptides on average), resulting in high-accuracy 
measurements which enabled us to determine monomers or multimers of proteins within 
a complex, thus providing highly valuable information from a structural perspective. The 
method can also be applied to study the dynamics of protein complexes, for example during 
stem cell differentiation or throughout the cell cycle. Finally, the method is easily scalable 
for high-throughput approaches and should be applicable to already existing large-scale 
label-free protein-protein interaction datasets. The method can be adapted to any label-
free single affinity enrichment workflow; we therefore expect it to become widely used in 
the chromatin and transcription field and beyond to determine protein-protein interactions 
and their stoichiometry.
Material and methods
BAC lines and cell culture
To ensure (near) endogenous transgenic protein expression, the proteins of interest were 
GFP-tagged using BAC-TransGeneOmics (Poser et al., 2008). Briefly, recombineered bacterial 
artificial chromosomes (BACs) were transfected in HeLa cells and stably integrated 
transgenes were selected for using media containing 400 µg/µL geneticin (G418, Gibco). 
The HeLa BAC-GFP lines and HeLa wild type cells were cultured in high glucose Dulbecco’s 
Modified Eagle Medium (DMEM, Invitrogen) supplemented with 10% (vol/vol) fetal bovine 
serum (FBS, Invitrogen) and 100 U/mL penicillin and streptomycin (Invitrogen). 
Nuclear extract isolation and GFP pull-down
Nuclear extracts from BAC-GFP and wild-type HeLa cells were generated as described (Dignam 
et al., 1983). Briefly, cells were incubated in hypotonic buffer after harvesting and homogenized 
using a type B (tight) pestle in the presence of 0.15% NP-40 (Roche) and complete protease 
inhibitors (Roche). The nuclei were pelleted by centrifugation and incubated with lysis 
buffer (420 mM NaCl, 0.1% NP-40 and complete protease inhibitors) for one hour to extract 
nuclear proteins. The nuclear extract was obtained by a final centrifugation step at 20.000 
g for 30 minutes at 4ºC.
The BAC-GFP HeLa and HeLa WT nuclear extracts were subjected to GFP-affinity enrichment 
using GFP nanotrap beads (Chromotek). As a second control, BAC-GFP HeLa nuclear extracts 
were incubated with beads lacking the GFP nanotrap (Chromotek). For each pull-down, 1 
mg of nuclear extract was incubated with 7.5-10 µL beads in incubation buffer (300 mM 
NaCl, 0.10% NP-40, 0.5 mM DDT, 20 mM HEPES-KOH (pH 7.9)) containing ethidium bromide 
at a final concentration of 50 µg/µL. Ethidium bromide is added to the reaction to prevent 
indirect, DNA-mediated interactions. Beads were then washed two times with incubation 
buffer containing 0.5% NP-40, two times with PBS containing 0.5% NP-40 and finally two 
times with PBS.
Sample preparation and mass spectrometry
Precipitated proteins were subjected to on-bead trypsin digestion as described previously 
(Hubner and Mann, 2011). In short, 50 µL of elution buffer (2M Urea, 10 mM DTT and 50 mM 
Tris-HCl pH7.5) was added to the beads in order to partially denature the proteins. After 
incubation for 20 minutes at RT in a thermoshaker, the supernatant was collected in a 
separate tube and iodoacetamide (IAA, Sigma) was added to a final concentration of 50 mM. 
The beads were then incubated with 50 µL of elution buffer containing 50 mM IAA instead of 
DTT for 5 minutes at RT. Proteins on the beads were then partially digested from the beads 
by adding 0.25 µg trypsin (Promega) for one hour at RT in a thermoshaker. The supernatant 
was then collected and added to the first supernatant. 0.1 µg of fresh trypsin was added and 
proteins were digested overnight at RT. Tryptic peptides were finally acidified and desalted 
using Stagetips(Rappsilber et al., 2007) prior to mass spec analyses.
After elution from the Stagetips, the tryptic peptides were applied to online nanoLC-MS/MS, 
using a 120 min gradient from 7% until 32% acetonitril followed by step wise increases up 
to 95% acetonitril. Mass spectra were recorded on a LTQ-Orbitrap-Velos mass spectrometer 
(Thermo Fisher Scientific), selecting the 15 most intense precursor ions of every full scan for 
fragmentation.
Data analysis
Raw data was analyzed by MaxQuant (version 1.2.2.5) (Cox and Mann, 2008) using standard 
settings with the additional options match between runs, label-free quantification (LFQ) 
and iBAQ selected. The generated ‘proteingroups.txt’ table was filtered for contaminants, 
reverse hits, number of unique peptides (>0) and number of peptides (>1) in Perseus (from 
MaxQuant package) or R. For interactor identification, T test based statistics was applied on 
LFQ as described before (Hubner et al., 2010). First, the logarithm (log2) of the LFQ values were 
taken, resulting in a Gaussian distribution of the data (Figure S1). This allowed imputation 
of missing values by normal distribution (width=0.3, shift=1.8), assuming these proteins 
were close to the detection limit. Statistical outliers for the GFP pull-down of the BAC HeLa 
compared to HeLa WT were then determined using two-tailed T test. Multiple testing 
correction was applied by using a permutation-based false discovery rate (FDR) method 
in Perseus. To determine the stoichiometry of the identified complexes, we compared the 
relative abundance of the identified interactors as measured by the iBAQ intensities. The 
background binding level of proteins as measured by the iBAQ intensity in the different 
control samples were subtracted from the BAC HeLa GFP pulldown iBAQ intensity. Next, 
these relative abundance values were scaled to the obtained abundance of the bait protein 
which was set to 1.
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Supplementary Figure 1. Gaussian distribution of the LFQ intensities obtained in the affinity pulldowns in triplicate. 
Each of these pulldowns shows a normal distribution.
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Abstract
Methylation of lysine 4 on histone H3 (H3K4) at promoters is tightly linked to transcriptional 
regulation in human cells. At least six different COMPASS-like multi-subunit (SET1/MLL) 
complexes have been described that contain methyltransferase activity towards H3K4, but 
a comprehensive and quantitative analysis of these SET1/MLL complexes is lacking. We 
applied label-free quantitative mass spectrometry to determine the subunit composition 
and stoichiometry of the human SET1/MLL complexes. We identified both, known and novel, 
unique and shared, interactors and determined their distribution and stoichiometry over 
the different SET1/MLL complexes. In addition to being a core COMPASS subunit, the Dpy30 
protein is a genuine subunit of the NURF chromatin remodeling complex. Furthermore, we 
identify the Bod1 protein as a discriminator between the SET1B and SET1A complexes and 
we show that the H3K36me-interactor Psip1 preferentially binds to MLL2 complex. Finally, 
absolute protein quantification in crude lysates mirrors many of the observed SET1/MLL 
complex stoichiometries. Our findings provide a molecular framework to understand the 
diversity and abundance of the different SET1/MLL complexes, which together establish the 
H3K4 methylation landscape in human cells.
Introduction
The basic repeating unit of chromatin in eukaryotic cells constitutes of ~147 base pairs of 
DNA wrapped around an octamer of histone proteins to form the nucleosome core particle 
(Luger et al., 1997). These histone proteins are subject to post-translational modifications 
(PTMs), such as methylation, acetylation, phosphorylation and ubiquitination (Jenuwein and 
Allis, 2001; Berger, 2007). In human cells, nucleosomes and their PTMs are involved in regulation 
of virtually all DNA-associated processes such as transcription, replication and response to 
DNA damage (Fischle et al., 2003a; Kouzarides, 2007). Methylated lysines and arginines are known 
to recruit effector proteins to specific genomic loci to impose their specific regulatory 
function upon the underlying DNA (Jenuwein and Allis, 2001). Methylation on histone H3 at 
lysine 4 (H3K4) is conserved from yeast to humans and is tightly linked to the transcription of 
genes by RNA polymerase II (Bernstein et al., 2005). Whereas tri-methylation of H3K4 (H3K4me3) 
primarily marks promoters of actively transcribed genes, mono-methylation (H3K4me1) in 
combination with H3K27 acetylation has recently been established as a hallmark of active 
enhancers (Heintzman et al., 2007; Heintzman et al., 2009). H3K4me3 can be recognized by PHD-
finger containing proteins such as the Bptf subunit of the NURF chromatin remodeling 
complex and the Taf3 subunit of the basal transcription factor TFIID, thereby recruiting the 
basal transcription machinery to activated promoters (Wysocka et al., 2006; Vermeulen et al., 2007). 
In yeast cells, the Set domain-containing protein Set1p is the only methyltransferase for H3K4. 
Set1p together with other proteins (Cps25/Sdc1p, Cps30/Swd3p, Cps35/Swd2p, Cps40/
Spp1p, Cps50/Swd1p, Csp15/Shg1p and Cps60/Bre2p) assembles into the Set1/COMPASS 
complex (Miller et al., 2001). In contrast, higher eukaryotes contain at least six COMPASS-like 
complexes with H3K4 methyltransferase activity. These complexes are distinguished by six 
different catalytic Set domain proteins (Set1a, Set1b, Mll1, Mll2, Mll3, Mll4; named HMTs 
for histone methyltransferases hereafter) (Shilatifard, 2012). The SET1A and SET1B complexes 
are responsible for maintaining global levels of H3K4me3 (Wu et al., 2008), whereas complexes 
with the mixed lineage leukemia proteins (Mll1-4) display gene-specificity. Interestingly, the 
Trr protein of fruit flies (and by analogy mammalian Mll3/4) has recently been found to 
be critical for H3K4me1 (Herz et al., 2012). SET1/MLL gene deletion studies in mice revealed 
diverse non-overlapping phenotypes, which indicate that these genes perform non-
redundant functions during development (Eissenberg and Shilatifard, 2010). The six distinct SET1/
MLL complexes share a conserved core consisting of Wdr5, Rbbp5, Ash2l and Dpy30 (named 
WRAD hereafter). This WRAD module can associate with the catalytic subunit and has been 
implicated in regulating its enzymatic activity (Dou et al., 2006; Steward et al., 2006; Patel et al., 2011). 
The specific subunits such as the Menin subunit of MLL1/2 and the Ptip subunit of MLL3/4, 
however, have been shown to direct these distinct complexes to certain genomic loci (Wang 
et al., 2009a).
The exact subunit composition and abundance of the SET1/MLL complexes in human cells 
is unknown at present, which complicates assessment of their contributions in establishing 
and maintaining methylation of H3K4. Recent developments in label-free quantitative mass 
spectrometry-based interaction proteomics (Hubner et al., 2010) and the application of a novel 
method for quantifying the stoichiometry of these interactions (Smits et al., 2013), enables a 
careful analysis of protein complex composition in a quantitative manner. Here we provide 
the first comprehensive and unbiased analysis of the six different SET1/MLL complexes in 
human cells. Single-step affinity purification of shared and unique subunits of the different 
complexes from nuclear extracts reveals a high degree of heterogeneity in the subunit 
composition. We find that the WRAD core subunits Dpy30 and Wdr5, but not Ash2l or 
Rbbp5, are present in other large protein complexes. Additionally, we propose that Bod1 
is the human homolog of yeast Shg1p. Furthermore, Bod1 and Psip1 bind selectively to the 
SET1B and MLL2 complexes, respectively.
Results
In order to obtain quantitative information on the different human COMPASS-like complexes, 
individual subunits of these complexes were tagged with GFP, allowing for single-step affinity 
purification and identification of complexes in a single liquid chromatography combined 
with tandem mass spectrometry (LC-MS/MS) run (Hubner et al., 2010; Vermeulen et al., 2010). 
We made use of HeLa cell lines in which expression of the tagged protein can be induced 
upon doxycycline addition (Tighe et al., 2008). Nuclear extracts obtained from these cells and 
from the parental cell line (WT) were subjected to GFP affinity purification in triplicate as 
described (Hubner et al., 2010), followed by direct on-bead digestion and mass spectrometry 
analysis on an LTQ-Orbitrap-Velos instrument. Once the interactors were identified, their 
relative stoichiometry was determined as described (Smits et al., 2013) (Fig. 1A). To allow 
comparison of stoichiometries between different experiments, all data were normalized 
to the total amount of catalytic subunit in that specific experiment and consequently the 
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stoichiometry is expressed relative to the total amount of HMT. We used this workflow to 
analyze the shared SET1/MLL complex subunits (Ash2l, Rbbp5, Wdr5 and Dpy30), as well 
as two specific subunits for MLL1/2 (Menin and Psip1), MLL3/4 (Pa1 and Ptip) and SET1A/B 
(Wdr82 and Cfp1).
SET1/MLL core subunit interactions
Rbbp5 and Ash2l are part of the stable core of the human SET1/MLL complexes (Fig. 1B,C). 
Ash2l, Rbbp5, Wdr5 and Dpy30 have previously been described to form the WRAD complex 
independently of the catalytic HMT subunit (Dou et al., 2006; Steward et al., 2006; Patel et al., 2009; 
Patel et al., 2011). Purification of Ash2l or Rbbp5 revealed that Ash2l, Rbbp5 and Dpy30 are 
more abundant than the combined Set1/Mll proteins (Fig. 1B,C). These observations suggest 
that a proportion of the WRAD module is not associated with HMT activity. The exception 
to this is the Wdr5 subunit, which is present in a 1:1 ratio with the HMTs (Fig.1B,C). This is 
in agreement with previously reported direct interactions between Mll1 and Wdr5 (Trievel 
and Shilatifard, 2009). These observations suggest the existence of a subcomplex consisting 
of Rbbp5, Ash2l and Dpy30. Alternatively, this putative RAD module is stabilized by 
overexpression of one of its components.
Wdr5 plays an important role in self-renewal and reprogramming and many of these functions 
are attributed to its role in SET1/MLL (Wysocka et al., 2005; Ang et al., 2011). In addition, Wdr5 
has been found in other complexes including the ATAC histone acetyltransferase complex 
(Trievel and Shilatifard, 2009; Spedale et al., 2012). We found Wdr5 to interact, either directly or 
indirectly, with almost 200 different proteins (Fig. 2A). As expected (Trievel and Shilatifard, 2009), 
amongst these are subunits of the ATAC, NSL, HBO1 and Anaphase Promoting complexes. 
Additionally, INO80 and TFIID subunits were identified as interactors. These complexes were 
not identified using the other (Ash2l, Rbbp5 and Dpy30) core subunits as baits indicating that 
they are exclusive for Wdr5 (Song and Kingston, 2008). Interestingly, intensities of the different 
identified complexes are comparable indicating that Wdr5 is equally distributed over several 
chromatin-associated protein complexes. This suggests that Wdr5 is more abundant in cells 
than the other WRAD members. To investigate this, we performed intensity based absolute 
quantification (iBAQ) of HeLa nuclear extract (Schwanhausser et al., 2011) (Table I). This analysis 
resulted in the identification and absolute quantification of ~4800 proteins. As expected, 
Wdr5 is ~10 fold more abundant than Rbbp5 and Ash2l (Table I). This supports the idea 
that Wdr5 is a universal hub in chromatin and transcription regulatory pathways (Trievel and 
Shilatifard, 2009). Strikingly, the WRAD members are at least four times more abundant than 
Table I. Absolute protein quantiﬁcation of HeLa nuclear extract 
Protein IDs Protein names
Amount 
(fmoles / 1 mg)
O75475 PSIP1 68047.34
P61964 WDR5 8870.15
B4DIS3 DPY30 5799.25
Q6UXN9 WDR82 4908.15
Q15291 RBBP5 894.73
Q9UBL3 ASH2L 596.69
Q8NFC6 BOD1/1L1 201.70
Q9P0U4-2 CFP1 189.01
O00255-2 MEN1 137.71
O15047/Q9UPS6 SET1A/B 133.68
Q6ZW49 PTIP 58.14
Q9BTK6 PA1 7.31
E9PQG7/Q9UMN6 MLL1/2 1.91
O14686-3/Q8NEZ4-3 MLL3/4 1.62
O15047 SET1A 132.68±7.0
O14686-3 MLL4 1.44±0.069
E9PQG7 MLL1 1.27±0.070
Q9UPS6 SET1B 1.00±0.48
Q9UMN6 MLL2 0.64±0.060
Q8NEZ4-3 MLL3 0.18±0.0024
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Figure 1. (A) Experimental workflow. Nuclear extracts were prepared from HeLa wildtype or GFP-fusion protein 
expressing cells. GFP pull-downs were performed in triplicate and analyzed separately by mass spectrometry. 
Raw data were analyzed by MaxQuant and specific interactors were selected from background using label-free 
quantification in Perseus. iBAQ intensities were used to calculate the relative abundance of interaction partners. 
(B, C) Identification of interacting proteins for Ash2l (B) and Rbbp5 (C) by volcano plots (left panel) and the 
stoichiometry (>0.01) of these interactors presented by bar graphs (right panel). In the volcano plots, the ratio of 
GFP over WT in label-free quantification are plotted against the -log10 of the false discovery rate (FDR) calculated 
by a permutation-based FDR adapted t-test. Significant outliers are labeled. Bar graphs indicate the stoichiometry 
of interacting proteins (indicated at bottom) relative to Set1/Mll proteins. Dashed line indicates a ratio to the total 
Mll/Set1 protein of 1. Error bars indicate the standard deviations of the biochemical triplicate for each experiment.
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the sum of all HMT subunits. This is in line with findings by others (Dou et al., 2006; Steward 
et al., 2006) and by us (Fig. 1 and 2) that Wdr5, Rbbp5, Ash2l and Dpy30 may form various 
subcomplexes. 
Dpy30 isolation led to the co-purification of SET1/MLL components, amongst which Ash2l 
showed the highest stoichiometry, which suggests a direct interaction between Ash2l 
and Dpy30 (Fig. 2B). Surprisingly, all known subunits of the NURF chromatin-remodeling 
complex co-purified with Dpy30 (Fig. 2B). This indicates that Dpy30 is also an integral 
component of the NURF complex. Due to its small size (11 kDa), this protein may have been 
missed in previous, gel-based analyses of the NURF complex (Barak et al., 2003). Roughly equal 
amounts of HMT and NURF complexes were present in the Dpy30 pull-downs. Bap18 is a 
core component of NURF (Vermeulen et al., 2010) and was used to validate the Dpy30-NURF 
interaction (Fig. 2C). We determined the stoichiometry of the NURF subunits in the Bap18 
and Dpy30 pull downs and found that Bap18 is present in two copies relative to the other 
subunits (Fig. 2D). By analogy we propose that Bap18 might serve as the direct anchor 
for Dpy30 in NURF. In the GFP-Dpy30 purifications we identified tryptic peptides from the 
junction of GFP-Dpy30 fusion protein and from N-terminus of endogenous Dpy30. This 
indicates co-purification of GFP-tagged and endogenous Dpy30, which reveals the existence 
of Dpy30 multimers (Fig. 2E). Notably, Dpy30 is 6-10 times more abundant in HeLa nuclear 
extracts compared to Rbbp5 and Ash2l (Table I). 
Relative abundance of the SET1/MLL complexes
Analysis of the shared subunits of the SET1/MLL complexes revealed that all six HMTs 
(Mll1-4 and Set1a/b) are present in a complex with the WRAD module (Fig. 1B,C and 2A,B). 
These homologous HMTs have evolved from a common ancestor and consequently share 
a number of tryptic peptides. To determine the exact stoichiometry of each HMT complex, 
HMTs that share tryptic peptides are collapsed into a single stoichiometry value. This 
analysis revealed that the MLL1/2 complexes are most abundant (on average 50% of all 
complexes), whereas SET1A/B and MLL3/4 accounts for 32% and 18% of the total pool of 
WRAD-bound HMT, respectively (Fig. 2F). Based on the intensity of the unique peptides for 
each HMT we estimated their relative abundance (Fig. 2F, stacking of bars). Whereas the 
Mll1 and Mll2 proteins are present in roughly equal amounts (both ~25%), Mll3 is fairly low 
compared to Mll4 (~3% versus ~15%, respectively). The same holds true for Set1a, which is 
more abundant than Set1b (~25% and ~7%, respectively; Fig. 2F). 
The relative presence of the enzymatic components in the SET1/MLL complexes could be 
regulated post-translationally or a direct effect of differential protein expression. Interestingly, 
Set1a is the most abundant HMT as indicated by its absolute protein abundance in HeLa 
nuclear extract (Table I), which is not reflected in its degree of integration in SET1/MLL 
complexes (32% of all complexes). MLL1/2 and MLL3/4 complexes have similar abundance 
(1.9 and 1.6 fmol/mg, respectively), whereas their degree of interaction with WRAD is not 
equal (50% versus 18%). Therefore, the integration of these enzymatic components is not 
strictly determined by their absolute abundance but probably due to the presence of certain 
HMTs (like Mll3/4 and Set1a) in other complexes lacking the WRAD proteins.
MLL1/2 specific interactors
Menin acts as a tumor suppressor in the neuroendocrine MEN1 tumor syndrome, but is 
an essential cofactor for the oncogenic activity of rearranged MLL (Hughes et al., 2004; Karnik 
et al., 2005). Menin binds to Mll1/2 and the transcription factor JunD in a mutually exclusive 
manner (Agarwal et al., 1999; Hughes et al., 2004; Huang et al., 2012). Purification of the core MLL 
subunits revealed a 4- to 5-fold lower abundance of Menin compared to Mll1/2, indicating 
that not all MLL1/2 complexes contain Menin (Fig. 1B,C and 2A,B). On the other hand the 
fraction of Menin, which is associated with Mll1/2, binds to the WRAD complex with an 
stoichiometry similar to 1:1/1/1/6 (Menin:Wdr5/Rbbp5/Ash2l/Dpy30) (Fig. 3A). Amongst 
the other Menin interacting proteins, JunD was highly enriched but in a lower stoichiometry 
than MLL1/2 complex subunits. Intriguingly, the JunD dimerization partners, c-Fos, Fos1l, 
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Atf2/7, and Atf3, were also identified in this experiment (Fig. 3A,C). This suggests that Menin 
interacts with dimers of JunD and other AP-1 transcription factors. Additionally, Menin was 
previously shown to localize to chromatin after UV radiation, which may depend on these 
AP-1 transcription factors (Farley et al., 2006). We also identified the nucleotide excision repair 
proteins Rad23a/b as novel Menin interactors, which may hint for a function for Menin in 
this pathway. Notably, the RNA binding protein Taf15 was also identified, which might link 
Menin to other non-MLL related functions.
Psip1 (Ledgf/p75) is well studied as the interaction partner for the HIV-integrase (Marshall et 
al., 2007) and was more recently also implicated in MLL-linked leukemia (Yokoyama and Cleary, 
2008). Like Menin, Psip1 does not interact with the Set1a/b or Mll3/4 methyltransferases. 
Analysis of the stoichiometry of Psip1-bound MLL subunits resulted in an identical picture 
as when Menin was used as bait (Fig. 3A,B). As the Menin protein has a 1:1 stoichiometry 
relative to Mll1/2 in the GFP-Psip1 purifications, it is likely that Menin and Psip1 only interact 
in the context of Mll1/2. On the other hand, Menin pull-down indicated that Psip1 is only 
present in ~25% of the Menin-MLL1/2 complexes. This low abundance is supported by the 
analysis of WRAD subunits as baits, in which Psip1 was not identified as an interactor (Fig. 
1B,C and 2A,B), together indicating that Psip1 is a sub-stoichiometric component in this 
complex. Interestingly, Psip1 enriches mostly Mll2, whereas Menin binds equal amounts of 
the Mll1 and Mll2 proteins (Fig. 3E). This indicates preferential binding of Psip1 to the MLL2 
complex.
Our analyses confirmed Cdca7l/Jpo2 as a Psip1 interactor (Maertens et al., 2006). We find that 
Psip-Cdca7l is 18-fold more abundant than the Psip-MLL1/2 complexes (Fig. 3D). This is 
confirmed by the absolute protein quantification dataset, which shows that Psip1 is the 
most abundant SET1/MLL interactor with a 100-fold higher abundance than Rbbp5 and 
Ash2l (Table I). As reported previously, Psip1 interacts with Dbf4 and Cdc7, which likely form 
a complex, and with the Pogz transcription factor (Bartholomeeusen et al., 2009; Hughes et al., 2010). 
These interactions are of a lower abundance than Mll1/2. Together, these observations 
reveal that only ~5% of Psip1 is present in MLL complexes, and that the bulk of Psip1 
performs other functions.
Hcfc1 and -2 were previously identified as members of the MLL1 complex, but they are also 
linked to the SET1 complexes (Wysocka et al., 2003). Our experiments validate these proteins 
as sub-stoichiometric interactors for SET1A/B and MLL1/2 and provide no evidence for an 
interaction of Hcfc1/2 with the MLL3/4 complexes (Fig. 3A,B and 4A,B).
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MLL3/4 specific interactors
Ptip was previously identified as a bona fide subunit of the MLL3/4 complexes and found 
to be associated with the 53bp1 protein involved in the DNA damage response pathway 
(Manke et al., 2003; Cho et al., 2007). The interaction with Mll3/4 was confirmed (Fig. 4A) and 
Ptip bound MLL3/4 complexes seem to have an 1:1/1/1/3 (Ptip:Wdr5/Rbbp5/Ash2l/Dpy30) 
stoichiometry. Interestingly, Dpy30 is approximately present as a trimer compared to the 
hexamer in MLL1/2. Other known MLL3/4 subunits, the histone H3K27 demethylase Kdm6a/
Utx and the nuclear receptor co-activator NcoA6 are present in only ~19% and ~30% of Ptip 
pull-downs relative to Mll3/4, respectively (Fig. 4A,B). This indicates that these subunits are 
genuine sub-stoichiometric components of the Ptip-containing MLL3/4 complexes.
Notably, Ptip-53bp1 complexes are more abundant than Ptip-HMT complexes (Fig. 4C). The 
GFP-Ptip purification (Fig. 4C) also identified Dclre1C, Mdc1 and Blm, which are all implicated 
in the DNA damage response pathway (Thompson, 2012). These proteins were not identified 
previously as Ptip interactors, which may indicate that they interact via 53bp1. The zinc 
finger transcription factor Zbtb2 has been implicated in the p53 pathway (Jeon et al., 2009), 
and it was found as a strong Ptip interactor. The Zbtb2-Ptip interaction seems independent 
from the SET1/MLL complexes, because Zbtb2 was not identified in WRAD purifications (Fig. 
4C). Furthermore, the Smad2/3 proteins interacted with Ptip. Interestingly, a role in TGFβ 
signaling via interaction with Smad proteins was previously described for the Xenopus Ptip 
homolog Swift (Shimizu et al., 2001). The novel interaction found with the zinc-finger Znf639 may 
hint to a role for this protein in localizing Ptip and its associated proteins to specific genomic 
loci. It is important to note that these interactions were not found with Pa1 or other SET1/
MLL proteins and could therefore also be linked to the 53bp1 DNA damage pathway or to 
novel functions of the Ptip protein. 
Ptip-associated (Pa1) protein interacts with the MLL3/4 complexes with similar stoichiometry 
as Ptip, 1:1/1/1/3 (Pa1:Wdr5/Rbbp5/Ash2l/Dpy30) (Fig. 4B). Moreover, a larger proportion 
(~2 fold) of Ptip compared to Mll3/4 is found in these experiments. Conversely, Pa1 was 2-fold 
more abundant relative to Mll3/4 in the GFP-Ptip analysis (Fig. 4A). Ptip and Pa1 are found 
with a lower stoichiometry than Mll3/4 in the pull-downs of the WRAD components, which 
makes a Ptip/Pa1 dimer within the MLL3/4 complex unlikely (Fig. 1B,C and 2A,B). Instead, 
these data suggest that Ptip and Pa1 form a complex outside of the MLL3/4 complex. Analysis 
of the distribution of Mll3 and Mll4 proteins in the Ptip and Pa1 pull-downs, show similar 
Mll3 and Mll4 distributions as found in the WRAD purifications, indicating no preference of 
Ptip and Pa1 for either of these HMTs (Fig. 4D). 
SET1A/B specific interactors
The beta-propeller protein Wdr82 is part of the SET1A/B complexes and directly involved in 
regulation global levels of H3K4me3 (Lee et al., 2007; Wu et al., 2008). Wdr82 has also been found 
to interact with the PP1 phosphatase complex (Lee et al., 2010). Wdr82 is a stoichiometric 
component of the SET1A/B complexes based on pull-downs of Ash2l, Rbbp5 and Dpy30 
(Fig. 1A,B and 2B). Purification of Wdr82 indicated stoichiometric amounts of Cfp1 and 
Set1a/b and slightly lower amounts of the WRAD components (Fig. 5A). Again, Dpy30 is 
present as a trimer. The Wdr82 purification also identified the Bod1 and Bod1L1 proteins as 
novel interactors, which we studied further (see below). As expected (Lee et al., 2010) we also 
identified the whole PP1 protein phosphatase complex (Tox4, Pp1a/b/c/, Ppp1R10), which 
was present at a ~10-fold higher abundance than the Set1a/b proteins (Fig. 5C). In addition we 
identified several novel Wdr82-interacting proteins, which are in much lower abundances 
than PP1 and SET1A/B complexes (Fig. 5C). 
Cfp1 purification resulted in SET1A/B complex members and appears to be an exclusive 
and specific SET1A/B subunit (Fig. 5B). Similar to Wdr82 purification, the Bod1 and Bod1L1 
proteins were identified as interactors, which suggests that they are genuine interactors of 
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the SET1A/B complexes. Analysis of Cfp1 stoichiometry in WRAD pull-downs indicated that 
Cfp1 binds with a stoichiometry of approximately 1.6 relati ve to the total HMT subunit, 
1.6:1/1/1/2 (Cfp1:Wdr5/Rbbp5/Ash2l/Dpy30). This may indicate a potenti al dimerizati on of 
Cfp1 in the SET1A/B complexes.
Bod1 and Bod1L1 are human paralogs of yShg1p and exclusive to SET1B
The bi-orientati on defected 1 protein (Bod1) is important for proper chromosome 
segregati on during mitosis (Porter et al., 2007). Bod1 and the highly similar Bod1L1 were 
identi fi ed in our experiments to interact with all members of the WRAD complex (Fig. 1B,C 
and 2A,B). Purifi cati on of the specifi c SET1A/B subunits Cfp1 and Wdr82 revealed that Bod1 
and Bod1L1 are exclusively present in SET1A/B complexes, as we fi nd specifi c and shared 
pepti des for both proteins (Fig. 5A,B). 
To investi gate this further we constructed a GFP-Bod1 expressing cell line and analyzed its 
interactors. Interesti ngly, Set1b was the only HMT interactor (Fig. 5E). Esti mati on of the 
relati ve abundance of Set1a and Set1b in the Bod1, Cfp1 and Wdr82 pull-downs, confi rmed 
that Bod1 exclusively interacts with the SET1B complex (Fig. 5D). In contrast, Cfp1 and 
Wdr82 interact mostly, but not exclusively, with Set1a and the rati o of Set1a/Set1b being 
similar to the rati os in the WRAD purifi cati ons (Fig. 5D and 2F).
The Bod1 pull-down identi fi ed unique pepti des for Bod1L1 with higher iBAQ intensity than 
the other SET1B complex members, which may indicate that Bod1 and Bod1L1 could interact 
outside of the SET1B complex. Alignment of the Bod1 homologous sequences from human, 
fruit fl y and zebrafi sh revealed a high degree of similarity with the S. cerevisiae protein Shg1p 
(data not shown). Intriguingly, Shg1p (a.k.a. Csp15) is part of the yeast COMPASS complex. 
Shg1p interacts with RNA, which aff ects yeast SET1 complex assembly (Dehe et al., 2006; Halbach 
et al., 2009). Based on the identi fi cati on of Bod1 in SET1B and the high sequence similarity we 
propose that Bod1 and Bod1L1 are the higher eukaryoti c paralogs of yeast Shg1p.
Discussion
Recent developments in quanti tati ve mass spectrometry allowed an unbiased, quanti tati ve 
and comprehensive interacti on study on the six COMPASS-like H3K4 methyltransferase 
complexes in humans (Smits et al., 2013). We identi fi ed many known interactors illustrati ng 
the high quality of our data sets and calculated their stoichiometries. The ten SET1/MLL 
pull-downs were clustered based on the identi fi ed interactors and presented as a heat-map 
refl ecti ng their stoichiometry (Fig. 6A and summarized in Fig. 6B). Our approach indicates a 
high degree of diversity in the peripheral subunits of the diff erent HMT complexes.
The smallest core subunit of the SET1/MLL complexes, Dpy30, shows an interesti ng behavior. 
It was shown to interact with Ash2l as a dimer (Patel et al., 2009). However, we observe a 
stoichiometry of ~6 in Mll1/2, whereas Mll3/4 and Set1A/B bind ~3 molecules of Dpy30 
per complex (Fig 6B). This argues for additi onal binding sites on the Mll and Set proteins or 
on the peripheral subunits. Dpy30 is only 11 kDa, therefore the quanti fi cati on is based on a 
limited number of trypti c pepti des, leading to the observed higher standard deviati on. We 
also identi fi ed all members of the NURF complex (Barak et al., 2003) in the GFP-Dpy30 pull-
down and we identi fi ed Dpy30 in the pull-down with the Bap18 subunit of NURF (Fig 2C). 
These fi ndings imply that Dpy30 is a genuine subunit of NURF and that its functi on should 
not be interpreted solely in the context of HMT complexes (Jiang et al., 2011). 
The same holds true for Wdr5, which was identi fi ed as a central hub in chromati n associated 
complexes. Since Wdr5 was described as a SET1/MLL complex member, many Wdr5 
interactors have previously been linked to the SET1/MLL complexes, such as the INO80, 
TFIID and NSL complexes (Trievel and Shilati fard, 2009). This annotati on is sti ll present in gene 
ontology databases. These interacti ons are, however, not found in the other core SET1/
MLL subunit pull-downs (Rbbp5, Ash2l or Dpy30). This indicates that rather than SET1/
MLL complex interactors, these protein complexes should be annotated as exclusive Wdr5 
interactors. It was shown that Wdr5 binds to the tail of histone H3 and that this may 
facilitate methylati on by HMTs (Song and Kingston, 2008; Dharmarajan et al., 2012). Similarly, H3 tail 
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Rbbp5, Ash2L and Dpy30 pull-downs. Bait proteins are indicated on top and identi fi ed interactors on the right. 
Coloring (ascending from grey to red via yellow and orange) is based on the stoichiometry of the interactor in 
that pull-down, relati ve to the total amount of Set1a/b and Mll1-4 proteins found for that bait. Signifi cant outliers 
are indicated (+) for each bait protein. (B) Summary of the compositi on and relati ve amounts of the SET1/MLL 
complexes determined in this study. Dpy30 is present as a multi mer dependent on the complex context. Proteins 
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presentation by Wdr5 could be relevant for the binding or modification by the complexes 
identified as Wdr5 interactors here.
Our results address the question of the limiting components for the assembly of SET1/MLL 
complexes in cycling HeLa cells. With the exception of Set1a, the HMTs are present in low 
amounts in crude nuclear extracts. The WRAD subunits and specific interactors like Wdr82, 
Psip, Menin and Bod1 are more abundant. These observations support the existence of (W)
RAD subcomplexes lacking the HMT subunit (Steward et al., 2006). Furthermore, our unbiased 
approach shows that the complex-specific subunits can also be part of other complexes, like 
Dpy30 in NURF, Wdr82 in the PP1 phosphatase (Lee et al., 2010) and Psip in the Cdc7/Dbf4/
Cdca7l complexes (Maertens et al., 2006; Hughes et al., 2010). These observations raise questions 
regarding the regulation of these different interactions during the cell cycle or upon 
cellular stress. Interestingly, different components of the MLL1 complex display differential 
chromatin binding during mitosis (Blobel et al., 2009).
Whereas Menin binds Mll1 and Mll2 with equal affinity, Psip1 shows a striking preference for 
Mll2, under the used conditions in HeLa cells (Fig. 6B). This conflicts with an earlier protein-
protein interaction study using fragments of these proteins (Huang et al., 2012). Although 
Psip1 and Menin are sub-stoichiometric MLL1/2 subunits, both proteins are essential for 
oncogenic transformation by Mll1 fusions (Yokoyama et al., 2005; Yokoyama and Cleary, 2008). Our 
observation that Psip is mainly a MLL2 complex member may imply that the function of 
Psip during Mll1-fusion mediated oncogenesis is dependent on MLL2 function as much as it 
depends on the wild type MLL1 complex (Thiel et al., 2010).
Bod1 has been linked previously to chromosome segregation during mitosis (Porter et al., 2007). 
The phenotype of Bod1 depletion and the association of the other SET1B complex member 
Wdr82 with PP1, of which inactivation leads to a mitotic arrest (Fernandez et al., 1992), hints to 
a link between the SET1B complex, histone methylation and mitotic progression. In yeast, 
Set1p was reported to inhibit aurora kinase function during chromosome segregation, 
which involves methylation of the Dam1p kinetochore protein (Zhang et al., 2005). Based on 
these observations, we speculate that the SET1B complex plays a similar role during mitosis 
in mammalian cells.
The absolute protein quantification data of the nuclear extract are in good (but not perfect) 
agreement with the observed stoichiometries of SET1/MLL complex subunits. The higher 
abundance of WRAD subunits supports existence of free (W)RAD subcomplexes (Steward et 
al., 2006). Additionally, the finding that Wdr5 and Dpy30 are subunits of other chromatin 
regulatory complexes is mirrored by their higher abundance in nuclear extracts. This 
suggests that absolute protein quantifications could be predictive for multimerization and/
or association with multiple complexes. This concept could be applied to predict composition 
of protein complexes in tissue samples for which insufficient material is available for 
biochemical purification. 
Taken together, our quantitative mass spectrometry analysis of the major H3K4 
methyltransferase complexes in human cells, revealed both known and novel, unique 
and shared, interactors and determined their distribution and stoichiometry over the 
different SET1/MLL complexes. The comprehensive and quantitative mapping of subunit 
composition and abundance provides a molecular framework to understand the diversity 
and contributions of the SET1/MLL complexes in establishing H3K4 methylation patterns.
Material and methods
Plasmids and cell culture
The ORF of the bait protein was amplified by PCR using the relevant human cDNA constructs 
and introduced into pDONR2.1. The DNA sequence of the amplified ORF was verified and 
introduced into a GATEWAY-compatible pCDNA5/FRT/TO. All proteins except for Menin 
were tagged by GFP at the N-terminus. cDNA constructs for Wdr5, Dpy30, Rbbp5 and Ash2l 
(short isoform) were kindly provided by dr. Ali Shilatifard and Bod1 cDNA was a kind gift 
from dr. Jason Swedlow. Human Pa1 and Cfp1 and mouse Wdr82 and Ptip cDNAs were 
obtained from Source Bioscience (Cfp1: IRATp970F0412D, Wdr82: IRCKp5014J0617Q, Pa1: 
IRAUp969E1119D, Ptip1: IRAV9968G04124D). Stable doxycycline-inducible cell lines were 
created by transfecting pCDNA5/FRT/TO and pOG44 into HeLa FRT cells carrying the TET 
repressor using polyethyleneimine followed by antibiotic selection. Cells were grown in 
DMEM with high glucose supplemented with pen/strep and L-Glutamine (all LONZA) under 
blasticidin and hygromycin B selection. Protein expression was induced by addition of 0.5 
µg/ml doxycycline to the culture media 16 hours prior to cell harvesting. Expression of the 
proper-sized GFP-fusion protein was validated by immunoblotting and by fluorescence 
microscopy. Bap18-GFP bacterial artificial chromosomes were stably transfected in HeLa 
cells and selected using geneticin (G418, Gibco).
GFP affinity purification and sample preparation
Extract preparation (Dignam et al., 1983) and affinity purifications using GFP-beads (Hubner et 
al., 2010) were performed essentially as described before. Briefly, nuclei were isolated and 
nuclear extracts were prepared using hypotonic lysis. Purifications for GFP lines and WT 
HeLa cells were performed in triplicate using 1 mg of nuclear extract per purification and GFP 
binder beads (CHROMOTEK) in 20 mM HEPES-KOH pH 7.9, 20% glycerol, 300 mM NaCl, 2 mM 
MgCl2, 0.2 mM EDTA, 0.1% NP-40, 0.5 mM DTT and complete protease inhibitors (Roche). All 
purifications included 50 µg/ml ethidium bromide to suppress DNA mediated interactions. 
After 2.5 hours incubation at 4°C the beads were extensively washed and on-bead digestion 
was performed using trypsin (Promega). After desalting and concentration on StageTips the 
peptides were applied to online nanoLC-MS/MS, using a 120 min acetonitrile gradient (5.6 
- 76%). Mass spectra were recorded on an LTQ-Orbitrap-Velos mass spectrometer (Thermo) 
selecting the 15 most intense precursor ions of every full scan for fragmentation.
Data analysis
Raw data were analyzed using MaxQuant 1.3.0.5, with label-free quantification (LFQ), match 
between runs (between triplicates) and the iBAQ algorithm enabled (Cox and Mann, 2008). The 
identified proteins were filtered for known contaminants and reverse hits, as well as hits 
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without unique peptides. Protein interactor identification was done as described (Hubner 
et al., 2010). In short, the normalized mass spectrometric intensities (LFQ intensities) were 
compared between the GFP-tagged and control sample, using an adapted permutation-
based false discovery rate (FDR) t-test in Perseus (MaxQuant package). The threshold for 
significantly identify interactors is both based on the FDR and the ratio between GFP and 
control sample. This threshold is empirically optimized for each experiment.
The stoichiometry was determined for significant interactors as previously (Smits et al., 
2013). Here, mass spectrometric intensities were normalized for the theoretical number 
of observable peptides by the iBAQ algorithm. Thereby, the normalized intensities (iBAQ 
intensities) give a measure for protein abundance and can be directly compared between 
proteins. The iBAQ intensities measured in the control sample indicate the amount of 
background binding and were therefore subtracted from the iBAQ intensities obtained in the 
GFP sample. Finally, the corrected iBAQ intensities were scaled to the total amount of Set1/
Mll subunit, thereby allowing direct comparison of the different purifications. The average 
and standard deviation of the resulting stoichiometries were calculated per triplicate. 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner 
repository (Vizcaino et al., 2013) with the dataset identifier PXD000172.
Absolute protein quantification in HeLa nuclear extract
Nuclear extracts from the HeLa Kyoto cell line were subjected to absolute protein 
quantification using iBAQ and a universal protein mix standard (UPS2), as described before 
(Schwanhausser et al., 2011). Briefly, 3 µg of UPS2 was added to 10 µg of HeLa nuclear extract, 
followed by FASP digestion (Wisniewski et al., 2009b). In parallel, 100 µg of HeLa nuclear extract 
was applied to FASP followed by strong anion exchange (SAX) chromatography resulting in 8 
fractions. After purification on stage tips, all 9 samples were separately measured by LC-MS/
MS over a 4 hour acetonitrile gradient (5.6% - 76%). Raw data were analyzed by MaxQuant 
1.3.0.5 with iBAQ quantification enabled. A linear regression curve was made between the 
known UPS2 concentrations (log scale) and the measured iBAQ intensities for these proteins 
(log scale), which was used to extrapolate the absolute protein numbers of all measured 
proteins in this sample. Next, linear regression of these absolute protein abundance and 
their iBAQ intensities of these in the SAX dataset, allowed to quantify the absolute amounts 
for all proteins found in the large SAX dataset.
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Figure S1. Full volcano plots of the plots presented in the main figures. Support of Figures 1,2 and 3.
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Abstract
Quantitative mass spectrometry-based approaches have greatly contributed to the 
understanding of protein-protein and protein-DNA interactions. Currently, most approaches 
use epitope-tagging of proteins of interest in order to enrich them and their interactors from 
complex mixtures. The usually N- or C-terminus fused tags however have the potential to 
perturb protein functionality due to their size. Unnatural amino acids (UAAs) harboring small 
reactive handles can be site-specifically incorporated into proteins and could overcome the 
problems associated with conventional epitope tagging. Here, we introduce Click-MS, which 
combines the power of site-specific UAA incorporation and quantitative mass spectrometry-
based proteomics to develop a comprehensive protein-protein interaction identification 
workflow. By incorporating p-azido-l-phenylalanine (azF) in the protein of interest, the 
protein can be modified or immobilized using bioorthogonal chemistry. The system was 
developed using the mCherry-GFP model protein and extended to the methyl-CpG-
binding domain protein 3 (MBD3), which assembles in the Nucleosome Remodeling and 
Deacetylase (NuRD) complex. With the used site of UAA incorporation and under optimized 
bioorthogonal chemistry conditions, we were able to demonstrate the validity of the Click-
MS concept by specifically enriching MBD3 and a partial NuRD complex. 
Introduction
Many proteins assemble into protein complexes. Typically, protein complexes comprise 
of stoichiometric core subunits and substoichiometric interactors. The identification of 
protein-protein interactions (PPIs) is critical to understand protein function. During the 
last two decades, mass spectrometry-based proteomics has emerged as a powerful tool to 
study these protein-protein interactions. Traditionally, protein complexes were purified to 
near purity using tandem-affinity purification workflows (Gavin et al., 2006; Krogan et al., 2006). 
Recently, quantitative methods were developed that facilitate the identification of high-
confidence PPIs using single-affinity purifications (Vermeulen et al., 2008). These methods rely 
on the incorporation of stable isotopes in proteins or on label-free quantification algorithms 
(Rinner et al., 2007; Sardiu et al., 2008; Hubner et al., 2010).
Affinity purifications can be based on immunoprecipitation of endogenous proteins, 
relying on high-quality antibodies that are often of limited availability (Gingras et al., 2007). 
Furthermore, these antibodies often exhibit cross reactivity, therefore requiring elaborative 
validation experiments such as knockdown of the protein of interest (POI) to obtain high-
confidence interactors (Selbach and Mann, 2006). More often, epitope tags are fused to the 
target protein, enabling the use of well-characterized antibodies, for example TAP (Gavin et 
al., 2002), FLAG (Ho et al., 2002) and GFP tags (Cristea et al., 2005). However, proteins or peptides 
that are fused to the N- or C-terminus as a purification tag, can interfere with the structure 
and/or function of the POI, as was reported for example for Myef2 (van Riel et al., 2012). As a 
consequence, important protein-protein interactions at the termini might not be detected 
due to sterical hindrance of the fused tag.
A small reactive handle that can be placed at any position inside a protein could potentially 
overcome these technical problems. The amber suppression technology, which was 
developed by Schultz and coworkers, provides a powerful method to site-selectively 
incorporate an unnatural amino acid (UAA) into a POI (Wang et al., 2001). In this approach, 
an amber stop codon is introduced into the target protein and a 21st orthogonal tRNA and 
aminoacyl-tRNA synthetase pair is added to the endogenous translational machinery of the 
host organism. Among a variety of different UAAs, azido-functionalized UAAs have been 
site-selectively incorporated into different proteins using this methodology (Chin et al., 2002; 
Liu et al., 2007). The azide is a reactive handle, that is small in size as well as bioorthogonal 
meaning it shows no interference with the biological surrounding (Sletten and Bertozzi, 2009; 
Borrmann and van Hest, 2014). It can be selectively functionalized with alkyne-bearing probes 
even in complex biological samples containing other nucleophiles such as amines or thiols. 
The first biorthogonal reaction utilizing the azide was the Staudinger ligation, in which the 
azide reacts with a triarylphosphine (Saxon and Bertozzi, 2000). Next to triarylphosphine, azides 
can also react with alkynes (Scheme 1). Two types of reactions of alkyne-azide reactions 
are known: i) the copper-catalyzed azide-alkyne reaction (CuAAC, often referred to as ‘click 
chemistry’) that uses Cu(I) as the catalyst for the reaction of azides with terminal alkynes 
(Rostovtsev et al., 2002; Tornoe et al., 2002) and ii) the strain-promoted azide-alkyne cycloaddition 
(SPAAC, ‘copper-free click chemistry’) which uses ring strain to activate the alkyne (Agard et 
al., 2005). Recently, Tirrell and coworkers have successfully developed an elegant technique 
to monitor proteome-wide changes in expression using the azide/alkyne pair (Dieterich et al., 
2006). This method enables the specific enrichment and subsequent identification of newly 
synthesized proteins, yet it does not allow for the enrichment of a single protein of interest. 
Here, we combine the power of amber suppression technology and quantitative mass 
spectrometry-based proteomics to develop a comprehensive PPI identification workflow 
without the need of fusing a tag to the POI. By incorporating p-azido-l-phenylalanine (azF) 
Cu(I)CuAAC:
Copper-catalyzed
click reaction
SPAAC:
Copper-free
click reaction
N
N
NN3 protein+
proteinN3
N
O
+
N
N
N
protein
N
O
protein
Scheme 1. Schematic representation of the two bioorthogonal reactions employed in this chapter. The copper-
catalyzed azide–alkyne cycloaddition (CuAAC) and the strain promoted azide–alkyne cycloaddition  (SPAAC).
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in the protein of interest, the protein can be modified or immobilized using bioorthogonal 
chemistry. The immobilized protein and its interactors can subsequently be identified using 
mass spectrometry. The system was developed using the mCherry-GFP model protein 
and extended to the methyl-CpG-binding domain protein 3 (MBD3). MBD3 assembles in 
the Nucleosome Remodeling and Deacetylase (NuRD) complex (Kehle et al., 1998; Xue et al., 
1998; Zhang et al., 1998). Initially, NuRD was postulated to act as a repressor, but recently the 
complex has also been implicated in activation or modulation of transcription (Reynolds et 
al., 2012; Zhang et al., 2012). The characterization of MBD3/NuRD is of high interest to dissect 
its role in transcriptional regulation. With the currently used site of UAA incorporation and 
under optimized bioorthogonal chemistry conditions, we specifically enrich MBD3 and a 
partial NuRD complex. This finding shows that direct enrichment of the protein of interest is 
feasible, but for comprehensive PPI identification multiple sites of UAA incorporation need 
to be tested.
Results
Amber suppression set-up
Given the limitations associated with N-or C-terminal peptide or protein fusions, we aimed 
to develop an enrichment strategy to purify a single protein and its interactors from whole 
cell lysate using click chemistry in combination with quantitative mass-spectrometry 
based proteomics. For this purpose, we selected a tRNA and aminoacyl tRNA synthetase 
(aaRS) pair that enables the incorporation of an azido-moiety into the growing peptide 
chain of a protein-of-interest in response to the amber (UAG) stop codon (Fig. 1A) (Ye et 
al., 2009; Naganathan et al., 2013). To test the incorporation of the unnatural amino acid azF, 
we first selected an mCherry-GFP construct, that contains a TAG stop codon in the linker 
region between the two proteins (mCherry-GFPTAG) (Plass et al., 2012). HEK293T cells were 
transiently co-transfected with three plasmids each carrying the tRNA, aaRS or mCherry-
GFPTAG genes. Cells were cultured for 36-48h in the presence of 250 µM azF, before being 
analyzed by confocal microscopy for orange and green fluorescence. Green fluorescence 
was only detected when cells were grown in the presence of azF showing the successful 
incorporation of azF into mCherry-GFPTAG (Fig. 1B). Flow cytometry analysis further revealed 
that approximately 60% of all cells were successfully transfected with the mCherry-GFPTAG 
construct and half of these cells also showed green fluorescence due to amber suppression 
(Fig. 1C). Taken together, these data indicate the successful incorporation of azF in response 
to the amber stop codon.
Proteomic investigation of amber suppression 
Before using amber suppression technology for quantitative mass spectrometry-based 
studies, it is important to investigate whether an additional tRNA and aaRS pair inside 
the cell has an effect on the proteome of the cell. Since the TAG stop codon is a naturally 
occurring stop codon (≈20% of all genes (Sun et al., 2005)), it might be that the incorporation 
of azF at those endogenous TAGs affects expression of other proteins inside the cell. To 
investigate a potential effect on the proteome, we performed a stable isotope labeling 
of amino acids in cell culture (SILAC) experiment. To this end, we incubated cells grown 
in ‘heavy’ medium (supplemented with heavy lysine (13C6
15N2
1H14
16O2) and heavy arginine 
(13C6
15N4
1H14
16O2)) with 250 µM azF, and cells grown in ‘light’ medium (supplemented with 
normal lysine and arginine) were left untreated (Fig. 2A). As a control, we also performed 
a ‘reverse’ experiment by incubating light-labeled cells with azF and leaving heavy-labeled 
cells untreated. After 24h of incubation the appropriate heavy- and light-labeled cells were 
combined and lysed. Proteins were digested and prepared for mass spectrometry using 
filter-aided sample preparation (FASP) (Wisniewski et al., 2009b) and analyzed by LC-MS/MS. 
Each peptide that will be identified by mass-spectrometry analysis will have a heavy-to-light 
ratio (H/L) corresponding to its relative abundance in the heavy and light samples. Proteins, 
that are identified in the ‘forward’ experiment and that will be affected by azF can have 
either a high H/L ratio in case of protein up-regulation or a low H/L ratio in case of down-
regulation (Fig. 2A). In the reverse experiment, upregulated proteins will have a low H/L 
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Figure 1. Amber suppression set up using the model protein mCherry-GFPTAG. (A) Transfection of tRNA, aaRS and 
mCherry-GFPTAG plasmids with the addition of azF results in suppression of the amber stop codon, incorporation of 
azF and expression of the full length protein. (B) Confocal microscopy pictures of transfected cells with or without 
the addition of azF. Scale bar represents 50 µm. (C) FACS analysis of the transfected cells with or without the 
addition of azF using red and green fluorescence.
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rati o and downregulated proteins a high H/L rati o.
Using MaxQuant analysis soft ware (Cox and Mann, 2008), we quanti fi ed rati os for all identi fi ed 
pepti des and corresponding proteins to investi gate the eff ect of azF incubati on on protein 
expression. As shown in fi gure 2B, no substanti al changes could be observed when cells 
were treated with azF. One out of 2000 quanti fi ed proteins showed a slightly changed 
expression profi le. Interesti ngly, analysis of the SILAC samples that were transfected with 
the tRNA and aaRS carrying plasmids revealed a small upregulati on of four histone proteins 
(Fig. 2C). Transfecti on of tRNA and aaRS-plasmids followed by incubati on with azF resulted 
in upregulati on of 6 proteins (Fig. 2D). To increase the depth of the proteome, we applied 
strong anion exchange (SAX) fracti onati on (Fig. S1) (Wisniewski et al., 2009a). In total, 4600 
proteins were quanti fi ed of which only 5 proteins showed an over 1.5 fold upregulati on. 
None of the identi fi ed regulated proteins in all experimental conditi ons showed an H/L rati o 
greater than three. Notably, these proteins are not directly involved in cellular pathways 
involving stress responses or cell cycle regulati on. Additi onally, none of the proteins contain 
an amber stop codon. In summary, possible translati onal read-through at endogenous UAG 
stop codons does not seem to result in drasti c changes in the proteome. These data suggest 
that the additi on of the tRNA/aaRS pair and azF is well tolerated by the cell without aff ecti ng 
the expression of other proteins.
Bioorthogonal labeling and immobilizati on
In order to purify an azido-functi onalized protein and its interactors from cell lysate, we next 
examined whether we could label the incorporated azide with an alkyne probe using either 
copper-catalyzed or copper-free click chemistry (Scheme 1). Copper(I) is used as the catalyst 
in the copper-catalyzed reacti on to promote the reacti on between the azide and a terminal 
alkyne, whereas in copper-free click chemistry ring strain is solely used to accelerate the 
reacti on between the azide and alkyne. Since copper can complex with biomolecules, it 
is important to add a copper-binding agent to the reacti on mixture when this reacti on is 
performed in biological samples such as cell lysate. One commonly used ligand that has been 
successfully applied in copper-catalyzed click reacti ons is tris-(benzyltriazolylmethyl)amine 
(TBTA) (Chan et al., 2004). To label azido-containing mCherry-GFPTAG using CuAAC, cells were fi rst 
lysed in HEPES buff er containing 1% NP-40 followed by incubati on with the copper catalyst, 
TBTA and an alkyne-modifi ed fl uorescent dye for 2 h at 25°C. Samples were then analyzed by 
SDS-PAGE and in-gel fl uorescence. As shown in Fig. 3B (also Fig. S2), a fl uorescent band was 
visible at the expected height of the mCherry-GFPTAG (≈70 kDa), demonstrati ng successful 
labeling with the alkyne-dye. Notably, two species of lower molecular weight also showed 
fl uorescent labeling. These two lower-molecular weight bands are likely truncated forms 
of the mCherry-GFPTAG fusion protein, since immunoblot analysis for GFP showed the same 
patt ern as was observed for the fl uorescent labeling (Fig. 3A) strongly suggesti ng that all 
three protein species contain azides. An additi onal but fainter band was observed below 50 
kDa (marked with an asterisk), which likely is a result of nonspecifi c labeling.
For copper-free labeling, we used an aza-dibenzocyclooctyne (DBCO)-conjugated fl uorescent 
dye that was incubated with cell lysates for 2 h at 25°C before being analyzed for in-gel 
fl uorescence. As seen in Fig. 3C (also Fig. S2), a fl uorescent signal at the expected height 
was visible, however other bands were also fl uorescently labeled. These proteins were also 
labeled in the control sample that was not treated with azF, indicati ng azide-independent 
labeling of proteins by the DBCO-dye (Fig. 3C, -azF). It has been previously shown that 
cyclooctynes can also react with thiols and that preincubati on with iodoacetamide (IAA) can 
prevent thiol-mediated labeling of proteins by cyclooctynes (van Geel et al., 2012). Therefore, 
we preincubated cell lysates of all samples with 50 mM IAA for 30 min and subsequently 
performed labeling with the DBCO-functi onalized dye for 2 h at 25°C. In-gel fl uorescence 
NIT2
Contaminants
Downregulated
Upregulated
Contaminants
Downregulated
Upregulated
H3.3
H2B H2A
H4
Contaminants
Downregulated
Upregulated
H3.3
H2B
EBNA1BP2
H2A
METAP2
H4
-4 -2 0 2 4
4
2
0
-2
-4
Forward H/L (log2)
azF
R
ev
er
se
 H
/L
 (l
og
2)
1 out of 1992
BA
tRNA + aaRS
-4 -2 0 2 4
4
2
0
-2
-4
Forward H/L (log2)
R
ev
er
se
 H
/L
 (l
og
2)
4 out of 1761
C
tRNA + aaRS + azF
-4 -2 0 2 4
4
2
0
-2
-4
Forward H/L (log2)
R
ev
er
se
 H
/L
 (l
og
2)
6 out of 1961
D
HeavyLight
1) azF
2) tRNA + aaRS
3) tRNA + aaRS + azF
m/z
In
te
ns
ity
Lysis, FASP and LC-MS/MS
down
up
Figure 2. Amber suppression is well tolerated by the cell without aff ecti ng the proteome. (A) Schemati c 
presentati on of the whole proteome analysis upon azF, tRNA + aaRS or tRNA + aaRS + azF treatment. (B, C, D) 
Scatt erplots of the protein rati os obtained in the diff erent treatments. Upper right corner represents upregulated 
proteins, lower left  corner the downregulated proteins and upper left  contaminants. Cutoff  depicted as dashed 
lines at 1.5 fold diff erence.
74 75
Chapter 5 Click-MS
5 5
analysis indeed showed a decrease in background fl uorescence owing from thiol cross-
reacti vity and hence an improved signal to noise rati o for the azide-specifi c labeling of 
mCherry-GFPTAG (Fig. 3C). Again, a faint nonspecifi c ally labelled protein was observed 
(asterisk), which was also present in the empty vector control (Fig. 3C, EV). These data 
confi rm that both the copper-catalyzed as well as the copper-free click reacti on can be 
uti lized for the specifi c labeling of azido-containing proteins in complex protein mixtures, as 
was shown before (Rabuka et al., 2006; Ngo et al., 2009; van Geel et al., 2012; Elliott  et al., 2014).
Next, we examined whether we could selecti vely immobilize the azido-mCherry-GFPTAG from 
cell lysate using alkyne- or DBCO-functi onalized agarose beads. We performed a depleti on 
experiment, in which cell lysates were incubated with alkyne- or DBCO-functi onalized beads 
followed by centrifugati on and immunoblot analysis of the supernatant with an anti -GFP 
anti body (Fig. 3D). A decrease in mCherry-GFPTAG signal should be noti ceable compared 
to the input samples, if azido-mCherry-GFPTAG was successfully captured by the beads. 
Incubati on with DBCO-modifi ed beads indeed showed depleti on of mCherry-GFPTAG (≈80% 
effi  ciency) (Fig. 3E). As a control experiment, we also incubated unmodifi ed agarose beads 
with cell lysates and did not observe unspecifi c binding of proteins to the beads. Immunoblot 
analysis of the ubiquitous protein GAPDH was used as a loading control to assess azide-
independent protein loss. Signal intensity of GAPDH was similar for all samples. These 
results indicate that azido- mCherry-GFPTAG could be selecti vely enriched from cell lysates. 
When the depleti on experiment was performed with alkyne-modifi ed beads and CuAAC, 
selecti ve enrichment was not observed for the azido- mCherry-GFPTAG (Fig. 3F). Both GAPDH 
and GFP signals were reduced, indicati ve of protein precipitati on. To circumvent protein 
precipitati on, we switched to the water soluble Cu(I) ligand tris-(hydroxypropyltriazolyl)
methylamine (THPTA), which was also recently uti lized for click chemistry in biological 
samples (Hong et al., 2009). The GAPDH level was only slightly aff ected using THPTA and 0.2 
mM CuSO4, whereas a clear reducti on was observed for the GFP level (≈50% effi  ciency) (Fig. 
3G). In summary, azide-functi onalized proteins can be selecti ve immobilized using copper-
free and copper-catalyzed click chemistry with THPTA as the copper-chelati ng ligand. 
AzF incorporati on into MBD3
To study the feasibility of click chemistry-based protein enrichment and PPI identi fi cati on, 
we chose to study MBD3, a protein that assembles in the NuRD complex. As MBD3/NuRD 
is involved in transcripti onal regulati on, the characterizati on of the complex compositi on is 
of high interest. We developed fi ve diff erent amber mutants for MBD3 spanning the enti re 
protein (Fig. 4A). Sites were selected to be outside highly conserved regions and functi onal 
domains as well as to be inside predicted hydrophilic amino acid stretches and loops. For 
initi al screening purposes, we used a C-terminal GFP fusion protein. All amber mutants were 
validated to show MBD3-GFP expression upon successful amber suppression by additi on 
of azF (Fig. S3). However, R3TAG already showed green fl uorescence without the additi on of 
azF. The integrity of the protein was checked by western blotti  ng (Fig. 4B). The full length 
protein was detected for all amber mutants upon azF additi on, although R3TAG also gave 
rise to a truncated product. The size of this truncated product indicates that it could be a 
result of translati on initi ati on from an internal ATG codon (M74), explaining the observed 
azF-independent expression (Fig. S3). Taken together, these results show the successful 
generati on and expression of MBD3 amber mutants.
The incorporati on of functi onal azF was tested by labeling of MBD3-GFP with DBCO-dye, 
which showed azF-dependent labeling of the MBD3 ambers (Fig. 4C). The full length protein 
of R3amber was weakly labeled, whereas the truncated product was not, indicati ng that only 
the full length product contained a functi onal azF. The successful labeling of these MBD3 
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an initial screen, the V89TAG, T211TAG and L231TAG were incubated with DBCO agarose beads 
and the remaining lysate was compared with the input levels of MBD3 (Fig. 4D). The MBD3 
levels were clearly reduced in all tested MBD3 amber mutants, whereas the GAPDH levels 
were only slightly affected. Therefore, DBCO agarose beads can be used to capture azide-
functionalized MBD3 from cell lysate.
MBD3T211TAG Click-MS
The successful immobilization of MBD3 amber mutants using copper-free click chemistry 
prompted us to incorporate this enrichment strategy in our mass spectrometry-based 
protein-protein interaction screens (Hubner et al., 2010; Smits et al., 2013). We dubbed this new 
bioorthogonal chemistry-based interaction proteomics workflow Click-MS. For this purpose, 
we generated whole cell lysates from MBD3T211TAG and empty vector (EV) expressing cells, 
which both expressed tRNA and aaRS and were treated with azF (Fig. 5A). The lysates were 
incubated with DBCO agarose beads, followed by extensive washing of the beads and on-
bead digestion, before applying the peptides to LC-MS/MS. The enrichments were done 
in triplicate to allow label-free quantification and statistical testing, and the EV served as 
a control for quantitative comparison to distinguish interactors from background binding 
proteins.
The experiments were performed with a higher protein content than for the initial 
experiments as shown in figure 4 in order to get good coverage of all proteins in the LC-MS/
MS analysis. The MBD3T211TAG depletion was checked on western and showed a reduction 
of around 50%, whereas GAPDH levels remained comparable (Fig. 5B). This is a slightly less 
efficient reduction, which could be due to the higher protein content of these depletions. 
The enriched proteins were digested and analyzed by mass spectrometry. The resulting 
quantification of all identified proteins was depicted in a volcano plot, which plots the false 
discovery rate (-log scale) against the observed enrichment (MBD3T211TAG/EV ratio, log2 scale) 
(Fig. 5C). We observed an over 1000-fold enrichment of MBD3 compared to the EV control. 
This extreme enrichment illustrates the efficient and highly specific purification of azF-
containing MBD3 from cell lysate. We also found GATAD2A and GATAD2B enriched in these 
pulldowns (Fig. 5C). Both the proteins are part of the NuRD complex. Although this only 
resembles a partial NuRD complex, the identification of these protein interactors already 
illustrates the capability of Click-MS to identify protein-protein interactions.
As a second comparison, we performed a set of Click-MS experiments for MBD3T211TAG with 
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and without azF as well as the empty vector control (Fig. S4A). Although the noise levels 
were higher for these experiments, MBD3 was clearly enriched in the MBD3T211TAG +azF 
versus –azF (Fig. S4B) as well as the MBD3T211TAG versus EV comparison (Fig. S4C). However, 
the background cloud did not show a symmetric distribution when the –azF control was used 
as a control. This might lead to more false positive hits, putting forward the empty vector 
sample as the more appropriate control. Of note, these false positive hits did not contain 
endogenous amber stop codons. This experiment also allowed for the direct comparison 
between the EV and –azF pulldowns (Fig. S4D). Significantly enriched proteins in the EV 
samples compared to the –azF samples could indicate azF incorporation in endogenously 
expressed proteins that contain the amber stop codon. However, we did not identify such 
enrichment in the empty vector control (Fig. S4D). This is in agreement with the notion that 
amber suppression does not perturb the cellular state as seen with the whole proteome 
analyses (Fig. 2). Together, these results establish Click-MS as a method to specifically enrich 
a protein of interest and its interactors without affecting the cellular state. 
Discussion
Affinity purification combined with mass spectrometry is an important tool for the 
identification of PPIs. Conventional techniques utilize antibodies for the purification of an 
epitope-tagged protein and its interactors. The site-directed incorporation of an UAA in 
response to the amber stop codon using an orthogonal tRNA/aaRS pair in combination with 
bioorthogonal chemistry offers an elegant way to circumvent N- or C-terminal peptide or 
protein fusions to the POI.
The amber suppression technology has already been used for many different types of 
applications such as spatiotemporal protein activation, direct mapping of protein-protein 
or protein-ligand interactions via photocrosslinking  and fluorescent protein labeling (Chin, 
2014). The site-directed incorporation of UAAs could even be extended from mammalian 
cells to the model organisms Caenorhabditis elegans and Drosophila melanogaster (D. 
melanogaster) (Greiss and Chin, 2011; Bianco et al., 2012). The effect of amber suppression 
technology in D. melanogaster was phenotypically examined by comparing the hatching 
rate of treated and untreated flies. In this comparison, no major differences were observed 
between the two populations. Another study by Chin and coworkers also reported no 
drastic effects on the viability of mammalian cells harboring a 21st tRNA/aaRS and UAA (Elliott 
et al., 2014). To the best of our knowledge, an analysis of the effect of amber suppression 
technology on a molecular level has not been reported yet. As a first effort, we studied the 
effect of amber suppression technology on the proteome using SILAC-based proteomics. 
The addition of an orthogonal tRNA/aaRS pair for incorporating azF inside mammalian cells 
resulted in the up-regulation of 5 out of approximately 4600 quantified proteins. None of the 
upregulated proteins exceeded 3 fold increase compared to untreated cells, indicating only 
a minimal effect on the cellular proteome. This result suggests that putative readthrough at 
endogenous amber stop codons does not have an effect on other cellular pathways.
In our experiments, cells were treated with 250 µM azF. Increasing concentrations of the 
amino acid could potentially result in more pronounced changes in the proteome. The fact 
that increased UAA concentrations can have an effect on the cellular proteome was recently 
demonstrated in a study by Tirrell and colleagues that described the residue-specific 
incorporation of an azido-containing methionine (Met) analogue in response to Met codons 
(Bagert et al., 2014). Incubation of cells with 1 mM of the azido-containing Met analogue for 24 
h resulted in substantial expression changes for 36% of all quantified proteins. However, co-
incubation of 1 mM of the azido-containing Met analogue with 33 µM of Met affected the 
proteome only minimally (3 out of 1257 proteins showed a slight effect). 
Once established that amber suppression does not affect the proteome, we focused on 
the selective enrichment of MBD3 using a minimal tag and biorthogonal chemistry. We 
successfully incorporated azF into MBD3 and were able to selectively enrich MBD3 from 
cell lysate and co-purify two of its known interactors using copper-free click chemistry . 
Preincubation with iodoacetamide (IAA) was required in order to increase the specificity 
of the copper-free click chemistry with DBCO. PPIs could be influenced by the treatment 
with IAA, which could be tested in a separate experiment with conventional GFP pulldowns. 
The copper-catalyzed click reaction is much more specific than its copper-free variant and 
hence a pretreatment with IAA is not needed. However, the copper-catalyzed click reaction 
can induce protein precipitation, which interferes with the specific enrichment of azido-
tagged protein. When we used the water-soluble copper-chelating ligand THPTA and 0.2 
mM copper, we observed specific enrichment of azido-tagged protein without simultaneous 
nonspecific precipitation of other proteins. Whether this copper-catalyzed click reaction is 
suitable for the identification of PPIs using quantitative mass spectrometry remains to be 
investigated. 
MBD3 is known to interact with at least all of the 12 members of the NuRD complex (Smits 
et al., 2013). We successfully identified two of its known interactors showing that enrichment 
with a minimal tag is feasible. Pulldown experiments using other amber mutants, each 
containing the azide at a different site, may result in the complete identification of all 
interactors and may provide additional information on the binding site of an interactor. 
Furthermore, increasing the bead-alkyne linker length could have a beneficial effect on the 
labeling efficiency, especially for mutants that contain the azide at a less accessible site within 
the protein. In addition, structural information on the POI can guide the choice on which 
residues are good candidates for mutation. Moreover, it was recently shown that residues 
close to the NLS sequence are potentially good candidates for the introduction of pulldown 
tags, since these residues are more likely solvent-accessible (Giraud et al., 2014). The use of 
the amber suppression technology for specific protein enrichment is a viable alternative to 
epitope tagging, especially for proteins that are not N- or C-terminally taggable. 
The 1000-fold enrichment that we obtained with our pulldown strategy is comparable to 
enrichment of a GFP-tagged protein (Smits et al., 2013). In contrast to the antibody-protein 
affinity method, Click-MS protein purification relies on the formation of a covalent 
bond for enrichment. The covalent bond permits stringent purification and washing 
conditions, resulting in a strong reduction of background binding proteins. Enrichment 
to near homogeneity should be beneficial for analysis techniques that are sensitive to 
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contamination, such as comprehensive PTM identification, crosslinking-MS, and chromatin 
immunoprecipitation purposes. Currently, such a homogeneous sample can only be obtained 
from tandem-affinity purification, consisting of two subsequent affinity purifications that 
reduce efficient recovery (Gingras et al., 2007). This requires very stable protein interactions 
and more input material. The Click-MS workflow holds promise for efficient, single step 
purification of a protein to near homogeneity.
In summary, Click-MS enables a robust, single-step purification and identification of proteins 
of interest and their interactions. Since the introduced azide is very small, it only minimally, 
if at all, affects protein structure in contrast to existing epitope-tagging approaches. In 
principle, any amino acid in a protein can be substituted by an UAA, which makes the 
method very flexible and allows for a comprehensive investigation of protein interactions. 
The site-specific incorporation of UAA by amber suppression technology in living organisms 
could in principle allow for the simple identification of tissue-specific protein-protein 
interactions and PTMs from whole organisms in future studies. The principle of Click-MS 
protein enrichment has great potential for both proteomics and genomics analyses, and 
we envision that the technique will be widely used to study a variety of biological systems.
Material and Methods
Cell culture
HEK293T cells were cultured in high-glucose Dulbecco’s modified Eagle medium (Gibco) 
supplemented with 10% (vol/vol) fetal bovine serum (Gibco) and 100 units/ml Pen/
Strep (Gibco). For SILAC labeling, HEK293T cells were cultured in dialyzed DMEM (Gibco) 
supplemented with 10% dialyzed FBS (Dundee Cell Products), 2mM Glutamine (Gibco), 
100 units/ml (P/S), 73 µg/ml Lysine (‘light’ (Sigma, L8662) or ‘heavy’ (13C6
15N2
1H14
16O2) 
(Silantes GmbH, 211603902)) and 30 µg/ml Arginine (‘light’ (Sigma, A6969) or ‘heavy’ 
(13C6
15N4
1H14
16O2—monohydrochloride) (Silantes GmbH, 201603902)). 
Transfections
Plasmids for transient transfections were purified using the Plasmid Maxiprep kits from 
Qiagen or JetStar™. For 10 cm dishes, 4.5x106 HEK293T cells were seeded the day before 
transfection. 10-15 µg total DNA was used with a 1:3 DNA to polyethylenimine (PEI) ratio 
(depending on cell density). pSVB.Yam-tRNACUA (Naganathan et al., 2013), tylRS and protein 
coding plasmids were mixed in a 1:0.3:1 ratio, respectively. DNA and PEI were mixed in 
DMEM, incubated for 20 minutes at room temperature and dropwise added to the cells. 
After incubated for 4 hours at 37 °C in serum free DMEM, 250 µM p-azido-l-phenylalanine 
(azF, Bachem) and DMEM supplemented with 20% FBS was added. The following day media 
was refreshed with 250 µM azF. 
Flow cytometry
0.1-1.0 x 106 cells were washed, resuspended in 500 µl PBS and applied to a BD FACSCalibur™ 
(Becton Dickson). GFP and mCherry reporter expression was determined on live cells using 
Cell Quest Pro Software and Flowing Software v2.5.
Fluorescence Microscopy
Cells were imaged using a Leica DM IRE2 TCS SP2 AOBS Confocal microscope at 40 × 
magnification. Fluorescent images were acquired at 0.1 µm intervals using a Leica DFC 420C 
camera. Excitation was set at 488 and 561 nm, and images were taken at 489-551 nm and 
574-750 nm, for GFP and mCherry respectively. Projections of z-stacks were generated using 
Image J software. 
Whole proteome analysis
SILAC labeled cells were counted using an automated cell counter (TC-20 BioRad) and 
appropriate light and heavy cells were mixed in a 1:1 ratio. Cells were lysed with 5 volumes 
lysis buffer (150 mM NaCl, 50 mM Tris pH 8.0 and 1% NP40) and rotated for 4 hours at 4 °C. 
Lysates were subsequently cleared by centrifugation for 30 minutes at 14000xg at 4 °C.
For mass spectrometry, lysates were processed using filter aided sample preparation (FASP) 
(Wisniewski et al., 2009b). 10 µg protein was applied to 30 kDa cut off Amicon filters (Millipore). 
After washing, proteins were alkylated by 50 mM iodoacetamide (Sigma Aldrich) treatment. 
After three washes with 8 M urea and 50 mM ammonium bicarbonate, proteins were 
digested with 0.5 µg trypsin overnight at 37 ˚C in a humidified chamber.
To increase proteome depth, peptides were fractionated using strong anion exchange (SAX) 
(Wisniewski et al., 2009a). Peptides were applied to SAX stage tips (2252-anion Empore) and the 
flow through as well as pH11, pH8, pH5 and pH2 elutions were collected. All samples were 
desalted and concentrated by the stage tips, before applying them to LC-MS/MS analysis 
with 4 hour gradients. Spectra were recorded on a Q Exactive (Thermo Scientific) using 
higher-energy collisional dissociation (HCD) fragmentation. Raw data were analyzed using 
MaxQuant (Cox and Mann, 2008) and scatterplots generated from the reported normalized 
ratios in R.
Site-directed mutagenesis
The amber mutation was introduced into the MBD3-GFP gene within pcDNA3.1(+) by 
PCR using Phusion Hot Start II High-Fidelity DNA polymerase (Thermo Scientific) and the 
primers listed on the next page. Whole plasmid amplification was performed according to 
the manufacturer’s protocol. Next, 20 µL of the PCR reaction mixture was incubated with 
1 µL of DpnI (New England BioLabs) for 2h at 37 °C. DH5α cells were transformed with 5 µL 
of the PCR reaction mixture by heat-shock and incubated for 45 min at 37 °C shaking at 
200 rpm in 1 mL LB medium, before being spread on an LB agar plate containing ampicillin. 
Colonies were selected and inoculated into 5 mL LB medium containing ampicillin and 
grown overnight at 37 °C, shaking at 200 rpm. Plasmids were purified using the Wizard® 
Plus SV Minipreps DNA Purification System (Promega). The insertion of the amber mutation 
was confirmed by sequencing.
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Bioorthogonal labeling
Cells were lysed with 5 volumes lysis buffer (150 mM NaCl, 50 mM Tris pH 8.0 and 0.5% 
NP40) and rotated for 4 hours at 4 °C. Lysates were subsequently cleared by centrifugation 
for 30 minutes at 14000xg at 4 °C. 50 µL 1 mg/ml whole cell lysates were labeled in the 
case of mCherry-GFPTAG and GFP enriched samples were labeled in the case of MBD3 amber 
mutants. For CuAAC, 0.5-1 mM copper sulfate (CuSO4, Sigma Aldrich) with 2 mM tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA, TCI Europe, N.V.) or 0.2-0.4 mM CuSO4 
with 0.5 mM tris(3-hydroxypropyltriazolylmethyl)amine (THPTA, Sigma Aldrich) was added 
to the lysate. For reduction of copper, 1 mM or 1.5 mM sodium ascorbate (Sigma Aldrich) 
was added for the TBTA or THPTA samples, respectively. Finally, 50 µM alkyne cyanine dye 
718 (Sigma Aldrich) was added and the sample was incubated for 2 hours at 25 °C. For 
SPAAC, lysates were treated with 50 mM iodoacetamide for 30 minutes, before addition 
of 50 µM dibenzocyclooctyne-PEG4-Fluor 545 (Sigma Aldrich) and incubation for 2 hours 
at 25 °C. Labeled samples were boiled in 1x Laemmli buffer and separated on an 8% SDS-
PAGE gel. In-gel fluorescence was measured on an Odyssey CLx (Licor) using 700 nm as 
the scanning wavelength or a G:BOX Chemi XT4 Fluorescent & Chemiluminescent Imaging 
System (Syngene) using 520 nm as excitation wavelength and emission was detected using 
the UV06 filter (572-625nm) for CuAAC or SPAAC, respectively.
GFP enrichment
GFP enrichment were essentially done as described before (Hubner et al., 2010). Briefly, 100 
µl whole cell lysate of MBD3 amber mutants was incubated with 10µl GFP-Trap beads 
(ChromoTek) for 90 minutes at 4 °C. After incubation beads were washed 3 times with lysis 
buffer (150 mM NaCl, 50 mM Tris pH 8.0 and 1% NP40). Beads containing fusion proteins 
were immediately used for bioorthogonal labeling in lysis buffer.
Protein enrichment using bioorthogonal chemistry 
MBD3 amber mutant were enriched from lysates as obtained in ‘Bioorthogonal labeling’. 
Alkyne-agarose beads (Click Chemistry Tools) or DBCO-agarose beads (Click Chemistry 
Tools) were used for CuAAC or SPAAC based immobilization, respectively. 100 µl beads were 
washed three times in lysis buffer, before 1 ml lysate (2 mg/ml) was added. The reactions 
were performed with exactly the same conditions as for the labeling, except that the samples 
were incubated overnight at 4 °C.
For western blot analysis, 30 µl of the supernatant was boiled in 1x Laemmli buffer and 
separated on an 8% SDS-PAGE gel, blotted and probed for GFP (Roche) and GAPDH (Abcam). 
For mass spectrometry analysis, beads were washed twice with lysis buffer containing 
300 mM NaCl and 0.5% NP40, twice with PBS containing 0.5% NP40 and three times with PBS. 
Proteins were alkylated by 50 mM iodoacetamide and on-bead digested using 0.5 µg trypsin 
overnight at 25 °C. All samples were desalted and concentrated by the stage tips, before 
applying them to LC-MS/MS analysis with 2 hour gradients. Spectra were recorded on a 
Orbitrap Fusion (Thermo Scientific) using collision-induced dissociation (CID) fragmentation.
Data analysis
Raw data were analyzed using MaxQuant (Cox and Mann, 2008), using default settings and the 
options ‘match between runs’ and ‘label free quantification’ enabled. Resulting proteins 
were filtered for reverse hits and contaminants. Label free quantification intensities were 
log2 transformed and filtered to have at least three valid values in one triplicate experiment. 
Enrichment of proteins was determined by comparing label free intensities between 
the amber mutant and control samples. Significant enrichment was determined by a 
permutation-adapted student t-test (Perseus analysis software in the MaxQuant software 
package). 
Acknowledgements
We thank Thomas Sakmar for providing us the pSVB.Yam-tRNACUA and tylRS plasmids and 
Edward Lemke for the mCherry-GFP plasmid. Saranga Naganathan and Manija Kazmi are 
acknowledged for advice on amber suppression technology. We also acknowledge Liesbeth 
Pierson from the General Instrumentation at the Radboud University and Pascal Jansen for 
technical assistance.
Primer Sequence 5’-3’ 
hMBD3 R3TAG FW TGGAGTAGAAGAGGTGGGAGTGC 
hMBD3 R3TAG RV CTCTTCTACTCCATGGTGGTATCTCCTT 
hMBD3 V89 TAG FW CCAGTAGAAGGGCAAGCCC    
hMBD3 V89 TAG RV CCTTCTACTGGTTGGAGGAGTCG 
hMBD3 T211 TAG FW ACACCTAGCAGCCCCTGTG 
hMBD3 T211 TAG RV GGCTGCTAGGTGTTGAGCC 
hMBD3 L230 TAG FW AAGAGTAGGTGCAGCAGGTGC 
hMBD3 L230TAG RV CTGCACCTACTCTTCCTGCTTC 
hMBD3 H290TAG FW GGAGTAGGTCGACCCAGCTTTCTT 
hMBD3 H290TAG RV GACCTACTCCATCTCCGGGTCC 
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Abstract
Despite minimal disparity at the sequence level, mammalian H3 variants bind to distinct 
sets of polypeptides. Though histone H3.1 predominates in cycling cells, our knowledge 
of the soluble complexes that it forms en route to deposition or following eviction from 
chromatin remains limited. Here, we provide a comprehensive analysis of the H3.1-binding 
proteome, with emphasis on its interactions with histone chaperones and components of 
the replication fork. Quantitative mass spectrometry revealed 170 protein interactions, 
whereas a large-scale biochemical fractionation of H3.1 and associated enzymatic activities 
uncovered over twenty stable protein complexes in dividing human cells. The sNASP 
and ASF1 chaperones play pivotal roles in the processing of soluble histones, but do not 
associate with the active CDC45/MCM2-7/GINS (CMG) replicative helicase. We also find 
TONSL-MMS22L to function as a H3-H4 histone chaperone. It associates with the regulatory 
MCM5 subunit of the replicative helicase.
Introduction
Nucleosomal histones are subject to an extraordinary array of chemical modifications, 
many of which have profound effects on chromatin structure and gene expression (Campos 
and Reinberg, 2009). While such posttranslational modifications (PTMs) can alter the epigenetic 
landscape, histones are systematically displaced from chromatin as DNA is transcribed, 
replicated or repaired (Annunziato, 2012; Campos et al., 2014). A number of histone deposition 
pathways are relatively well understood, but we have yet to fully understand the means by 
which nuclear histones are evicted and chaperoned as biological processes take place on 
chromatin.
While human histone H4 is invariant, the genome encodes a number of histone H3 variants. 
Studies identified three principal somatic forms of which the ‘replication-coupled’ H3.1 
and H3.2 are highly transcribed in S-phase (Wu and Bonner, 1981; Wu et al., 1982) and serve to 
complement the dilution of nucleosomal histones that segregate onto nascent DNA. 
‘Replication-independent’ H3.3 histones are expressed throughout interphase (Wu and 
Bonner, 1981; Wu et al., 1982) and thus viewed as ‘replacement histones’. Recent seminal studies 
described molecular pathways overseeing the deposition of these variants (Tagami et al., 2004; 
Drane et al., 2010; Goldberg et al., 2010; Wong et al., 2010). In the cytoplasm, heat-shock proteins fold 
and pair newly translated H3-H4 histone polypeptides (Campos et al., 2010; Alvarez et al., 2011). The 
resultant histone dimer is then bound by the somatic Nuclear Autoantigenic Sperm Protein 
(sNASP) histone chaperone (Campos et al., 2010) to protect histones from targeted proteolysis 
(Cook et al., 2011), and to promote the di-acetylation of histone H4 at lysines 5 and 12 by the 
Histone Acetyltransferase 1 (HAT1) holoenzyme (Kleff et al., 1995; Parthun et al., 1996; Verreault et 
al., 1998; Campos et al., 2010). These di-acetyl marks, concomitant with the monomethylation 
of H3 lysine 9 (H3K9me1), constitute a key signature of newly synthesized histones (Loyola 
et al., 2006). The mature histone pair is finally shuttled into the nucleus while bound to the 
Anti-silencing Factor 1 (ASF1) histone chaperone and the importin-4 karyopherin (Campos et 
al., 2010; Alvarez et al., 2011).
In the nucleus, replication-coupled H3-H4 dimers are transferred from ASF1 to the Chromatin 
Assembly Factor 1 (CAF-1) histone chaperone for (H3-H4)2 tetramer formation (Liu et al., 2012; 
Winkler et al., 2012) and deposition (Tyler et al., 2001; Mello et al., 2002; Tagami et al., 2004). CAF-1 binds 
PCNA and is found directly behind the replicative helicase on replicating DNA (Shibahara 
and Stillman, 1999). Tetrasomes are subsequently flanked by two H2A-H2B histone dimers to 
complete the mature nucleosome (Annunziato, 2012). Replication-independent histones are 
channeled through a number of distinct histone chaperones including HIRA (Tagami et al., 2004) 
and DAXX-ATRX (Drane et al., 2010; Goldberg et al., 2010; Wong et al., 2010). Despite these important 
developments, it remains unclear how nucleosomal histones carrying potential epigenetic 
information are chaperoned upon eviction from chromatin, especially as they encounter the 
replicative helicase.
In eukaryotes, the processive replicative helicase is composed minimally of the CDC45/
MCM2-7/GINS (CMG) complex (Gambus et al., 2006; Pacek et al., 2006; Ilves et al., 2010; Kang et al., 2012). 
GINS/CDC45 activates the MCM2-7 helicase activity by bridging a gap between the MCM2 
and MCM5 subunits (Costa et al., 2011). The MCM2 subunit of the CMG complex has been 
shown to cooperatively bind histones and the FACT histone chaperone (Tan et al., 2006; Foltman 
et al., 2013). This likely constitutes an early step in nucleosome disassembly at replication forks 
(Campos et al., 2014). The H3-H4 histone chaperone ASF1 has also been proposed to associate 
with the replicative helicase (Groth et al., 2007). While ASF1 dissociates (H3-H4)2 tetramers into 
H3-H4 dimers (English et al., 2006; Natsume et al., 2007), the bulk of H3.1-H4 histones segregate at 
the fork as tetrameric units (Xu et al., 2010b). This suggests that histones are either transiently 
dissociated into dimers at the fork, or are alternatively segregated independently of ASF1.
To better understand replication-coupled histone eviction and the stable protein complexes 
that ensue, we performed a comprehensive biochemical purification resulting in a detailed 
description of the soluble replication-coupled human H3.1 interactome. H3.1 protein 
complexes were analyzed for intrinsic enzymatic activities, with a particular focus on 
complexes formed in S-phase. We further surveyed the purified fractions for their ability to 
disassemble nucleosomal histones and identified TONSL-MMS22L as a histone chaperone 
with a preference for histone H3 monomethylated at lysine 9. TONSL-MMS22L was 
previously shown to promote homologous recombination (HR) during S-phase (Duro et al., 
2010; O’Connell et al., 2010; O’Donnell et al., 2010; Piwko et al., 2010). Disruption of either TONSL or 
MMS22L results in the accumulation of DNA damage, activation of the ATM/ATR checkpoint 
response, and accumulation of cells in G2 (Duro et al., 2010; O’Connell et al., 2010; O’Donnell et al., 
2010; Piwko et al., 2010). In this study we further demonstrate that purified fractions containing 
TONSL-MMS22L enhance histone eviction. Importantly, TONSL interacts with the regulatory 
MCM5 subunit of the replicative helicase, normally employed by GINS/CDC45 to bridge the 
MCM2–MCM5 junction and activate the MCM2-7 helicase (Costa et al., 2011).
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Results
Quanti tati ve MS analysis of the soluble human H3.1 proteome
A comprehensive biochemical analysis of the soluble H3.1 proteome was performed from 
HeLa S3 spinner cultures (Fig. 1A). The cells expressed low levels of epitope-tagged H3.1 
(eH3.1) thus averti ng the co-purifi cati on of closely related histone variants (Tagami et al., 
2004). In order to gain confi dence in the validity of putati ve interacti ng partners, a label-free 
quanti tati ve mass spectrometry (MS) approach (Smits et al., 2013) was fi rst exploited to compare 
affi  nity-purifi ed eH3.1 to mock purifi cati ons from diff erent subcellular compartments in 
S-phase as well as from an asynchronous state. Protein hits were considered to be of interest 
if reproduced across at least three independent immunoprecipitati ons and stati sti cally 
enriched over matching mock purifi cati ons (Fig. 1B). Two thirds of the 170 stati sti cally 
enriched proteins were unique to one of the three examined subcellular compartments (Fig. 
1C), highlighti ng variances in the subcellular handling of histones. As expected, ontology-
based classifi cati on of the associated proteins revealed a prevalence of proteins involved 
in complex assembly and organizati on in the cytoplasm, whereas ontology terms relati ng 
to transcripti on, and chromati n assembly, organizati on and modifi cati on abounded in the 
nuclear compartments (Fig. S1A).
MCM2, sNASP, and UBR7 were the most enriched proteins co-purifying with nuclear H3.1, 
exhibiti ng over a thousand-fold enrichment in label-free quanti fi cati on intensiti es relati ve 
to mock IPs, closely followed by an array of histone chaperones and transcripti on factors. 
UBR7 belongs to the N-recognin family of E3 ligases but harbors a PHD domain in lieu of a 
RING domain (Tasaki et al., 2005). Unlike the other highly enriched proteins, UBR7 did not stably 
co-purify with H3.1 upon further fracti onati on (see below), suggesti ng that the interacti on 
is abundant but unstable. Nonetheless, the observati on is interesti ng given that the related 
UBR2 protein targets H2A-H2B for ubiquiti nati on (An et al., 2012) and that the UBR7-related 
Mlo2 protein is involved in mitoti c chromosome segregati on in S. pombe (Javerzat et al., 1996).
In line with our report on cytosolic histone protein complexes (Campos et al., 2010), sNASP 
was the most enriched histone chaperone co-purifying with H3.1, an observati on that was 
parti cularly evident in S-phase (Fig. 1B,D). This was closely followed by SUPTH6, CAF-1, 
FACT, and TONSL, all of which co-purifi ed with over a hundred-fold enrichment over mock 
IPs. In all, a total of ten known histone chaperone polypepti des were identi fi ed with H3.1.
A direct comparison between the H3.1 proteome from asynchronously growing cells 
and a synchronized populati on in S-phase yielded surprisingly litt le diff erences (Fig. 
S1B,C). Specifi cally, MCM subunits of the replicati ve helicase were enriched with H3.1 in 
H3
H4
H3
H4
H3
H4
H3
H4
H3
H4
H3
H4
A
eH3.1
HeLa S3
cytoplasmic
extracts
nuclear
extracts
affinity purify
histone H3.1
quantitative
MS
biochemically fractionate
histone H3.1 protein complexes
soluble chromatin
extracts
cy
to
pl
as
m
nu
cl
eo
pl
as
m
so
lu
bi
liz
ed
 c
hr
om
at
in
-L
og
 [F
D
R
 (t
-te
st
)]
-L
og
 [F
D
R
 (t
-te
st
)]
-L
og
 [F
D
R
 (t
-te
st
)]
asynchronous S-phaseB
Log2 (FLAG/control)
FC > 5
FDR > 1.3010
8
6
4
2
-10 -5 0 5 10
NASP
ASF1B
-10 -5 0 5 10
5
6
4
3
2
1
0
FC > 4
FDR > 1.301
p150
p60
-10 -5 0 5 10
5
6
4
3
2
1
0
FC > 4.35
FDR > 1.301
NASP
RbAp48
TONSL
ASF1B
p150
p60
-10 -5 0 5 10
5
6
4
3
2
1
0
FC > 4.5
FDR > 1.301
RbAp48
ASF1B
p150
p60
SUPT6H
Log2 (FLAG/control)
-10 -5 0 5 10
6
4
2
0
FC > 4
FDR > 1.301
NASP
RbAp48
p150
p60
SUPT6H
5
4
3
2
1
0
-10 -5 0 5 10
FC > 4.16
FDR > 1.301
NASP
ASF1B
C 
19
40
15
9
6
27 54
cytoplasm nucleoplasm
solubilized
chromatin
D 
Lo
g2
 (F
LA
G
/c
on
tro
l)
14
12
10
 8
 6
 4
 2
 0
-2
CA
F-
1 p
15
0
CA
F-
1 p
60
Rb
Ap
48
Rb
Ap
46
AS
F1
B
SU
PT
6H
SU
PT
16
H
SS
RP
1
nu
cle
op
ho
sm
in
NA
SP
histone chaperones
Lo
g2
 (F
LA
G
/c
on
tro
l)
14
12
10
 8
 6
 4
 2
 0
-2
-4
MC
M2
MC
M3
MC
M4
MC
M5
MC
M6
MC
M7
TO
NS
L
replication fork
asynchronous nucleosol
asynchronous chromatin
S-phase nucleosol
S-phase chromatin
Lo
g2
 (F
LA
G
/c
on
tro
l) 12
10
 8
 6
 4
 2
 0
-2
ST
K3
8
ST
K3
8L
PP
2C
β
HA
T1
TR
IM
21
UB
R7
OT
UD
4
enzymes
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Figure 2. Biochemical isolati on of soluble eH3.1 protein complexes. (A,B) Anion exchange chromatography of 
eH3.1 affi  nity purifi ed from either nuclear extracts (A) or solubilized chromati n (B). Silver stained SDS-PAGE and 
western analyses revealed co-eluti ng proteins (top panels), whereas the extracts were further essayed for intrinsic 
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above the gels denote fracti ons where eH3.1 protein levels peaked. These fracti ons, as well as fracti ons containing 
enzymati c acti viti es towards histones were further fracti onated (see Fig. S2 and S3). KAT: lysine acetyltransferase, 
KMT: lysine methyltransferase, NC: negati ve control, PC: positi ve control, CBB: Coomassie Brilliant Blue, endo: 
Endogenous.
S-phase, along with the NASP and ASF1B chaperones. In comparison, the SUPT6H histone 
chaperone that is implicated in transcripti on (Bortvin and Winston, 1996) was inversely enriched 
in asynchronous cells (Fig S1C). While transient interacti ons are widely expected to change 
through the cell cycle and in response to diff erent sti muli, the overall stable interacti ons 
formed with histone H3.1 underwent litt le change. By implicati on, the observati on 
underscores the close coupling of soluble histone complexes and the replicati on machinery. 
The noisy distributi on of proteins in and out of S-phase may, however, also have hindered 
our ability to discern stati sti cal changes over the H3.1 interacti ons.
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Biochemical characterization of soluble H3.1 protein interactions
To further substantiate the identified H3.1 interactions and to dissect these into separate 
complexes, we performed successive biochemical fractionations on the affinity purified 
eH3.1 extracts. The eH3.1 affinity purified material was first resolved based on charge 
over an anion exchange chromatography column, and the protein fractions analyzed over 
silver stained SDS-PAGE and western blots (Fig. 2A,B, top panels). These fractions were 
also assayed for H3.1-associated enzymatic activities (acetyltransferase, methyltransferase, 
kinase, ATPase) with free or nucleosomal histones as substrates (Fig. 2A,B, bottom panels). 
Polypeptides co-eluting with H3.1 peak fractions, or with these enzymatic activities, were 
subjected to further biochemical fractionations based on the solubility and size of the 
protein complexes to reveal stable H3.1 interactions and identify the enzymes acting on 
histones (Fig. S2 and S3). Proteins were identified by MS after excision from silver stained 
gels, and confirmed by western blotting when possible. No less than 39 soluble nuclear 
proteins remained stably associated with eH3.1 following a number of chromatography 
steps, the majority of which were detected in the quantitative MS analyses above. These 
polypeptides distributed over 20 putative histone protein complexes (Fig. 3).
Nearly half of these protein complexes harbored proteins implicated in DNA replication 
despite being processed from asynchronous cells (Fig. 3). Few polypeptides pertained to 
transcription, suggesting that the most stable interactions formed with histone H3.1 primarily 
concerned cell cycle regulation. We observed H3.1 in association with an assortment of 
prominent MCM protein complexes, likely involved at different stages of the cell cycle. 
However, in spite of being detected in the input extracts, CDC45 and the GINS sub-complex, 
both of which are required to activate the MCM2-7 helicase (Gambus et al., 2006; Pacek et al., 2006; 
Ilves et al., 2010; Kang et al., 2012), did not co-purify with histone H3.1 nor were they observed 
in the quantitative MS analyses of the H3.1 S-phase proteome (Fig. S2C,D and S3B,C). This 
finding suggests that histone interactions with active CMG helicase complexes, as those 
reported in yeast (Foltman et al., 2013), are biochemically unstable if occurring in mammalian 
cells.
Excluding enzymatic activities, eH3.1 co-eluted either with protein complexes that 
contained a known histone chaperone, with TONSL-MMS22L, or with the uncharacterized 
C19ORF43 proteins (Fig. S2 and S3). The one fraction with seemingly unchaperoned histones 
represents minute amounts of nucleosomes (Fig. S3G), as histones would not have strongly 
bound our anion exchange resin in the absence of DNA. Indeed, free histones are seldom 
left unchaperoned in vivo (Campos et al., 2010) as their charged nature would result in adverse 
electrostatic interactions. Akin to cytosolic purifications (Campos et al., 2010; Alvarez et al., 2011), 
nuclear eH3.1 co-eluted with a broad range of interacting proteins with no free histones left 
to passively diffuse inside of cells (Fig. 2, 3, S2 and S3).
Methyltransferase, kinase, and acetyltransferase activities towards core nucleosomal 
histones also co-fractionated with the soluble, nuclear, eH3.1 (Fig. 2A,B). Despite the 
statistical enrichment of NuRD and BAF components in the quantitative MS analyses, ATPase 
activity towards nucleosomal substrates was not detected (Fig. S3H) nor did the complexes 
co-purify with soluble eH3.1 (Fig. S2 and S3). The methyltransferase activity directed 
towards histone H4 (Fig. 2A,B) originated from PRMT5 (Fig. S3B,C), a contaminant common 
to FLAG affinity purifications (Mellacheruvu et al., 2013). In contrast, the acetyltransferase 
activity (Fig. 2A) originated from nuclear HAT1 and associated with the sNASP histone 
chaperone (discussed below). Kinase activity towards histones (Fig. 2A,B) in turn emanated 
from the STK38 (NDR1) protein kinase (Fig. S2G). Although STK38 is a contaminant in FLAG 
purifications (Mellacheruvu et al., 2013), the recombinant protein does phosphorylate soluble 
kinase
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but not nucleosomal histones in vitro (Fig. S2H). The kinase however preferenti ally targeted 
H2A-H2B dimers for phosphorylati on (Fig. S2I).
Fracti ons containing ASF1B, TONSL-MMS22L, or nucleophosmin promote histone evicti on
To further understand the role of the eH3.1 protein-protein interacti ons, a quanti tati ve 
nucleosome disassembly test was designed to screen for fracti ons capable of histone evicti on 
in vitro, in the absence of ATP (Fig. 4A and S4). In this experiment, a [32P]-labeled PCNA ring 
was loaded onto a linear DNA fragment fl anked by a single nucleosome at one extremity and 
a streptavidin-bioti n block on the opposite end. The radiolabeled ring was free to slide on 
DNA but was locked onto the template by the nucleosome and the streptavidin (Fig. 4A and 
S4F). The PCNA probe co-eluted from a size exclusion spin column with the bulky DNA if the 
nucleosome was intact. The small radioacti ve ring however remained in the column when 
histones were removed. Thus, histone retenti on correlated with Cherenkov counts from the 
exclusion volume.
Surprisingly, a ti trati on of eH3.1-purifi ed proteins revealed that the nuclear extracts evicted 
nucleosomal histones more aptly than chromati n-associated proteins (Fig. S4H). The acti vity 
refl ected an acti ve loss of nucleosomes as no nuclease or phosphatase acti vity was detected 
in these extracts, under the same conditi ons (Fig. S4I-J). Three of the eH3.1 mono Q fracti ons 
shown in Figure 2, consistently yielded a reproducible nucleosome loss (Fig. 4B). These 
fracti ons were re-analysed by MS (Fig. 4C) and corresponded to eH3.1 bound by either: 
ASF1B, RAN, importi n-4 (Fig. S2A); MCM2-7, TONSL-MMS22L (Fig. S2C); or nucleophosmin 
(Fig. S2F). Since the assay was performed in the absence of ATP, the resultant disassembly 
likely arises from the acti on of histone chaperones rather than molecular chaperones 
present in the samples. Amongst the former, FACT and NASP were also detected within the 
MCM2-7-TONSL-MMS22L-containing fracti on.
Focus on histone chaperone complexes
Nuclear sNASP
We previously found sNASP to be a major H3-H4 histone chaperone associati ng with the 
histone acetyltransferase (HAT) holoenzyme (HAT1 and RbAp46) in the cytosol (Campos et al., 
2010). The complex was again isolated from the nuclear compartment (Fig. 5A). Two disti nct 
forms of the sNASP-HAT1 complex co-eluted by ion exchange chromatography but were 
resolved based on their solubility in the presence of ammonium sulfate (Fig. S2E and 4A). The 
fi rst was identi cal to the abundant cytoplasmic complex in that it comprised di-acetylated 
newly-synthesized histones that were otherwise largely unmodifi ed, and likely leached 
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from the cytosol (Fig. S2E). The second, however, contained histones heavily decorated 
with PTMs typical of both eu- and hetero-chromati n (Fig. 5A). Both protein complexes 
harbored catalyti cally acti ve HAT1 and were the source of the nuclear acetyltransferase 
acti vity (Fig. 5B), demonstrati ng that H4 di-acetylati on is not restricted to newly synthesized 
histones. Remarkably, nearly all of the soluble eH3.1 complexes isolated from the nucleus 
harbored H4K12ac regardless of whether they physically co-purifi ed with HAT1 or whether 
they encompassed other histone PTMs (Fig. S2). The ubiquitous HAT1 acti vity from soluble 
nuclear extracts suggests that evicted histones are re-acetylated when bound and recycled 
by sNASP.
Associati on of sNASP with evicted histones was confi rmed by immunoprecipitati ng 
epitope tagged sNASP from 293 cell extracts and immunoblotti  ng against tri-methyl marks 
on histone H3 (Fig. 5C). sNASP protects soluble histones from degradati on in vivo (Cook 
et al., 2011) and likely stores a soluble pool of histones for depositi on. Inhibiti on of DNA 
replicati on or transcripti on by targeti ng the appropriate polymerase with aphidicolin or α–
amaniti n, respecti vely, reduced H3 trimethyl marks but not acetylati on of histone H4 on 
sNASP-bound histones (Fig. S5), suggesti ng that histones can be captured by sNASP during 
both transcripti on and DNA replicati on. To further ensure that the di-/tri-methylati on on 
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sNASP-bound histones were acquired in the context of chromatin and not modified on the 
chaperone proper, we tested for the ability of the PRC2 methyltransferase to methylate 
sNASP-bound histone H3, given that its preferred substrates are nucleosomal histones (Cao 
et al., 2002). sNASP-bound histones were poor substrates for PRC2, even when compared to 
unbound counterparts, further confirming histone eviction as the source of sNASP-bound 
histone PTMs (Fig. 5D). Altogether these findings suggest a model in which evicted histones 
are captured and protected from proteolytic degradation by sNASP (Cook et al., 2011) and re-
acetylated by HAT1 prior to re-incorporation onto chromatin. We cannot however rule out 
the possibility that sNASP-HAT also directly acts on histones during deposition and eviction 
events as they occur on chromatin.
ASF1 and the replicative helicase
Two ASF1B-containing H3.1 complexes were purified in this study. We and others have 
reported that cytosolic histones associate with importin-4 karyopherin along with ASF1 
(Campos et al., 2010; Alvarez et al., 2011) and now observe the ASF1-importin-4 complex in 
nuclear extracts with the addition of sub-stoichiometric levels of the RAN GTPase (Fig. 
S2A). Furthermore, we isolated the ASF1B isoform along with the MCM2, -3, -5 proteins 
in association with eH3.1 (Fig. S2D) but not with the CDC45 and GINS subunits of the CMG 
helicase. It is known that ASF1 co-localizes and co-purifies with MCM proteins (Schulz and 
Tyler, 2006; Groth et al., 2007) and this interaction increases with replicative stress (Jasencakova 
et al., 2010). Therefore, the detection of ASF1 with the eH3.1 fractions containing MCM 
proteins but not CDC45/GINS, suggests that the H3.1-associated pool of ASF1B does not 
associate with the active CMG complex. To ensure that this was not due to the experimental 
processing of the samples, 293 cells expressing epitope tagged ASF1B were synchronized, 
released in S-phase, and treated with the cell-permeable amine-reactive crosslinking agent 
disuccinimidyl suberate (DSS). The DNA was then digested with benzonase and ASF1B was 
immunoprecipitated. Slow-migrating (crosslinked) species were excised from SDS-PAGE gels 
and the interacting proteins identified by MS (Fig. 5E). Although MCM proteins were well 
represented in ASF1B immunoprecipitates, ASF1B did not interact with CDC45 and vice-
versa, indicating that it does not interact with the replicative helicase. ASF1B did however 
interact with the HIRA and CAF-1 chaperones (Fig. 5E), as expected through its role in histone 
deposition (Tagami et al., 2004). Thus, while the ASF1B chaperone would be well positioned to 
recycle histones through CAF-1 (Tyler et al., 2001; Mello et al., 2002) and the complex does form in 
S-phase (Groth et al., 2007), our data implicates ASF1B with an inactive phase of the replicative 
helicase.
TONSL-MMS22L: A histone chaperone at stalled replication forks
In addition to purifying soluble eH3.1 with known histone chaperones, we were quite 
intrigued in the isolation of histones with MCM2-7 and TONSL-MMS22L (Fig. S2C). The TONSL-
MMS22L complex promotes homologous recombination at stalled or stressed replication 
forks (Duro et al., 2010; O’Connell et al., 2010; O’Donnell et al., 2010; Piwko et al., 2010). Knockdown of either 
TONSL or MMS22L results in spontaneous DNA double-strand breaks in S-phase, checkpoint 
activation and accumulation of cells in G2 (Duro et al., 2010; O’Connell et al., 2010; O’Donnell et al., 
2010; Piwko et al., 2010). Our TONSL-MMS22L-MCM2-7 complex harbored both endogenous 
and exogenous H3.1 as well as PTMs normally found on chromatin, suggesting that the 
proteins bind evicted (H3-H4)2 tetramers. In comparison to the replication-dependent CAF-1 
histone deposition machinery, which was enriched in MS but barely visible by silver staining 
(Fig. S2F), TONSL-MMS22L was relatively abundant and stable. Despite its association with 
MCM2-7, the H3.1-associated complex was readily detected in soluble nuclear extracts 
but was not found in chromatin extracts nor with GINS/CDC45 (Fig. S2C,D). To rigorously 
test whether MMS22L-TONSL interacts with CMG, a crosslinking experiment was again 
performed: replicating cells were exposed to the DSS cell permeable crosslinker, the DNA 
digested, and TONSL immunoprecipitated for MS analysis. Again, we observed a TONSL-
MMS22L interaction with MCM2-7 but failed to detect peptides derived from CDC45/GINS, 
indicating that like ASF1, TONSL-MMS22L does not associate with an active replicative 
helicase or the association is of very low abundance.
Since the soluble eH3.1 fractions containing TONSL-MMS22L poorly co-eluted with known 
histone chaperones, we sought to determine whether TONSL-MMS22L has histone chaperone 
activity. While MMS22L lacks recognizable histone binding domains, TONSL contains many 
protein modules including an acidic region—a feature that is common to histone chaperones 
(Fig. 6A). The presence of an acidic region, the co-elution of TONSL with histones, and the 
ability to disassemble nucleosomes, led us to explore the possibility that TONSL-MMS22L 
functions as a histone chaperone. In order to be considered a histone chaperone, the 
proteins must be capable of binding histones and promote nucleosomal assembly in vitro 
in the absence of ATPase activity. Isopycnic centrifugation over a sucrose gradient revealed 
that recombinant TONSL-MMS22L was capable of binding all four core nucleosomal histones 
(Fig. S6A). Histone-binding was mediated through two domains: the short acidic patch 
and the neighboring ankyrin repeats (Fig. S6B). Furthermore, TONSL-MMS22L was able to 
assemble chromatin in a supercoiling assay used to gauge histone deposition in vitro (Fig. 
6B). The full-length TONSL protein and a protein fragment encompassing the acidic region 
and ankyrin repeats of TONSL bound histones equally well (Fig. S6C, left panel). However, 
only the full-length TONSL protein exhibited histone chaperone activity in vitro (Fig. S6C, 
right panel). Since neither TONSL nor MMS22L possess a recognizable ATPase domain, our 
results indicate that TONSL-MMS22L is a bona fide histone chaperone.
The ankyrin repeats of the GLP and G9a methyltransferase proteins were recently found 
to form an aromatic cage that binds mono and di-methylated H3K9 (Collins et al., 2008). We 
therefore assessed whether TONSL displayed any binding preference towards methylated 
histones. We found that recombinant TONSL-MMS22L binds to unmodified recombinant 
histones but preferentially bound to hyper-methylated H3 when incubated with histones 
purified from HeLa cells (Fig. S6D). A similar result was obtained with recombinant TONSL in 
the absence of MMS22L (Fig. S6E). Furthermore, we found that TONSL immunoprecipitates 
both methyl-H3 and -H4 in vivo and binding of hyper-methylated H3 was augmented upon 
treating U2OS cells with DNA-damaging doses of camptothecin (Fig. S6F), a drug previously 
shown to mobilize the TONSL-MMS22L proteins onto chromatin (Duro et al., 2010; O’Connell et 
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al., 2010; O’Donnell et al., 2010; Piwko et al., 2010). Recombinant TONSL was therefore incubated 
with an array of H3 histone pepti des, spanning all known methyl-lysine modifi cati ons. 
TONSL exhibited preferenti al binding for H3K9me1 (Fig. 6C and S6G), an observati on further 
confi rmed by immunoprecipitati on of TONSL from U2OS cells (Fig. S6H).
While monomethylati on of histone H3 on lysine 9 has not been implicated in the DNA 
damage response, recent studies suggest that the H3K9me2/3 demethyltransferase KMD4B 
is mobilized within seconds to sustain DNA repair, whereas the SUV39H1 methyltransferase 
that is responsible for H3K9me1 catalysis is downregulated at the transcripti onal level (Young 
et al., 2013; Zheng et al., 2014). Laser microirradiati on of cells confi rmed a rapid recruitment 
of TONSL on damaged chromati n with peak accumulati on occurring 10-20 minutes aft er 
irradiati on, followed by a constant decline in chromati n-bound TONSL levels thereaft er 
(Fig. S6I). This suggests a dynamic mode of acti on, as TONSL promptly and transiently acts 
on chromati n to maintain the integrity of replicati ng DNA. However, we did not observe 
H3K9me1 accumulati ng on irradiated chromati n (Fig. S6J). Instead, H3K9me1 levels markedly 
increased on the soluble pool of TONSL as evidenced by TONSL immunoprecipitati on aft er 
inducti on of DNA damage (Fig. S7A). This indicates that methyl H3 alone is not a criti cal 
component of TONSL recruitment to DNA damage.
TONSL was highly enriched in two of the three eH3.1-purifi ed nuclear extracts exhibiti ng 
nucleosome disassembly (Fig. 4B-C). We therefore repeated the assay shown in Figure 3, 
but directly ti trati ng recombinant TONSL over the nucleosomal substrate. The additi on 
of TONSL in itself had litt le eff ect on the stability of nucleosomes (Fig. S7B, left  panel). 
Recombinant FACT also lacked any eff ect by itself. A similar ti trati on of FACT over the 
nucleosome substrate resulted in negligible disassembly (Fig. S7B, right panel), meaning 
that any electrostati c interacti ons between nucleosomal histones and these histone 
chaperones is not suffi  cient to dissolve nucleosomes. Since H3.1-purifi ed nuclear extracts 
contained nucleosome disassembly acti viti es (Fig. S4H), we re-ti trated TONSL over 1.5 μg 
of the H3.1-purifi ed nuclear extracts—the amount needed to dissociate roughly half of the 
nucleosomes (Fig. S4H). The eff ect was modest, but TONSL enhanced disassembly unti l a 
1:1 stoichiometric point was reached between TONSL and the nucleosomal octamers (100 
fmoles), aft er which a plateau was reached (Figure S7B, left  panel). This suggests that TONSL 
in itself lacks chromati n disassembly acti viti es but may indirectly support the process.
To explore the role of TONSL at stalled forks, we further sought to identi fy the TONSL-MCM 
protein-protein interacti ons. The recombinant TONSL-MCM2-7 complex was pre-incubated, 
crosslinked in vitro using an amine-reacti ve crosslinker (Fig. 6D), digested with trypsin, 
and the pepti des analyzed by MS to map interacti ng surfaces (Yang et al., 2012). Numerous 
intra-protein crosslinked pepti des were observed, along with crosslinks between MCM5-
MCM3, MCM7-MCM4, MCM4-MCM6 and MCM6-MCM2 (Fig. S7C), which is consistent with 
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electron microscopy tomography analyses of the MCM2-7 complex (Costa et al., 2011). Of note, 
the sixth TPR repeat of TONSL crosslinked to the extreme carboxyl terminus of MCM5 near 
its AAA+ ATPase domain (Fig. 6D). The finding is important since the same surface is utilized 
by CDC45/GINS (Costa et al., 2011) and suggests that TONSL can potentially maintain MCM2-
7 in an inactive state. To confirm the TONSL-MCM5 interaction, immobilized TONSL was 
incubated with in vitro translated MCM2-7 subunits. The MCM5 subunit clearly remained 
bound to TONSL (Fig. 6E). In a similar experiment, we again reproduced the TONSL-MCM5 
interaction using bacteria-expressed MCM subunits (Fig. S7D). Weak binding to MCM3 was 
also observed (Fig. 5E and S7D). Altogether these results illuminate the need for specialized 
histone chaperones taking on distinct functions through the course of DNA replication for 
histone processing, deposition, eviction and repair.
Discussion
The pathway leading to the deposition of newly-synthesized histones on replicated 
DNA intimately involves histone chaperones (Annunziato, 2012; Campos et al., 2014). Thus, the 
hypothesis emerged that histones confronting a replication fork are similarly chaperoned, 
as nucleosomes are being dismantled and histones are being recycled within replication 
bubbles. Indeed, the cooperative histone binding by FACT and MCM2-7 (Tan et al., 2006; 
Foltman et al., 2013) as well the interaction between ASF1 and MCM proteins (Groth et al., 
2007) substantiate this hypothesis. However, the question remains as to how histones are 
chaperoned at the forefront of the replication fork and throughout the remainder of the cell 
cycle. In this study we surveyed stable interactions between the replication-coupled histone 
H3.1 and histone chaperone protein complexes. We identified 11 histone chaperones that 
interact with histone H3.1, including the histone chaperone TONSL (Fig. 1D). The results 
showcase the diverse roles of chaperones at the forefront of replication.
We previously identified sNASP as a key H3-H4 histone chaperone in the processing 
of cytoplasmic histones (Campos et al., 2010). Here, we demonstrated that regardless of 
its subcellular localization, sNASP stably associates with the catalytically-active HAT1 
holoenzyme (Campos et al., 2010) (Fig. 5A). Albeit ubiquitous in the cytosol, a pool of the type 
B acetyltransferase is also found in the nucleus in S-phase (Parthun et al., 1996; Verreault et al., 
1998). Nuclear localization of sNASP has also been reported (Richardson et al., 2000), but we now 
observed a pool of nuclear sNASP in association with HAT1 and evicted histones (Fig. 5A-C). 
Our quantitative MS analyses confirmed the ubiquitous and abundant nature of this histone 
chaperone (Fig. 1B,D). The catalytic activity of the purified sNASP-histone complex (Fig. 5B), 
along with the acetylation of bound histone H4 (Fig. 5A-C), argues for a re-acetylation of 
evicted histone H4 prior to re-deposition. Like sNASP (Cook et al., 2011), loss of HAT1 has a 
limited impact on cell cycle dynamics (Nagarajan et al., 2013). However, absence of HAT1 results 
in hypersensitivity to DNA damage and increased global genomic instability (Nagarajan et al., 
2013), stressing the significance of its histone acetylation activity. Thus, the pool of evicted 
sNASP-bound acetylated histones may help sustain genomic stability.
Evidence strongly suggests that H2A-H2B histone chaperone FACT initiates nucleosome 
disassembly at replication forks. FACT was identified as a factor that facilitates transcription 
through chromatin in vitro (LeRoy et al., 1998; Orphanides et al., 1998). It does so by interacting 
with the DNA-binding surfaces of H2A-H2B to displace histone dimers (Hsieh et al., 2013). 
Mammalian FACT directly interacts with MCM4 (Tan et al., 2006), and the yeast CMG 
cooperatively binds histones via Mcm2, in the presence of FACT (Foltman et al., 2013). FACT 
is also enriched in mammalian replication foci (Hertel et al., 1999), and loss of FACT results in 
S-phase delays across species (Okuhara et al., 1999; Schlesinger and Formosa, 2000; Abe et al., 2011), likely 
due to impaired replication fork progression (Abe et al., 2011). While mechanistic evidence of 
H2A-H2B segregation accumulates, the mechanistic segregation of nucleosomal histones 
(H3-H4)2 remains elusive.
We purified two H3-H4 histone chaperones in stable association with MCM proteins (Fig. 
2,3). However, H3.1–CMG interactions were biochemically unstable in our conditions. Only 
upon chemical crosslinking were histones detected by MS in association with CDC45 (Fig. 
5E). Eukaryotic MCM proteins are abundant in cycling cells, and only a minute population is 
incorporated into the CMG complex (Moyer et al., 2006)—a severe limitation to our biochemical 
approach. Indeed, the lack of histone chaperone–CMG interaction could suggests that 
such transaction is transient and scant. Other factors may alternatively contribute to the 
recycling of nucleosomal H3.1-H4 histones within replication bubbles averting detectable 
histone-CMG interactions. These could be mediated by other components of the replication 
machinery, perhaps aided by the force of the helicase, ATP-dependent chromatin remodelers, 
or other transiently binding proteins. Therefore histone chaperone–MCM2-7 interactions 
hold specialized functions that need not be connected to the normal elongation phase of 
the CMG helicase, a notion well exemplified by ASF1 and TONSL.
Histone H3.1 purified with two ASF1B protein complexes, the first co-eluted with a 
karyopherin, importin-4, and RAN GTPase (Fig. S2A). RAN modulates cargo binding in 
the nucleus (Pemberton and Paschal, 2005) and hence, presumably releases the ASF1B-H3-H4 
complex coming from the cytoplasm. The latter protein complex, in association with MCM 
proteins (Fig. S2D), is intriguing. ASF1 has been singled as a candidate to recycle histones 
encountering replication forks (Groth et al., 2007). Like FACT, evidence does intimately associate 
ASF1 with the replication process. ASF1 is detected over DNA replication foci in both 
mammals and fruit flies, and a loss of ASF1 results in delayed S-phase progression (Schulz and 
Tyler, 2006; Groth et al., 2007). The role of ASF1 in the transport (Campos et al., 2010; Alvarez et al., 2011) 
and handover of new histones to CAF-1 (Tyler et al., 2001; Mello et al., 2002) is well described and 
required for normal fork progression (Mejlvang et al., 2014). However, ASF1B interactions ahead 
of the replication fork are less clear, and whether ASF1 travels with active CMG helicases has 
remained controversial.
H3.1-associated ASF1B lacked components of the CMG other than MCM proteins (Fig. S2D). 
We further used cell permeable DSS crosslinker and MS to univocally answer the question of 
whether ASF1 binds to an active CMG or inactive MCM2-7 helicase in the absence of stress. 
As such, MCM proteins crosslinked and were detected by MS from both immunoprecipitated 
ASF1B and CDC45 (Fig. 5E). However, ASF1 and CDC45 did not crosslink to the same protein 
complexes regardless of whether ASF1B or CDC45 was immunoprecipitated. The results 
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demonstrate that under normal growth conditions, ASF1–MCM interactions are limited 
to inactive helicase complexes. Since MCM proteins levels greatly exceed the number of 
replication origins, a biological function for this interaction remains to be fully determined.
Unlike ASF1, TONSL-MMS22L is not required for normal replication fork progression (O’Donnell 
et al., 2010). It instead promotes homologous recombination at stressed replication forks (Duro 
et al., 2010; O’Donnell et al., 2010). We found TONSL to have histone chaperone activity (Fig. 5B 
and S6A-C), and speculate a further supportive role in nucleosome disassembly (Fig. 4B-C 
and S7B, left panel). An attractive model entails TONSL recruitment to stalled or colliding 
replication bubbles, perhaps aided by transient accumulation of H3K9me1 alongside other 
factors associating with ssDNA. Once recruited, TONSL would subsequently contribute to 
the resolution of the stressed forks by binding to surfaces on MCM5/3, normally used by 
GINS/CDC45, resulting in the inactivation of CMG helicase activity (Fig. 6F). A related role has 
been demonstrated for the yeast Dia2 protein, which shares a similar structure with TONSL 
but harbors an F-box in lieu of the ankyrin repeats (Fig. 6A). The yeast protein interacts 
with MCM proteins via its TPR repeats (Mimura et al., 2009; Morohashi et al., 2009), and acts as a 
substrate-targeting subunit of the Skp1-Cdc53-F-box SCFDia2 E3 ligase complex (Koepp et al., 
2006). The complex targets MCM7, which in turn causes the Cdc48/p97 segregase protein 
to dismantle the CMG complex at the end of replication (Maric et al., 2014). While TONSL-
MMS22L was not part of an E3 ubiquitin-conjugating complex, we did detect a co-elution of 
TONSL with the CDC48/VCP ATPase (Fig. S2F), which may help dismantle stalled replication 
forks as well. Furthermore, like TONSL, Dia2-defective cells are susceptible to DNA damage 
in S-phase (Blake et al., 2006; Koepp et al., 2006). Regardless of whether TONSL is involved in the 
inactivation of the CMG complex, its interaction with the MCM5 subunit of MCM2-7 is 
highly intriguing. Further experiments will now be required to determine whether there is 
competition between TONSL and CDC45/GINS over the same binding surfaces of the MCM 
hexameric ring (Fig. 6F), and what it entails during homologous recombination.
Biochemical purification schemes are limited by the abundance of the material. While 
nucleosomal histones play profuse structural and regulatory epigenetic roles, the amount 
of soluble proteins complexes containing non-nucleosomal histones is highly limiting. The 
technicality severely impedes our ability to follow chromatin transactions in an unbiased 
manner. The large-scale analysis of the replication-coupled H3.1 protein revealed a number 
of unexpected roles for new and old histone chaperones. The purifications and experiments 
described herein not only provide a reference to the large number of soluble H3.1 protein 
complexes that exist in vivo, but also insights into the diverse functions undertaken by 
histone chaperones.
Material and methods
Constructs, Antibodies, Cell lines and Tissue Culture
The FLAG-HA H3.1 (eH3.1) Hela S3 lineage, FLAG-ASF1B and FLAG-sNASP 293 clones, as 
well as the inducible FLAG-TONSL U2OS cells were cultured as previously described (Tagami 
et al., 2004; Campos et al., 2010; O’Donnell et al., 2010). Thymidine-based cell synchronization, laser 
irradiation and immunofluorescence were performed as before (Campos et al., 2010; O’Donnell 
et al., 2010). TONSL (GenBank accession number BC008782.2) and MMS22L (NM_199467.2) 
cDNAs were obtained from OpenBiosystems and subcloned into pFASTBAC vectors 
(Invitrogen). Baculoviruses were generated using the Bac-to-Bac system (Invitrogen) as 
directed by the manufacturer. TONSL was further subcloned into pET28 (EMD Biosciences). 
Thymidine, α-amanitin, and aphidicolin were purchased from Sigma-Aldrich.  The following 
antibodies and reagents were used in addition to the ones that had been previously 
described (Campos et al., 2010; O’Donnell et al., 2010): CDC45 (Abcam), H2A (Cell Signaling), H2B 
(Millipore), H3K9me1 (Abcam), H3K27me1 (Millipore), H3K27me3 (Cell Signaling), H4me3 
(Upstate), H4K20me1 (Abcam), Ku70 (Abcam), MCM2 (Bethyl), MCM3 (Bethyl), MCM4 
(Bethyl), MCM5 (Pierce), MCM6 (Bethyl), MMS22L (SCBT), nucleophosmin (Abcam), pan-
methyl lysine (Abcam), PRMT5 (Abcam), TONSL (Pierce), RAN (SCBT), SLD5 (Proteintech), 
streptavidin-HRP (Jackson ImmunoResearch). Restriction enzymes were obtained from NEB.
Biochemical fractionation
The eH3.1 chromatin pellet from a ~200 L culture was resuspended and dounce homogenized 
with a loose pestle in 50 ml of buffer E (50 mM Tris, pH7.6, 25% glycerol (v/v), 5 mM 
MgCl2, 0.5 mM EDTA, 5 mM DTT, 0.2 mM PMSF). The soluble material was then separated 
from insoluble chromatin and lamina by adding ammonium sulfate to 300 mM (final 
concentration). Chromatin was then sonicated on ice and centrifuged at 185,000 x g for 1 
hour to separate the solubilized protein complexes from the insoluble chromatin and lamina. 
The supernatant was collected, diluted two folds in buffer E, and two volumes of saturated 
ammonium sulfate solution slowly added to precipitate the protein complexes. Precipitates 
were pelleted by centrifugation (35,000 x g for 30 min) and re-suspended in BC50 (20 mM 
Tris, pH 7.6, 50 mM NaCl, 10% glycerol (v/v), 0.2 mM EDTA, 10 mM β-mercaptoethanol) and 
dialyzed against the same buffer. Salting-out was performed by adding ammonium sulfate 
to the indicated concentrations and centrifuging at 30,000 x g for 30 min. Ion exchange, 
gel filtration chromatography, immunoprecipitations, and silver stains were performed as 
described (Campos et al., 2010). Protein-protein interaction plots were generated by comparing 
the purified proteins to experimental results in STRING (Franceschini et al., 2013), and organized 
using Cytoscape (Shannon et al., 2003). 
Density gradient sedimentation of recombinant proteins were performed as described 
(Campos et al., 2010) at 4°C using an SW60-Ti rotor (Beckman Coulter). Histone–TONSL-
MMS22L interactions were resolved over 15-30% linear sucrose gradients in BC300 + 0.05% 
NP-40 (v/v), centrifuged at 42,000 RPM in for 16 hrs. In vitro translation was performed as 
described by the manufacturer (TNT system—Promega).
Enzymatic Assays
Histone acetyltrasferase and methyltransferase reactions were performed as described 
(Campos et al., 2010) using purified HeLa histones. Recombinant p300 (Abcam) and G9A (Abcam) 
were respectively used as positive controls.  Kinase reactions were performed using [γ -32P] 
ATP (Perkin-Elmer) and 1 μl of 1:10 dilutions of the eH3.1 fractions in 20 mM HEPES, pH 
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7.2, 25 mM KCl, 5 mM Mg(OAc)2, 10 mM (NH4)2SO2, 0.1 mM EDTA and 20 pmoles of HeLa 
histones at 30°C for 30 min. CKII (Abcam) was used as a positive control.  Samples were 
resolved by SDS-PAGE, coomassie-stained, and visualized by autoradiography. ATPase assays 
were performed on chromatinized plasmids generated by salt dialysis (Margueron et al., 2008), 
and performed as described using [γ -32P] ATP (Lee and Hurwitz, 2000) and recombinant RSF 
(Loyola et al., 2003) as a positive control. Recombinant PRC2 was purified as described (Margueron 
et al., 2008). Histone tetramers and sNASP-bound histones were selected by gel filtration and 
methylated using recombinant PRC2 as described (Margueron et al., 2008).
Label-free quantitative mass spectrometry
S100, NE and SNP extracts were obtained as described above. 2-5 mg extract was incubated 
with 15 μl M2 resin (Sigma-Aldrich) (Flag IP) or 15 μl agarose beads (Chromotek) (control) 
for 90 min at 4°C in 430 μl final volume containing 300 mM KCl, 0.15% NP-40 and 50 mg/ml 
ethidium bromide. All IPs were performed in triplicate. Beads were washed twice with 1 ml 
BC300 + 1% NP-40, twice with 1 ml PBS + 1% NP-40 and finally twice with 1 ml PBS. Bound 
proteins were eluted from the beads using two 30 μl 200 mM glycine pH 2.5 elutions, which 
were incubated at 25°C for 5 min and subsequently neutralized in 10 μl 1 M tris, pH 8. The 
eluted proteins were partially denaturated and reduced in 2 M urea, 25 mM tris, pH 8.5 and 
10 mM DTT for 20 min, after which they were alkylated with 50 mM IAA for 10 minutes and 
digested with 0.5 μg trypsin (Promega) overnight at 25°C. Digested peptides were desalted 
and concentrated using C18 stagetips prior to online LC-MS/MS analysis. 120 minute 
gradients (6-75% acetonitrile) were applied (nanoLC1000, Thermo Scientific) and spectra 
were recorded on an Orbitrap Velos (Thermo Scientific), selecting the 15 most intense 
precursor ions for fragmentation for each full scan.  Data analysis was done as described 
before (Smits et al., 2013). Top ontology terms, along with the terms ‘replication’, ‘transcription’, 
‘DNA repair’, ‘chromatin assembly or disassembly’ and ‘chromatin modification’, were 
queried and compared to the input material using the DAVID functional annotation tool 
(Dennis et al., 2003).
Crosslinking and Mass Spectrometry Analysis
In vivo crosslinking of cells was performed after a 3 hr release from a double-thymidine 
block, after which cells were trypsinized, washed, and resuspended at 2.5 x 107 in PBS, pH 
8 at room temperature (RT). DSS (Pierce) was added to 2 mM (final concentration) and 
the sample allowed to incubate for 30 min at RT with gentle rotation. The reaction was 
quenched by adding tris, pH 6.8 to 20 mM. The ensuing partial crosslinking allowed the 
immunoprecipitation of lysine-containing epitopes from cells in S-phase. Cells were gently 
pelleted at 800 x g and lysed in 5 pellet volumes of 20 mM tris, pH 6.8, 150 mM NaCl, 0.2 
mM EDTA, 30% glycerol (v/v), 0.5 mM MgCL2, 0.5% NP-40 (v/v), 1 mM DTT in the presence 
of protease inhibitors, and the DNA digested with 0.2 U/ml benzonase (Sigma-Aldrich) at 
4°C with gentle rotation overnight. The samples were then centrifuged at 30,000 x g for 30 
min to remove insoluble material. The resulting partial crosslinking allowed for subsequent 
immunoprecipitation using the lysine-containing FLAG epitope from the aforementioned 
stable clones. Immunoprecipitates were resolved by SDS-PAGE, coomassie-stained, and high 
molecular weight species excised for MS analysis.
For the analysis of protein-protein interactions, recombinant proteins were pre-incubated in 
10 mM HEPES, pH 8, 150 mM NaCl for 30 min at RT. Crosslinking reactions were performed 
with DSS as described above. Crosslinked proteins were reduced with 20mM DTT, alkylated 
with 50 mM iodoacetamide, and digested using trypsin as described (Muellenbeck et al., 2013). 
Tryptic peptides were separated on an EASY spray 50cm C18 analytical HPLC column with 
<2 μm bead size using the auto sampler of an EASY-nLC 1000 HPLC and gradient eluted 
using a two hour gradient into a Q Exactive Orbitrap Mass spectrometer.  High resolution 
full MS spectra were acquired with a resolution of 70,000, AGC target of 1e6, maximum 
ion time of 120ms, and scan range of 400 to 1500 m/z. Following each full MS twenty data-
dependent high resolution HCD MS/MS spectra were acquired. All MS/MS spectra were 
collected using the following instrument parameters: resolution of 17,500, AGC target of 
5e4, maximum ion time of 250ms, one microscan, 2m/z isolation window, fixed first mass 
of 150 m/z, and Normalized Collision Energy (NCE) of 27. For discovery of linear peptides, 
ions with charge state +2, +3, +4, +5 were selected for MS/MS, for the crosslink analysis only 
ions with charge state of +4, +5 and +6 were selected for MS/MS. The spectra for the linear 
peptide analysis were searched against the Uniprot human database using Sequest within 
Proteome Discoverer. Cysteine carbamidomethylation was selected as static modification 
and oxidation of methionine, deamidation of glutamine and asparagine and monolink 
mass addition of 156.07864 Da on lysine residues and N-termini was selected as variable 
modification. Proteins with an FDR of 1% and at least two unique peptides were extracted to 
create a focused database for subsequent search of the crosslinked data. For identification 
of crosslinked peptides the data was searched against the focused database using the pLink 
(Yang et al., 2012) search algorithm including the static and variable modifications as above and 
the crosslink mass shift of 138.06809 Da. Hits with pLink scores below 1E-04 was excluded 
from the analysis and higher scoring spectra were manually verified.
DNA Supercoiling Assay
Chromatin assembly and DNA supercoiling assay was done as described (Fyodorov and 
Kadonaga, 2003), with the following modifications. The drosophila topoisomerase fragment 
ND423 was expressed from BL21 cultures and purified over NiNTA resin (Qiagen) followed 
by anion exchange chromatography. One ng ND423 was used per 20 fmoles of circular 
plasmid, which was relaxed at 30°C for 30 min in 50 mM tris, pH 7.6, 10 mM MgCl2, 0.1 mM 
EDTA, 0.5 mM DTT, 50 μg/ml BSA. HeLa histone:histone chaperones were simultaneously 
incubated in Assembly Buffer (10 mM tris, pH 7.6, 100 mM KCl, 2 mM MgCl2, 1 mM DTT, 
0.1 mg/ml BSA) at the desired molar ratios. Chaperone-mediated chromatin assembly was 
then performed by mixing 100 fmoles of the relaxed plasmid (directly from ND423 mixture) 
and 10 pmoles HeLa histone (from the histone:chaperone mixture), with an equal reaction 
volume of 2X Assembly Buffer. Reactions proceeded at 37°C for 2.5 hrs and were stopped 
by adding an equal volume of 2X Stop Buffer (20 mM EDTA, pH 8, 0.5 mg/ml glycogen, 
0.1% SDS (w/v)) and 2.5 μg proteinase K, and incubating at 50°C for 30 min. DNA was then 
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Figure S1, Related to Figure 1. (A) Ontology groups associated with H3.1-associated proteins. (B) Cell cycle 
distributi on of cells used to compare H3.1 interacti ons between asynchronous and synchronized, replicati ng cells. 
(C) Quanti tati ve MS analysis of affi  nity purifi ed H3.1 material. Each volcano plot represents three independent H3.1 
pull-downs comparing asynchronous cell extracts to extracts from replicati ng cells. The x axis denotes the intensity 
of the MS signal whereas a false discovery rate (FDR) adapted t-test is on the y axis.
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Supplementary Figuresextracted with phenol:chloroform, ethanol precipitated and resolved over an 0.8% agarose 
gel in the absence of intercalati ng agents. Gels were then stained with ethidium bromide 
and visualized under UV light. Yeast NAP-1 served as a positi ve control. The protein was 
expressed from BL21 cultures, purifi ed over glutathione sepharose (GE Life Science), and 
the eluti ons further resolved by anion exchange chromatography.
Pepti de pulldowns
Bioti nylated pepti des spanning histone H3 1-21, 21-44, and 69-89 were purchased from 
Anaspec. 250 pmoles of pepti des were immobilized onto 10 μl Strep-Tacti n macroprep 
slurry (IBA) per pulldown. 10 pmoles of recombinant TONSL, TONSL-MMS22L, or protein 
fragments were incubated with the beads in 500 ul BC150 for 3 hrs at 4°C with gentle 
rotati on. The resin was collected by centrigugati on (1000 x g, 2 min, 4°C) and washed 3 x 
BC300 + 0.05% NP-40 (v/v) followed by a BC150 wash. Beads were resuspended in Laemmli 
buff er, boiled and resolved by SDS-PAGE for western analysis.
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HeLa (modifi ed) histones. (C) Left  panel: Binding of HeLa histones to immobilized full-length TONSL or a protein 
fragment encompassing the acidic region and ankyrin repeats (AA); Right panel: Supercoiling assay comparing the 
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7 7
Discussion Concerning Chromatin Biology
In this thesis, we aimed to characterize chromatin-protein interactions in order to get a 
better understanding of their function in transcriptional regulation. We used the power of 
quantitative mass spectrometry-based proteomics to identify protein-protein interactions 
and developed novel workflows to gain additional information on interactors.
Protein complex composition
In Chapter 3, we developed a method to measure the abundance of interactors obtained 
in AP-MS experiments. This information is useful to prioritize interactors, i.e. distinguish 
core interactions from transient and/or weaker interactions, and to obtain complex 
stoichiometries. We applied this method to determine the stoichiometry of the co-
repressor complexes NuRD and PRC2 (Chapter 3) as well as the activator SET1/MLL 
complexes (Chapter 4). Interestingly, for each of these complexes we observed multiple 
substoichiometric interactors. The substoichiometric abundance of these subunits might 
indicate that they are only present in a subset of the complexes or that they are instable 
and lost during purification. To rule out the latter, we performed AP-MS experiments for six 
of these substoichiometric interactions of the SET1/MLL complexes. All these purifications 
indicated that these interactions are stoichiometric in a subset of SET1/MLL complexes, 
indicating the presence of a family of complexes. Reciprocal AP-MS experiments were not 
performed for NuRD and PRC2, but the substoichiometric interactions observed for these 
complexes likely indicate that these complexes also consist of families of complexes.
Recently, the existence of a family of distinct polycomb repressive complex 1 (PRC1) 
complexes was reported (Gao et al., 2012). Together with our findings, this postulates the 
hypothesis that the presence of these families of complexes, which consist of complexes 
with shared core subunits and differential subunits (Fig. 1A), is a general phenomenon in 
chromatin biology. The existence of these families of complexes has important implications 
for the study of their biological functions. Differential subunits present in distinct complexes 
likely alter the characteristics of the protein complex. These subunits can contain chromatin-
binding domains, leading to differential recruitment of the complex to chromatin and 
thereby to an altered genome-wide localization. Differential localization of distinct PRC1 
complexes has also been observed (Gao et al., 2012). Furthermore, alternative complex 
compositions can modify enzymatic activities. Recently, one variant of PRC1 complex was 
identified as an activator of transcription (Gao et al., 2014), as opposed to the transcriptionally 
repressive canonical PRC1 complex (Laugesen and Helin, 2014). This example emphasizes the 
need to investigate the exact function of distinct complexes of the same family. Research 
on the functional diversity of these complexes might reveal previously unknown and even 
unexpected functions for individual complexes. 
The detailed investigation of NuRD and PRC2 complexes (Chapter 3) is particularly interesting, 
as their function is currently debated. Originally, NuRD was reported as a transcriptional 
repressor (Kehle et al., 1998; Xue et al., 1998; Zhang et al., 1998), however recent studies implicated 
the complex in activation or modulation of transcription (Reynolds et al., 2012; Zhang et al., 
2012). In our NuRD AP-MS experiments, we identified substoichiometric zinc-finger domain 
containing proteins. Zinc-finger domains are important eukaryotic sequence-specific DNA-
binding modules (Nardelli et al., 1991). As these zinc-finger containing proteins probably exhibit 
sequence-specific DNA binding, these proteins might target subsets of NuRD complexes to 
specific loci. Other substoichiometric interactors might be present in different cell types, 
which may affect the enzymatic activity of the complex. Thus, the family of NuRD complexes 
may consist of loci-specific transcriptional activating and repressing complexes.
The recruitment of PRC2 to chromatin has been a topic of discussion for a long time. The 
complex is thought to be recruited to specific loci through subunits containing histone and 
DNA binding domains. However, other models postulate that the complex has a general 
affinity for unmethylated CpG islands and is only excluded from these CpG islands when 
the corresponding genes are actively transcribed (Klose et al., 2013; Voigt et al., 2013). As we 
have identified many substoichiometric interactions, a subset of PRC2 complexes might be 
recruited directly to target loci, whereas another subset might lack such specific chromatin 
binding. Recently, Jarid2 has been implicated in H3K27me3 deposition at loci devoid of 
this mark (Sanulli et al., 2015). Jarid2 is present in ~15% of the NuRD complexes in our AP-MS 
experiments and this subset of PRC2 complexes might be essential for the establishment 
of transcriptional repressive domains. A family of PRC2 complexes with distinct localization 
and activities would be able to reconcile the different observations made for this complex.
The interactomes of WDR5 and DPY30, in our analysis of the SET1/MLL complexes (Chapter 
4), contain multiple chromatin-associated complexes. These complexes do not overlap in 
composition, except for the presence of WDR5 or DPY30. Especially WDR5 is present in 
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Figure 1. Schematic representation of a family of complexes sharing the same core subunits and different 
complexes sharing a single subunit. (A) Hypothetical composition of a family of complexes with core and 
differential subunits. The percentage indicates the abundance of the different complexes as compared to the family 
of complexes. (B) Hypothetical composition of three complexes sharing a common subunit. 
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a multitude of complexes, which cover a diverse set of biological functions. This indicates 
the presence of functionally diverse complexes that share a single subunit (Fig. 1B). This 
notion warrants careful interpretation of experiments performed on the shared subunit. For 
example, genome-wide localization of the shared subunit cannot be extrapolated to one of 
the complexes nor can the effect of knockdown studies on the shared subunit be ascribed 
to a specific complex. This is particularly important for WDR5, as this protein was initially 
identified as a SET1/MLL interactor (Wysocka et al., 2005). WDR5 interactors were therefore 
regularly annotated as SET1/MLL interactors (Trievel and Shilatifard, 2009), whereas these proteins 
are subunits of other complexes that WDR5 is part of. Additionally, WDR5 knockdown has 
been extensively used to reduce global H3K4me3 by lowering SET1/MLL complex enzymatic 
activity. For example, vertebrate development was shown to be dependent on WDR5 (Wysocka 
et al., 2005) and histone acetylation was reduced upon WDR5 reduction (Wang et al., 2009c). 
However, these knockdowns will also influence all other WDR5-containing complexes and 
the conclusions based on WDR5 knockdown cannot be generalized to SET1/MLL complex 
function.
Novel enrichment strategy
The second introduced technique in this thesis, Click-MS (Chapter 5), implements the 
incorporation of unnatural amino acids in combination with bioorthogonal chemistry to 
specifically enrich proteins of interest. This eliminates the use of large N- or C-terminal 
epitopes that can potentially interfere with interactions or subcellular protein localization, 
and enables the purification of proteins of interest to (near) purity in a single step. We show 
the feasibility of the workflow by enriching the NuRD complex member MBD3. Under the 
current conditions of MBD3 purification, we could only co-enrich a partial NuRD complex. 
This observation shows that direct enrichment of the protein of interest is feasible, but for 
comprehensive PPI identification, multiple sites of unnatural amino acid incorporation need 
to be tested.
The site-specific incorporation of unnatural amino acids in proteins was pioneered in 
bacteria, in which the amber stop codon is strongly underrepresented (Wang et al., 2001). It has 
been extended to yeast and mammalian cell culture systems, in which the UAG is present 
in 20% of the genes (Chin et al., 2003; Liu et al., 2007). Although the amber stop codon is present 
more frequently in eukaryotes, this did not lead to observable stress caused by potential 
read-through of endogenous amber stop codons. Recently, the technique was advanced to 
living organisms, allowing unnatural amino acid incorporation in worms (Greiss and Chin, 2011) 
and flies (Bianco et al., 2012). This emphasizes the compatibility of site-specific unnatural amino 
acids incorporation with normal cellular homeostasis and even tissue development. In our 
proteomic analysis, we also observed a minimal, if at all, effect on the cellular proteome 
upon amber suppression. This gives a first indication that amber suppression does not alter 
the cellular state on a molecular level. Therefore, we are confident to use this system for 
detailed characterization of protein PTMs and protein-protein interactions in cell lines, 
developing worm or fly embryos and tissues of these organisms. 
The technique can be used for fundamental research on the dynamics of protein complex 
composition in development and research on tissue-specific protein-protein interactions. 
Because of the introduction of unnatural amino acids, the cells or organisms have to be 
handled in the laboratory, as is the case with epitope tagging approaches. For studies on 
protein-protein interactions in human tissues or clinical samples, epitopes or unnatural 
amino acids cannot be used. In order to facilitate such research, technical improvements are 
necessary for the efficient enrichment of protein-protein interactions from small amounts 
of material and such improvements will be discussed below in the discussion concerning 
interaction proteomics.
Histone H3.1  interactions
The potential of mass spectrometry-based interaction proteomics to help answering 
biological questions is highlighted by the work on Histone H3.1 interactions (Chapter 
6). Eviction of histones from chromatin and deposition of histones onto chromatin is 
dependent on histone chaperones. We used quantitative interaction proteomics to obtain 
a comprehensive interactome of H3.1, the replication-coupled histone H3 variant. The 
interactions are distinct for different cellular compartments and the nuclear interactors 
could be assigned to twenty separate complexes.
Among the interactors are 11 different histone chaperones, which assemble in complexes 
containing different activities and are involved in different processes. In the nucleus, 
the paths of newly translated histones and recycled parental histones converge. Newly 
synthesized histones are transported into the nucleus by ASF1B and transferred to CAF-
1, which is associated with the replication fork, and histones tetramers are formed before 
deposition onto chromatin (Tagami et al., 2004; Campos et al., 2010). However, how parental 
histones are handled during replication remains elusive. ASF1B interacts with MCM proteins 
and could chaperone H3-H4 dimers of parental histones (Groth et al., 2007). However, a mass 
spectrometry-based investigation indicated that parental (H3-H4)2 tetramers are not 
partitioned during replication (Xu et al., 2010b). Therefore, the (H3-H4)2 tetramer has to be 
handled by a different chaperone or it is only transiently split into dimers. In our proteomic 
analysis, we identified histones in complex with the histone chaperone NASP in the cytosol 
and nucleus. NASP binds newly translated H3-H4 dimers in the cytosol (Campos et al., 2010) and 
is now identified to also bind parental H3-H4 dimers in the nucleus. Whether this chaperone 
is also directly involved in the recycling of parental histones during replication remains an 
open question.
Recently, MCM2, a member of the replicative helicase, was reported to contain histone 
chaperoning activity (Foltman et al., 2013; Huang et al., 2015). This raised the hypothesis that the 
replicative helicase itself can be the chaperone responsible for histone H3-H4 eviction and 
CAF-1 for histone deposition onto chromatin. The implication would be that all other histone 
H3.1 chaperones are not directly involved in replication-coupled histone eviction. NASP and 
ASF1B are likely important in the buffering of histones and to supply histones just behind the 
replication fork. Other H3.1 chaperones will function in different contexts, as exemplified 
by TONSL which is probably required at stalled replication forks. This highlights the diverse 
biological functions of histone chaperones.
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Discussion Concerning Interaction Proteomics
The novel mass spectrometry-based workflows described in this thesis yield additional 
information on protein interactions. This leads to new perspectives on these interactions 
and can shed light on their biology, as exemplified by the identification of the abundant 
novel PRC2 interactor C17orf96 and the identification of quantitative dynamics in complex 
composition in differentiation and characterization of SET1/MLL subcomplexes. Here, 
we discuss the implications of these improvements and highlight future challenges and 
opportunities involved in the different steps of interaction proteomics workflows (Fig. 2).
Target purification 
The first step in MS-based interaction proteomics workflows is the purification of the protein 
of interest with the aim to co-purify and identify its interactors (Fig. 3). Commonly used 
workflows are based on affinity purification of the bait protein using specific antibodies or 
antibodies against epitope tags (AP-MS) (Gavin et al., 2002; Ho et al., 2002). However, antibodies 
against endogenous proteins are of limited availability. Furthermore, they often exhibit cross 
reactivity, therefore requiring elaborative validation experiments using target knockdown 
(Selbach and Mann, 2006). More often, epitope tags are used for which high quality enrichment 
reagents are available, such as FLAG (Ho et al., 2002; Sowa et al., 2009), TAP (Gavin et al., 2002; Gavin et 
al., 2006; Krogan et al., 2006) and GFP tags (Cristea et al., 2005; Hubner et al., 2010).
Recently, the use of nanobodies have revolutionized antibody-based research, as these 
nanobodies contain a single antigen-binding domain (VHH) which can easily be cloned and 
engineered yielding high affinity probes (Muyldermans, 2013). This led to the development of a 
high affinity and specific anti-GFP nanobody (Rothbauer et al., 2006; Rothbauer et al., 2008), which 
is now routinely used in AP-MS workflows (Hubner et al., 2010; Baymaz et al., 2014). In 2014, a 
nanobody dimer was developed with even higher affinity for GFP that could be used for 
extremely fast and efficient affinity purification (Fridy et al., 2014). Nanobodies are especially 
advantageous for AP-MS purposes, because the small size of nanobodies reduce potential 
background binding and limit the number of peptides released from the affinity resin in on-
bead digestion.
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Figure 2. Mass Spectrometry-based characterization of protein-protein interactions: challenges and 
opportunities. The challenges and opportunities are depicted at the appropriate points in the mass Spectrometry-
based PPI characterization workflow and will be discussed in this chapter.
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Figure 3. Different target purification methods. Target purification methods can rely on direct enrichment using 
immunoprecipitation, streptavidin-biotin binding or click chemistry. Additionally, the interactions can be studied 
on a global level by studying co-behavior of proteins in biochemical purifications or perturbation experiments.
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As an alternative to antibody based affinity purification, the very high affinity of streptavidin 
for biotin (KD = 10
-14 M) has been used to purify targets (Fig. 3). In a pioneering study, a 
protein of interest was tagged with an artificial peptide that was biotinylated by BirA and 
could be subsequently enriched using streptavidin (de Boer et al., 2003). This technique is now 
a generally applied technique that has been used in landmark papers identifying protein-
protein interactions (Wang et al., 2006; Sharif et al., 2007) but also protein-DNA interactions (Mito et 
al., 2005; Kim et al., 2008). A caveat of this technique is the fact that endogenously biotinylated 
proteins will also be enriched, as was already observed in the original paper (de Boer et al., 
2003). Recently, Burke and colleagues used a promiscuous biotin protein ligase (BirA*) protein 
fusion to biotinylate all proteins in close proximity of the protein of interest (Roux et al., 2012). 
The direct in vivo tagging of potential interactors allows stringent enrichment and washing 
conditions, thereby limiting background binding. However, it cannot discriminate between 
direct interactors and proximal proteins. In summary, protein biotinylation facilitates 
highly efficient streptavidin-based affinity purification, but co-enrichment of endogenously 
biotinylated proteins is a clear drawback.
More recently, protein interaction identification workflows have been developed that are not 
based on affinity purification of a specific complex of interest. In contrast, interactions are 
investigated on a global level by studying co-behavior of proteins in biochemical purifications 
(Havugimana et al., 2012; Kristensen et al., 2012) or perturbation experiments (Savitski et al., 2014) 
(Fig. 3). These techniques are promising as they aim to characterize an entire interactome 
within a single experiment. However, this also highlights the limitation of these techniques, 
namely the fact that an extreme proteome depth, advanced bioinformatics analyses and 
very consistent quantification across different fractions are needed for reliable identification 
of all protein-protein interactions. In biochemical purification approaches, the proteome 
was fractionated in order to separate protein complexes, leading to the identification of 
hundreds of putative complexes, including known complexes with novel subunits (Havugimana 
et al., 2012; Kristensen et al., 2012). This required extensive fractionation involving extreme salt 
concentrations in ion exchange chromatography that might disrupt weaker and transient 
interactions. Additionally, it is possible that functionally unrelated complexes co-elute, 
leading to false assignment of protein-protein interactions. In a recent perturbation study, 
the thermal stability of proteins was characterized in the presence and absence of a drug 
(Savitski et al., 2014). Due to the accurate characterization of protein melting temperatures, i.e. 
the temperature at which the protein denaturates, and the ability to identify shifts of those 
upon drug presence, direct drug targets but also their physical and/or functional interactors 
were identified. Although this technique has only been introduced recently and will likely 
be optimized in the upcoming years, the current inability to distinguish between physical 
and functional interactions is a clear limitation for protein interaction studies. In summary, 
global interactome studies are promising complementary techniques to AP-MS workflows, 
but they still suffer from technical limitations and are at the moment rather labor intensive. 
As a more direct alternative to antibody- or biotin-based AP-MS, we introduced Click-MS 
(Chapter 5). By incorporating unnatural amino acids that harbor an azide in the protein of 
interest, the protein can be chemoselectively modified or immobilized in a bioorthogonal 
manner (Fig. 3). The immobilized protein and its interactors can subsequently be identified 
using mass spectrometry. For a comprehensive interactome of the bait, the unnatural amino 
acid can be incorporated at diverse sites within the protein. This will circumvent the classical 
tagging related-problems for antibody- or biotin-based AP-MS, in which the N- or C-terminal 
tags might interfere with protein interaction and function. Compared to these tags, the 
minimal size of the azide and the ability to incorporate it at any user-defined position 
make Click-MS a technique with unprecedented flexibility and minimal to no structural 
interference.
The great potential of Click-MS protein purification is not restricted to protein complex 
identification. In contrast to the traditional antibody-protein affinity methods, Click-MS 
protein purification relies on the formation of a covalent bond for enrichment. This allows 
for stringent purification and washing conditions, which result in a strong reduction of 
background binding proteins. Enrichment to near homogeneity should be beneficial 
for analysis techniques that are sensitive to contamination such as, but not limited to, 
comprehensive PTM identification, crosslinking-MS, and chromatin immunoprecipitation 
(ChIP). Until now, such a pure sample preparation could only be achieved using tandem 
affinity purification (TAP). This procedure involves the enzymatic cleavage of one of 
the epitope tags and subsequent depletion of the protease in between the two affinity 
purifications. The extra experimental steps result in less efficient recovery of the protein 
of interest and require a drastic increase in input material. Click-MS holds great promise of 
straightforward, efficient single-step enrichment of the protein of interest to near purity. 
As mentioned before, amber suppression has been extended to living organisms. Recently, 
the incorporation of unnatural amino acids could even be targeted to a specific tissue 
(Elliott et al., 2014). The application of Click-MS in these systems in principle allows for the 
simple identification of tissue-specific protein-protein interactions and PTMs from whole 
organisms.
Enrichment of diverse biomolecules and their interacting proteins
The incorporation of bioorthogonal moieties in proteins, as described for Click-MS, can also 
be done in a proteome wide manner. Analogues of methionine harboring these moieties 
can be effectively incorporated in all proteins by the endogenous machinery in bacteria 
(van Hest et al., 2000) and mammalian cells (Dieterich et al., 2006). A noteworthy application of 
this technique is the enrichment of newly synthesized histones (Deal et al., 2010), secreted 
proteins (Eichelbaum et al., 2012) and newly synthesized proteins in primary cells (Howden et al., 
2013). Interestingly, similar to the site-specific UAA incorporation as used in Click-MS, the 
proteome wide labeling can also be applied in a tissue specific manner (Ngo et al., 2009). 
This residue-specific labeling is complementary to site-specific labeling and can be used 
to study the global proteome. An interesting interaction proteomics application would be 
the enrichment of newly synthesized proteins followed by biochemical fractionation to 
investigate the timing of the establishment of protein-protein interaction and incorporation 
into protein complexes. 
Bioorthogonal groups can also be incorporated in precursors of post-translational 
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modifications. These precursor analogues, called chemical reporters, allow for the labeling 
and enrichment of proteins with the modification of interest. The quantitative workflow 
we developed for Click-MS is directly applicable for these modified proteins and can be 
used to identify these proteins as well as their interactors. The chemical reporter technique 
was pioneered with sugar analogues to label cell surfaces (Saxon and Bertozzi, 2000) and was 
shown to be applicable to living animals (Laughlin et al., 2008).  Other sugar analogues have 
been developed to monitor protein O-GlcNAcylation (Vocadlo et al., 2003; Zaro et al., 2011). 
Most other PTMs are, however, relatively small and the enzymes involved need to be 
engineered to recognize the precursor analogues. Although labor intensive, this has been 
done for protein methyltransferases and in conjugation with SAM analogues this deposited 
clickable methylation-analogues on the targets (Peters et al., 2010; Wang et al., 2011). Interestingly, 
the methyltransferase G9A, which catalyzed the transcriptionally repressive mark  H3K9 
methylation, was also evolved for this purpose (Islam et al., 2011). The efforts in the field 
now allow the use of chemical reporters for, amongst others, acetylation (Yang et al., 2010), 
glutathione (Feng et al., 2014) and malonylation (Bao et al., 2013). The application of all these 
clickable PTM analogues to quantitative proteomics will allow for deep coverage of PTM 
sites and the rapid development of novel analogues will increase the scope of modifications 
studied.
Other yet less explored classes of biomolecules such as nucleic acids and lipids can also be 
modified with bioorthogonal groups. In recent efforts, bioorthogonal chemistry has been 
used to label DNA (Salic and Mitchison, 2008; Wang et al., 2013; Winz et al., 2015), RNA (Salic and Mitchison, 
2008; Cahova et al., 2015; Li et al., 2015) and lipids (Haberkant et al., 2013). In DNA labeling, ethynyl-
modified nucleosides were incorporated in entire virus genomes (Wang et al., 2013) and more 
recently DNA was labeled in vitro using nucleotidyl transferase (Winz et al., 2015). The latter 
approach could be used to functionalize genomic fragments in vitro, without altering DNA 
and possibly its function in vivo. Additionally, the DNA modifications cytosine (hydroxyl)
methylation were tagged with clickable groups  (Dalhoff et al., 2006; Song et al., 2011), enabling the 
purification and sequencing of the modified DNA fragments. This workflow would also allow 
the identification of proteins interacting with these fragments in vivo and could complement 
our recent work on in vitro reconstitutions of DNA-protein interactions (Spruijt et al., 2013). For 
RNA labeling, two recent papers reported the in vitro enzymatic incorporation of clickable 
groups by enzymatically modifying a tRNA sequence (Li et al., 2015) or the NAD cap in bacteria 
(Cahova et al., 2015). The latter approach allowed for the purification of the modified transcripts, 
the subsequent sequencing and the interrogation of the NAD modification function in RNA. 
Strikingly, this report focused on the sequence of the transcripts and did not touch upon 
the transcript-protein interactions. Finally, the importance of lipid-protein interactions was 
only recently appreciated in interaction studies using proteins (Zhu et al., 2001; Maeda et al., 2013) 
and lipids (Gallego et al., 2010; Saliba et al., 2014). The reported alkyne modified lipids (Haberkant 
et al., 2013) in combination with quantitative proteomics hold promise to revolutionize the 
identification of these interactions. In conclusion, bioorthogonal chemistry enables the 
enrichment of diverse biomolecules and in combination with the quantitative workflow we 
developed for Click-MS this facilitates the study of their protein interactions in vivo.
Quantification of protein-protein interactions
In the last decade, the introduction of isotope labels in mass spectrometry-based proteomic 
workflows has revolutionized the way to discriminate true hits from background proteins 
(Bantscheff et al., 2007). This is especially highlighted in protein-protein interaction identification, 
in which affinity purification always yields nonspecific binding proteins to for example the 
support matrix (Mellacheruvu et al., 2013). Implementation of a quantitative filter to distinguish 
background binding proteins from real interactors, enabled high-confidence detection 
of interactors from single step affinity purifications (Vermeulen et al., 2008) (Fig. 4A). These 
developments resulted in the identification of tens of interactors per protein of interest, 
as exemplified in recently published interactomes of thousands of interactions using single 
step purifications with 1796 antibodies against endogenous proteins (Malovannaya et al., 2011) 
or 2594 FLAG-HA tagged proteins (Huttlin et al., 2015).
The prioritization of these interactions is not trivial and has been a challenge for biological 
follow-up studies. Interactions have been scored and ranked using different computational 
methods in order to predict the most robust and important interactions (Sardiu et al., 2009; 
Mazloom et al., 2011).  Recently, we have developed a more direct measurement of the 
importance of these interactions. By measuring the abundance of the protein of interest 
and that of its interactors in single-step affinity purifications, the relative stoichiometry of 
these interactions can be assessed (Smits et al., 2013). Importantly, it does not rely on data 
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Figure 4. Quantitative characterization of protein-protein interactions for topology and stoichiometry 
determination. (A) Implementation of a quantitative filter enables high-confidence detection of specific interactors 
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dynamics. (E) Quantitative information of interactors enables accurate stoichiometry determination.
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of hundreds of affinity purifications as is the case for other prioritizing computational 
methods, but can be directly applied to AP-MS data of a single protein of interest and a 
matched control. The additional quantitative information can directly be used to distinguish 
core interactors from those that are substoichiometric (Fig. 4B).
An additional challenge lies within the identification of differential protein interactions in 
distinct environments. In the last decade it was shown that protein interactions can be 
dynamic in development, after stimuli and between wild type and disease mutants. A clear 
example are embryonic and neuronal specific subunits of the BAF chromatin remodeler 
complex (Ho et al., 2009; Ronan et al., 2013). Recently, mutant specific interactions were also 
reported for neurodegenerative disease proteins (Hosp et al., 2015) and ALS-associated 
VAPA/VAPB proteins (Huttlin et al., 2015). While in these examples the dynamic interactions 
are completely absent in one of the two conditions, a lot of changes are expected to be 
more subtle and will be missed by the classical qualitative protein-protein interaction 
identification (Fig. 4C). For example, identified interactions of CDYL in mESC and NPC were 
very comparable, whereas  the quantification of interactor abundance did identify dynamics 
within complex composition (Escamilla-Del-Arenal et al., 2013). In another recent study, dynamics 
of the Cullin-RING Ubiquitin Ligase Network upon drug treatment could only be detected 
using isotope-labelled peptide-based absolute quantification of the subunits (Bennett et al., 
2010). These studies indicate that for the identification of dynamic interactions, abundance 
measurement of interactors is more sensitive than classical qualitative PPI identification and 
has the potential to provide new insights in protein complex dynamics and function (Fig. 4D). 
Therefore, quantification of protein interactions in development, cell cycle phases and upon 
stimuli and drug treatment will likely unravel important changes in complex composition 
that fine tune the complex characteristics and function. 
Structural proteomics
Absolute quantification of protein interactors also yields valuable information for structural 
biologists, as these values reveal protein complex stoichiometry. Stoichiometry values can 
be obtained using spike-in experiments with AQUA peptides (Wepf et al., 2009; Bennett et al., 
2010; Schmidt et al., 2010), but we established an inexpensive, less labor-intensive and label-
free quantification workflow (Fig. 4E) (Smits et al., 2013), which is based on the iBAQ algorithm 
(Schwanhausser et al., 2011) that is implemented in the MaxQuant software (Cox and Mann, 2008). 
As further illustrated below, this information is especially interesting in combination with 
recently developed crosslinking mass spectrometry workflows (XL-MS), which allows the 
identification of directly interacting protein complex subunits. Although this technique 
was already introduced in 2000 (Young et al., 2000), developments in crosslinking reagents, 
instrumentation and analysis software have allowed a broad use of XL-MS (Leitner et al., 
2010; Rappsilber, 2011; Herzog et al., 2012). Recently, this methodology has been optimized to be 
compatible with single affinity enrichments and can be performed in parallel to the label-
free protein-protein interaction identification and quantification (Makowski et al., 2015; Shi et al., 
2015).
The combination of data on protein-protein interactions, their stoichiometry and direct 
interaction constrains can allow for complex architecture modeling. A modeling approach 
based on interactor identification and weights on interactions based on reported contacts 
was recently reported (Agarwal et al., 2015). Incorporation of stoichiometry information in these 
modeling algorithms will probably result in more accurate architecture predictions solely 
based on bottom-up mass spectrometry data. This can be further supplemented with data 
from native mass spectrometry-based proteomics (Heck, 2008; Mehmood et al., 2015). Although 
native mass spectrometry is still considered to be a specialized technique that is applied 
in a limited number of proteomics labs, its advancements will likely make it more broadly 
applicable in the future. The integration of native and shotgun mass spectrometry enables a 
more sophisticated structural modeling of the complex architecture (Politis et al., 2014).
A more commonly used technique to complement MS-based data is high resolution cryo-
EM. This approach was shown to be successful for the first time in the characterization of 
the nuclear pore complex (Alber et al., 2007a; Alber et al., 2007b). Nowadays, cryo-EM can reach 
atomic resolution for proteins and near-atomic resolution for protein complexes thanks to 
technological developments in instrumentation, workflows and analysis software (Cheng, 
2015; Nogales and Scheres, 2015). These advances revolutionized the field of structural biology 
and recent structural breakthrough papers are based on the combination of high resolution 
cryo-EM and XL-MS (Nguyen et al., 2013; Tosi et al., 2013; Greber et al., 2014; Huis in ‘t Veld et al., 2014). 
Typically, known crystal structures of complex subunits are fitted within the cryo-EM shape 
based on its volume and the constraints from identified inter-subunit crosslinks. Information 
on subunit stoichiometry will be extremely useful in this process, for example for the fitting 
of Rvb1/Rvb2 proteins that were found to be in heterododecamer and heterohexamer 
stoichiometry in INO80 and SWR1, respectively (Nguyen et al., 2013; Tosi et al., 2013). Therefore, 
our label-free relative stoichiometry determination can also be of high value for structural 
studies based on XL-MS and cryo-EM.
Sample downscaling
The final challenge for interaction proteomics studies, and proteomics in general, lies 
within the fact that many biological samples can only be retrieved in limited quantities. For 
example, highly relevant biological systems such as the developing embryo, primordial germ 
cells, organoid cultures, but also clinical samples contain only thousands of cells. These 
numbers are far lower than the average millions of cells obtained from cell cultures. In 
proteomics, the main theme has been to increase the depth of proteomes. This led to major 
publications reporting the first comprehensive yeast proteomes (de Godoy et al., 2008; Picotti et 
al., 2009), mammalian cell line proteomes (Beck et al., 2011; Nagaraj et al., 2011) and eventually even 
the human proteome (Kim et al., 2014; Wilhelm et al., 2014). To accommodate proteomic research 
on the biological systems consisting only of thousands of cells, the focus in proteomic 
development has to shift from deepest coverage with millions of cells to decent proteome 
coverage with limited material. To achieve this, both the efficiency of workflows and the 
sensitivity and dynamic range of the instrumentation have to be improved.
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Mass spectrometry instrumentation is continuously developed within companies. The 
development of the Orbitrap series by Thermo Scientific led to the most recent report of 
close to 4000 proteins in an one hour run (Hebert et al., 2014; Richards et al., 2015). But also Bruker 
developed competitive instrumentation (Beck et al., 2015) and the TripleTOF instrument from 
AB-Sciex revolutionized the field of independent data acquisition, a complementary MS 
fragmentation and analysis strategy (Collins et al., 2013; Lambert et al., 2013; Guo et al., 2015).
The development of workflows for small scale proteomic applications has just started in 
whole proteome measurements. Xenopus oocytes are relatively large and allowed for the 
first reported whole proteomes from single oocytes with small technical adjustments (Smits 
et al., 2014; Sun et al., 2014). More extensive workflow adaptions were reported in attempts to 
reduce the experimental handling and contact with plastics, e.g. the in-stage tip and single-
pot solid-phase-enhanced sample preparation procedures (Hughes et al., 2014; Kulak et al., 2014). 
These workflows can be used to measure whole proteomes, but for interaction proteomics 
other optimizations are necessary. The first improvement has been the direct digestion of 
enriched proteins on the affinity matrix instead of the elution of proteins and digestion 
in solution or on filters (Hubner et al., 2010). Further developments are necessary to enable 
the enrichment and identification of protein interactions from the lysates of thousands of 
cells. Possible options for enhancements are listed as follows: Firstly, affinity purifications 
can be done with more potent nanobodies, such as the dimer nanobody against GFP (Fridy 
et al., 2014). Secondly, lysis, affinity purification and digestion could be reduced to a single 
well, thereby reducing handling steps, as is common in single-cell genomic workflows. 
Thirdly, purification of proteins and peptides after enrichment can also be optimized, for 
example by using paramagnetic beads that allow for efficient single-tube purification based 
on the binding of proteins and peptides to the hydrophilic surface of these beads in organic 
solvents (Hughes et al., 2014). Eventually, development of microfluidic systems / flow cells for 
(interaction) proteomics purposes (Chao and Hansmeier, 2013; Tan et al., 2013), that incorporate 
the ideas described above, can allow for the experimental steps to be done within a single 
chamber and with minimal handling steps, buffer volumes and contact with plastics. 
Although sample downscaling will be challenging, developments will likely take place in the 
upcoming years that will pave the way to study highly relevant biological systems consisting 
of limited cell numbers.
Concluding remarks
In the last decades, mass spectrometry-based proteomics has revolutionized biological 
research. New technologies and workflows have increased the depth, precision and accuracy 
of the measurements, and the study of protein interactions has greatly benefitted from 
these developments. In this thesis, we used these techniques to study interactions relevant 
to chromatin biology. By comprehensively characterizing chromatin-associated complexes, 
we contributed to the biological knowledge of these complexes. For example, we identified 
different SET1/MLL subcomplexes as well as many H3.1 chaperoning complexes that are 
involved in different biological processes. Additionally, we introduced novel workflows to 
gain extra information on these interactions. By quantifying the abundance of interactions 
we could prioritize them and sensitively quantify their dynamics in different cellular states 
or phenotypes. The use of bioorthogonal chemistry for target purification allowed us to 
develop a flexible enrichment method with minimal structural interference. This method has 
potential to be used for comprehensive PTM identification, crosslinking-MS, and chromatin 
immunoprecipitation (ChIP) applications, amongst other things. With these developments 
we also contributed to the development of the fields of quantitative interaction proteomics 
and molecular biology in general. Technical developments are of invaluable importance, 
because they enable us to answer new biological questions and fuel biological discoveries.
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Samenvatting
Het menselijk lichaam bestaat uit miljarden cellen. Deze cellen zijn niet allemaal hetzelfde, 
maar verschillen in vorm, grootte en functie. Voorbeelden hiervoor zijn de extreme 
verschillen tussen huidcellen, spiercellen en neuronen. Deze specifieke eigenschappen van 
een cel bij elkaar, worden ook wel het fenotype van een cel genoemd. Verschillende soorten 
cellen, ook wel celtypes genoemd, hebben dan ook verschillende fenotypes.
Elke cel bestaat voor een groot gedeelte uit eiwitten. Deze eiwitten zijn te beschouwen 
als de machines van de cel, die de cel hun vorm geven, reacties uitvoeren en zorgen voor 
communicatie. De eiwitten in een cel zijn dus essentieel voor de functie van een cel. De 
eiwitten worden gemaakt aan de hand van een bouwplan, dat staat geschreven in het 
DNA. Het DNA bevat de informatie die nodig is om alle eiwitten te maken en dit wordt de 
genetische informatie genoemd. Om een eiwit te maken, moet het bouwplan dat in het DNA 
staat worden afgelezen en gekopieerd, een proces dat we transcriptie noemen. 
Interessant genoeg bezitten alle cellen van het lichaam dezelfde genetische informatie en 
ze zou zouden in principe dus ook alle eiwitten kunnen maken. Het is echter zo dat het 
DNA wordt opgevouwen om het zo netjes op te slaan in de kern van een cel. Hierdoor 
zijn sommige stukken van het DNA makkelijker en andere stukken lastiger te lezen en te 
kopiëren. Het opvouwen van DNA heeft dus invloed op transcriptie. De eiwitten waarvan 
het bouwplan ligt in de stukken DNA die lastig te lezen zijn, zullen dan ook niet of veel 
minder gemaakt worden. Uiteindelijk is het dus zo dat elk celtype een unieke opvouwing 
van zijn DNA heeft, waardoor een unieke set van eiwitten kan worden gemaakt en dus elk 
celtype zijn unieke fenotype krijgt. 
Het opvouwen van DNA gebeurd met behulp van bepaalde eiwitten, histonen genaamd, en 
de eiwitten en DNA bij elkaar worden chromatine genoemd. In dit proefschrift bestuderen we 
de eiwitten die invloed hebben op het opvouwen van DNA en daardoor ook de transcriptie. 
Deze eiwitten werken vaak samen in groepjes, zogenaamde eiwitcomplexen, en om te 
snappen wat de eiwitten doen moeten we deze complexen kunnen identificeren. Dit doen 
we met behulp van massaspectrometrie, een heel ingenieus en geavanceerd apparaat wat 
het gewicht kan meten van deze eiwitten waardoor we precies weten welke eiwitten het 
zijn.
Hoofdstuk 1 introduceert allereerst chromatine en de veranderingen in het chromatine die 
invloed hebben op transcriptie. Vervolgens wordt er in hoofdstuk 2 een overzicht gegeven 
van de verschillende massaspectrometrie methodes die gebruikt kunnen worden om eiwit-
eiwit interacties te identificeren.
De massaspectrometrie methodes tot nu toe zijn erg goed in het identificeren van eiwit-
eiwit interacties, maar het meten van de hoeveelheid van bepaalde eiwitten is nog erg lastig. 
In hoofdstuk 3 wordt een nieuwe techniek geïntroduceerd waarmee de hoeveelheden van 
alle eiwitten in een bepaald eiwitcomplex kunnen worden gemeten. Nadat deze techniek 
is opgezet, worden eiwitcomplexen bestudeerd die betrokken zijn bij het reguleren van 
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chromatine opvouwing en transcriptie. In hoofdstuk 3 worden eiwitcomplexen bestudeerd 
die voor sterkere opvouwing en lagere transcriptie zorgen, namelijk het PRC2 en NuRD 
complex. In hoofdstuk 4 wordt een familie van eiwitcomplexen, de zogenoemde SET1/MLL 
complexen, bestudeerd die juist voor activatie van transcriptie zorgen in de veel minder 
opgevouwde stukken DNA,. Met behulp van de nieuwe methode werden eiwitten gevonden 
die veel aanwezig zijn in een complex en die zeer waarschijnlijk een belangrijke algemene 
functie uitvoeren in het eiwitcomplex, maar er waren ook eiwitten die weinig aanwezig zijn 
en mogelijk een meer specifieke functie uitvoeren in een klein deel van de complexen.
Om de eiwit-eiwit interacties te bestuderen, zuiveren we altijd eerst het eiwit waar we in 
geïnteresseerd zijn en identificeren vervolgens de eiwitten die aan dit eiwit in het complex 
zitten. Voor het zuiveren van een bepaald eiwit, wordt er vaak een label aan het eiwit gezet. 
Tot nu toe wordt er vaak gebruikt gemaakt van het erg grote label GFP, wat echter voor 
problemen kan zorgen. In hoofdstuk 5 ontwikkelen we daarom een label-techniek die 
gebaseerd is op kleine synthetische moleculen die we in een eiwit zetten. De synthetische 
groep kan vervolgens gebruikt worden om met een zogeheten click-reactie het eiwit te 
verrijken. Om te testen of deze techniek gebruikt kan worden om eiwit-eiwit interacties te 
bestuderen met behulp van massaspectrometrie, wordt een eiwit van het NuRD complex 
met deze scheikundige groep gelabeld. Na zuivering via click-chemie en het meten van de 
eiwitten met massaspectrometrie, blijken we een deel van het NuRD complex op te zuiveren. 
Dit resultaat laat zien dat er nog meer onderzoek nodig is om het gehele eiwitcomplex te 
verrijken, maar laat al wel zien dat de techniek werkt voor het opzuiveren een eiwit naar 
interesse.  
De histon eiwitten, die samen met het DNA chromatine vormen, zijn erg belangrijk voor 
de opvouwing van het DNA. Net voor een celdeling moet het DNA in zijn geheel worden 
gekopieerd, zodat beide cellen een kopie van het DNA krijgen. In dit proces moeten de 
histon eiwitten echter van het DNA worden afgehaald en na het kopiëren er weer netjes 
op worden gezet. Om alle eiwitten te identificeren die bij dit proces betrokken zijn, hebben 
we in hoofdstuk 6 histon H3.1 verrijkt en alle eiwit-eiwit interacties in kaart gebracht. We 
hebben 20 verschillende eiwitcomplexen geïdentificeerd, die verschillende enzymatische 
activiteiten hadden en in uiteenlopende processen betrokken zijn.
Summary
The human body consists of billions of cells. These cells are not all the same, but they differ 
in shape, size and function. This is exemplified by the extreme differences between skin, 
muscle and neuron cells. The specific characteristics of a cell type are termed the phenotype 
(or phenotypes) of this cell. Different cell types thus display different phenotypes.
Every cell consists largely of proteins. These proteins, which shape the cell, catalyze reactions, 
and facilitate communication, are essential for cellular function. Proteins are produced based 
on a blueprint encoded in the DNA, a blueprint which contains all information needed to 
produce all proteins. To produce a protein, the DNA blueprint is read and copied, a process 
known as transcription.
Interestingly, every cell in the body contains the exact same DNA blueprint and should be 
capable of producing all proteins. However, DNA is compacted within the nucleus of a cell 
in order to safely store it. As a consequence, some parts of the DNA are easier to read and 
copy, whereas other parts are less accessible. Thus, the compaction of the DNA influences 
transcription. Proteins that are encoded in compacted and less accessible parts of DNA will 
be produced in far lower amounts, or not at all. DNA is compacted uniquely for every cell 
type, resulting in an unique set of expressed proteins.
DNA is compacted using proteins called histones, and the sum of histone proteins and DNA 
is termed chromatin. In this thesis, I study the proteins that influence the compaction of 
DNA and thereby affect transcription. These proteins often combine and work together in 
so called protein complexes. It is essential to be able to identify these protein complexes in 
order to study their biological function. To this end, we use mass spectrometry, an advanced 
instrument able to identify proteins by precisely measuring their mass. 
In chapter 1, chromatin and chromatin modifications that influence transcription are 
introduced. Next, chapter 2 presents an overview of different mass spectrometry methods 
that can be used to identify protein-protein interactions.
Current mass spectrometry methods robustly identify protein-protein interactions; 
however, they cannot be used to determine exact amounts of protein present. In chapter 
3, a novel technique is introduced that can  measure the amounts of all proteins present in 
a protein complex. After establishing this method, protein complexes involved in chromatin 
compaction and transcriptional regulation are studied . In chapter 3, protein complexes that 
compact chromatin and repress transcription, namely the PRC2 and NuRD complexes, are 
studied. In chapter 4, a family of protein complexes that activates transcription at loosely 
compacted part of chromatin, the so called SET1/MLL complexes, is characterized. Using 
this novel method, we were able to identify proteins present in large amounts that likely 
have important general functions within the complex as well as proteins present in low 
amounts which likely have more specialized functions in a subset of the complexes.
In order to detect protein-protein interactions, we always purify our protein of interest in 
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order to identify all proteins that co-purify with that specific protein. Typically, the protein of 
interest is labeled in order to purify it. The most commonly used tag is the large protein GFP, 
which can disrupt protein function. Therefore, we develop a labeling technique in chapter 
5 that is based on very small chemical molecules that can be specifically incorporated into 
a protein of interest. This chemical group can subsequently be used to enrich the protein 
using so-called “click” chemistry. To validate whether this technique could be used to study 
protein-protein interactions, a subunit of the NuRD complex was tagged with this chemical 
molecule. The click chemistry-based purification of this protein and subsequent protein 
identification using mass spectrometry indicated a partial enrichment of the NuRD complex. 
Though this result emphasizes the need to further develop this enrichment approach, it 
nonetheless indicates that the approach is useful for purification of a protein of interest.
Histones, which together with DNA form chromatin, are crucial for proper compaction 
of DNA. DNA is duplicated just before mitosis such that both daughter cells have a single 
copy of the DNA blueprint. In this duplication process, histones are evicted from DNA and 
afterwards inserted again. In chapter 6, in an effort to characterize all proteins involved 
in this process, we purified histone H3.1 and comprehensively identified protein-protein 
interactions. We identified 20 different protein complexes handling histone H3.1, most 
of which contain different enzymatic activities and are likely involved in a wide variety of 
processes.
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 “There is nothing in the world so irresistibly contagious
as laughter and good humor.”
― Charles Dickens, A Christmas Carol
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